REQUEST FOR QUALIFICATION (RFQ) CUM …dghealth.up.nic.in/PDF/RFQ cum RFP-890-19-04-2017.pdfno liability to any person, including any Bidder under any law, statute, rules or regulations

RFP for Empanelment of Approved Analytical Testing Laboratories for Analysis of Drugs, Surgical & Sutures Items

1 | P a g e

REQUEST FOR QUALIFICATION (RFQ) CUM REQUEST FOR PROPOSAL (RFP) BID DOCUMENT


PART I – INSTRUCTION TO BIDDERS

RFP Reference: RFQ cum RFP - 890

Directorate of Medical & Health Services, Uttar Pradesh

Director, CMSD Swasthya Bhawan, Kaisarbagh, Lucknow (Uttar Pradesh) India Phone & Fax: 0522- 2625809

Website: www.uphealth.up.nic.in & www.dghealth.up.nic.in

Email: [email protected]

12th April, 2017


2 | P a g e

This page has been intentionally left blank.


3 | P a g e

Glossary

S. No. Item Abbreviation Description or Definitions / Interpretations

1. Arbitrator Dispute resolving Authority – Arbitrator Tribunal shall consist of Three Arbitrators.

2. AERB Atomic Energy Regulation Board

3. Bidder A Sole Bidder or Principal Bidder in case of a Consortium.

4. Associate A person who controls, is controlled by, or is under the common control with such Bidder (as used in this definition, the expression “control” means, with respect to a person which is a company or corporation, the ownership, directly or indirectly, of at least 51% (fifty one per cent) of the voting shares of such person, and with respect to a person which is not a company or corporation, the power to direct the management and policies of such person, by operation of law ).

5. CMS Central Medical Superintendent

6. Contract Signing Authority

Director General Medical and Health, Department of Medical Health & Family Welfare, Government of Uttar Pradesh

7. DD Demand Draft

8. DGMH Director General Medical and Health, Department of Medical Health & Family, Government of Uttar Pradesh

9. EMD Earnest Money Deposit or Bid Security

10. FD Fixed Deposit

11. GLP Good Laboratory Practices

12. LLP Limited Liability Partnership

13. NHM National Health Mission

14. Nodal Authority


15. Paying Authority


16. POA Power of Attorney

17. OPC One person company

18. RFP Request for Proposal

19. RFQ Request for Qualification


4 | P a g e

This page has been intentionally left blank.


5 | P a g e

Table of Contents

Table of Contents ......................................................................................................................... 5

1 RFP for Empanelment of Approved Analytical Testing Laboratories for Analysis of Drugs,

Surgical & Sutures Items .............................................................................................................. 6

1.1 Disclaimer ................................................................................................................................ 6

1.2 Notice Inviting Bid and Bid Data Sheet .................................................................................... 8

1.3 Structure of the RFP ................................................................................................................. 8

1.4 Background Information .......................................................................................................... 9

1.5 Instructions to the Bidders .................................................................................................... 10

1.6 Criteria for Evaluation ............................................................................................................ 19

1.7 Empanelment Process ........................................................................................................... 20

1.8 Scope of Work ........................................................................................................................ 23

1.9 Payment Terms ...................................................................................................................... 25

1.10 Other Terms and Conditions of the RFP and Contract .......................................................... 26

1.11 Conflict of Interest ................................................................................................................. 28

1.12 Damages for Mishap/Injury ................................................................................................... 30

1.13 Termination of Contract ........................................................................................................ 30

1.14 Arbitration ............................................................................................................................. 31

Appendix A: Forwarding Letter .......................................................................................................... 33

Appendix B: Bidder’s Information ..................................................................................................... 35

Appendix C: Performance Statement ................................................................................................ 37

Appendix D: Personnel Details .......................................................................................................... 38

Appendix E: List of Equipment/Instrument/Apparatus available in Lab ........................................... 39

Appendix F: Microbiological Facilities ............................................................................................... 40

Appendix G: Declaration by the Bidder ............................................................................................. 41

Appendix H: Litigation Declaration Proforma.................................................................................... 43

Appendix I: Proforma for Bank Guarantee for EMD & Performance Security .................................. 44

Format for Bank Guarantee for Earnest Money Deposit (EMD) ....................................................... 44

Format for Bank Guarantee for Performance Security ..................................................................... 45

Appendix J: Format for Power of Attorney for Signing of Proposal .................................................. 48

Appendix K: Financial Bid ................................................................................................................... 50


6 | P a g e

RFP FOR EMPANELMENT OF APPROVED ANALYTICAL TESTING LABORATORIES

FOR ANALYSIS OF DRUGS, SURGICAL & SUTURES ITEMS

1 RFP for Empanelment of Approved Analytical Testing Laboratories for

Analysis of Drugs, Surgical & Sutures Items

1.1 Disclaimer

The information contained in this Request for Qualification cum Request for Proposal document

(hereafter referred as the “RFP”) or subsequently provided to Bidder(s), whether verbally or in

documentary or any other form by or on behalf of the Nodal Authority or any of its employees or

advisors, is provided to Bidder(s) on the terms and conditions set out in this RFP and such other

terms and conditions subject to which such information is provided.

This RFP is not an agreement and is neither an offer nor invitation by the Nodal Authority to the

prospective Bidder(s) or any other person. The purpose of this RFP is to provide interested parties

with information that may be useful to them in submitting Bids pursuant to this RFP. This RFP

includes statements, which reflect various assumptions and assessments arrived at by the Nodal

Authority in relation to the Projects. Such assumptions, assessments and statements do not purport

to contain all the information that each Bidder may require. This RFP may not be appropriate for all

persons, and it is not possible for the Nodal Authority, its employees or advisors to consider the

investment objectives, financial situation and particular needs of each party who reads or uses this

RFP. The assumptions, assessments, statements and information contained in the Bidding

Documents may not be complete, accurate, adequate or correct. Each Bidder should, therefore,

conduct its own investigations and analysis and should check the accuracy, adequacy, correctness,

reliability and completeness of the assumptions, assessments, statements and information

contained in this RFP and obtain independent advice from appropriate sources.

Information provided in this RFP to the Bidder(s) is on a wide range of matters, some of which may

depend upon interpretation of law. The information given is not intended to be an exhaustive

account of statutory requirements and should not be regarded as a complete or authoritative

statement of law. The Nodal Authority accepts no responsibility for the accuracy or otherwise for

any interpretation or opinion on law expressed herein.

The Nodal Authority, its employees and advisors make no representation or warranty and shall have

no liability to any person, including any Bidder under any law, statute, rules or regulations or tort,

principles of restitution or unjust enrichment or otherwise for any loss, damages, cost or expense

which may arise from or be incurred or suffered on account of anything contained in this RFP or

otherwise, including the accuracy, adequacy, correctness, completeness or reliability of the RFP and

any assessment, assumption, statement or information contained therein or deemed to form part of

this RFP or arising in any way for participation in this Bid Stage.


7 | P a g e

The Nodal Authority also accepts no liability of any nature whether resulting from negligence or

otherwise howsoever caused arising from reliance of any Bidder upon the statements contained in

this RFP.

The Nodal Authority may in its absolute discretion, but without being under any obligation to do so,

update, amend or supplement the information, assessment or assumptions contained in this RFP.

The issue of this RFP does not imply that the Nodal Authority is bound to select a Bidder or to

appoint the Selected Bidder for the Projects and the Nodal Authority reserves the right to reject all

or any of the Bidders or Bids without assigning any reason whatsoever.

The Bidder shall bear all its costs associated with or relating to the preparation and submission of its

Bid including but not limited to preparation, copying, postage, delivery fees, expenses associated

with any demonstrations or presentations which may be required by the Nodal Authority or any

other costs incurred in connection with or relating to its Bid. All such costs and expenses will remain

with the Bidder and the Nodal Authority shall not be liable in any manner whatsoever for the same

or for any other costs or other expenses incurred by a Bidder in preparation or submission of the Bid,

regardless of the conduct or outcome of the Bidding Process.

The statements and explanations contained in this RFP are intended to provide a better

understanding to the Bidders about the subject matter of this RFP and should not be construed or

interpreted as limiting in any way or manner the scope of work and obligations of the Service

Provider set forth in the Service Agreement or the Nodal Authority’s rights to amend, alter, change,

supplement or clarify the scope of work or the Project, to be awarded pursuant to this RFP.

Consequently, any omissions, conflicts or contradictions in the Bidding Documents including this RFP

are to be noted, interpreted and applied appropriately to give effect to this intent, and no claims on

that account shall be entertained by the Nodal Authority.


8 | P a g e

1.2 Notice Inviting Bid and Bid Data Sheet

Director General Medical and Health, Department of Medical Health & Family Welfare,

Government of Uttar Pradeshhereinafter known as the Nodal Authority, invites RFQ cum RFP from

eligible Analytical Testing Laboratories situated in situated in Uttar Pradesh and neighboring

states/UTs – Delhi, Haryana, Madhya Pradesh, Himachal Pradesh, Uttarakhand, Rajasthan, Punjab,

Chandigarh, Bihar , Jharkhand and Chhattisgarhfor analysis of Drugs, Surgical & Sutures Item.

The bidders are being provided with this Bid Data Sheet (BDS) comprising of important, factual data

on the bid.

S. No. Description Schedule

1. Date of Sale of Bid documents - Opens 20th April, 2017

2. Website for download of Bid Documents http://dghealth.up.nic.in http://uphealh.nic.in

3. Cost of Bid Enquiry document Cost of Bid Enquiry document will be non-refundable fee of Rs. 60375/- (Rupees Sixty Thousand , three hundred and Seventy Five Only).

4. Pre-Bid meeting date and time 27th April, 2017at 12:00 hours

5. Pre-Bid meeting venue. OFFICE OF THE DIRECTOR GENERAL MEDICAL & HEALTH U.P LUCKNOW (C.M.S.D. Section)

6. Closing date and time of receipt of Bid 25thMay, 2017at 12:00 hours

7. Time, date and venue of opening of Technical Bid

25thMay , 2017 at 14:30 hoursat OFFICE OF THE DIRECTOR GENERAL MEDICAL & HEALTH U.P LUCKNOW (C.M.S.D. Section)

8. EMD (Earnest Money Deposit) Rs 200,000/- (Rupees two lakhs only)

9. Bid Parameter(s) Rates for complete analysis of one sample of each product, exclusive of Service Tax

10. Performance Security Rs 500,000/- (Rupees Five Lakhs only)

1.3 Structure of the RFP

This Request for Proposal (RFP) document issued by the Nodal Authority –Director General Medical

and Health, Department of Medical Health & Family Welfare, Government of Uttar Pradeshfor the

Empanelment of Approved Analytical Testing Laboratories for Analysis of Drugs, Surgical & Sutures

Items, comprises of the following.

1.3.1 Instructions on the Bid process.

The Instructions on the Bid Process for the purpose of responding to this RFP are, a) General instructions to Bidders for bidding process (Section 1.5) b) Bid evaluation process including the parameters for Bid Qualification, Technical

responsiveness evaluation and financial evaluation to facilitate Nodal Authority in determining bidder’s suitability as the Service Provider (Section 1.6)

http://dghealth.up.nic.in/


9 | P a g e

c) Empanelment process (Section 1.7) d) Payment Terms (Section 1.9) e) Bid submission document formats (Appendix A, B, C, D, E, F, G, H, I, J & K)

1.3.2 Delivery Requirements of the project.

The contents of the document broadly cover the following areas, a) About the project and its objectives (Section 1.4) b) Scope of work for the Service Provider (Section 1.8) c) Service requirements for the Service Provider (Section 1.8)

The bidder is expected to respond to the requirements as completely and in as much relevant detail

as possible, and focus on demonstrating bidder’s eligibility to become Service Provider of the Nodal

Authority.

The bidders are expected to examine all Instructions, Forms, Terms, Project requirements and other

information in the RFP documents. Failure to furnish all information required as mentioned in the

RFP documents or submission of a Bid not substantially responsive to the RFP documents in every

respect will be at the Bidder's risk and may result in rejection of the Bid.

1.4 Background Information

1.4.1 Basic Information

1.4.1.1 Nodal Authority, Director General Medical and Health, Department of Medical Health &

Family Welfare, Government of Uttar Pradeshinvites responses (“Bids”) to this Request

for Qualification cum Request for Proposals (“RFP”) from Service Providers (“Bidders”) for:

Empanelment of Approved Analytical Testing Laboratories for Analysis of Drugs,

Surgical & Sutures Items as per details in Appendix K

Details arealso further described under Section 1.8 of this RFP document.

1.4.1.2 Any contract that may result from this Government procurement process will be issued for

a term of 01 (One) years (“the Term”).

1.4.1.3 The Nodal Authority reserves the right to extend the Term for a period of 06 (six) months

on the same terms and conditions, or those mutually agreed between the Nodal Authority

and Selected Bidder / Service Provider, subject to the Nodal Authority’s obligations at law.

1.4.1.4 Bids must be received not later than time, date and at the venue mentioned in the Bid

Data Sheet. Bids that are received late will be rejected.

1.4.2 Project Background


10 | P a g e

Currently, at the time of supply, the vendor is required to supply a Certificate of Analysis for each

batch of Drug, Surgical or Suture item, tested at a third party NABL accredited laboratory.

Post distribution, the state Food & Drug Administration (FDA) takes random samples for testing at

various stocking points (District Hospital, District Warehouse, Health Facility). The sample is sent to

FDA drug testing laboratory for detailed testing. In case of Quality failure, the entire batch is

returned to the supplier.

Going forward, in addition to the existing process, at the time of receipt of every batch of Drug,

Surgical or Suture items, the state plans to conduct analytical tests through approved analytical

testing laboratories. The state would like to empanel approved analytical testing laboratories for

this.

1.5 Instructions to the Bidders

1.5.1 General Instructions

1.5.1.1 The bidder shall prepare and submit its offer as per instructions given under this Section

1.5.

1.5.1.2 The bids shall be complete with all documents. Those submitted by fax or by email with

attachments shall not be considered.

1.5.1.3 The price quoted shall be firm and shall be quoted in the format as per attached Appendix

Konly.

1.5.1.4 The bids (comprising of Technical and Financial) shall be submitted (with a Forwarding

Letter as per Appendix A) before the last date of submission. Late bids shall not be

considered.

1.5.1.5 All information supplied by Bidders may be treated as contractually binding on the Bidders,

on successful award of the assignment by the Nodal Authority on the basis of this RFP.

1.5.1.6 No commitment of any kind, contractual or otherwise shall exist unless and until a formal

written contract has been executed by or on behalf of the Nodal Authority. Any

notification of preferred bidder status by the Nodal Authority shall not give rise to any

enforceable rights by the Bidder. The Nodal Authority may cancel this public procurement

at any time prior to a formal written contract being executed by or on behalf of the Nodal

Authority.


11 | P a g e

1.5.1.7 This RFP and its contents supersedes and replaces any previous public documentation &

communications on this RFP and its process, and Bidders should place no reliance on such

communications.

1.5.1.8 Right to Terminate the Process

1.5.1.8.1 Nodal Authority may terminate the RFP process at any time and without assigning any

reason. Nodal Authority makes no commitments, express or implied, that this process

will result in a business transaction with anyone.

1.5.1.8.2 This RFP does not constitute an offer by Nodal Authority. The bidder's participation in

this process may result Nodal Authority selecting the bidder to engage towards execution

of the contract.

1.5.2 Compliant Bids / Completeness of Response

1.5.2.1 Bidders are advised to study all Instructions, Forms, Terms, Requirements and other

information in the RFP documents carefully. Submission of the bid shall be deemed to have

been done after careful study and examination of the RFP document with full

understanding of its implications.

1.5.2.2 Failure to comply with the requirements of this paragraph may render the bid non-

compliant and the bid may be rejected. Bidders must:

1.5.2.2.1 Follow the format of this RFP and respond to each element in the order and form as set

out in this RFP

1.5.2.2.2 Comply with all requirements as set out within this RFP.

1.5.3 Pre-Bid Meeting & Clarifications

1.5.3.1 The Nodal Authority will conduct a pre-bid meeting with the interested /prospective

bidders as mentioned in Bid Data Sheet.

1.5.3.2 The Nodal Authority may modify the RFP by issuing a Corrigendum before the Proposal

Due Date. Any Corrigendum thus issued shall be part of the RFP and shall be uploaded on

the following website: www.uphealth.up.nic.in & www.dghealth.up.nic.in

1.5.3.3 To give prospective Bidders reasonable time in which to take Corrigendum into account in

preparing their bids, the Nodal Authority may, at its sole discretion, extend the Proposal

Due Date.


12 | P a g e

1.5.4 Key Requirements of the Bid

1.5.4.1 RFP Document Fees

1.5.4.1.1 RFP document can be downloaded from www.uphealth.up.nic.in &

www.dghealth.up.nic.in

1.5.4.1.2 The bidder will submit non-refundable fee of amount as specified in Bid Data Sheet in the

form of account payee Demand Draft, drawn on a scheduled bank in India, in favour of

Director General of Medical & Health Services, Uttar Pradesh payable at Lucknow. The

demand draft of RFP document fees should be submitted along with bids.

1.5.4.1.3 Cost of RFP / Bid Enquiry document will be non-refundable fee of amount as specified in

Bid Data Sheet even if a bidder opts to bid for empanelment for conducting analytical

tests for more than one Drug, Surgical or Suture Item.

1.5.4.2 Earnest Money Deposit (EMD)

1.5.4.2.1 Bidders shall submit, along with their Bids, EMD of of amount as specified in Bid Data

Sheet. EMD should be in the form of a Fixed Deposit or Bank Guarantee (in the format

specified in Appendix I) issued by any Nationalized/Scheduled Indian bank in favor of

Director General of Medical & Health Services, Uttar Pradesh, Lucknow.

1.5.4.2.2 Amount to be furnished as EMD shall be as specified in Bid Data Sheeteven if a bidder

opts to bid for empanelment for conducting analytical tests for more than one Drug,

Surgical or Suture Item.

1.5.4.2.3 No bidding entity is exempt from deposit of EMD along with its bid. Bids submitted by

bidders without EMD shall be rejected.

1.5.4.2.4 The EMD of unsuccessful bidder will be returned to them without any interest, within 30

days after the signing of agreement with the successful bidder.

1.5.4.2.5 The EMD of the successful bidder will be returned without any interest, after receipt of

its Performance Security as per the terms of the Contract.


13 | P a g e

1.5.4.2.6 EMD of a bidder may be forfeited without prejudice to other rights of the Nodal

Authority, if the bidder withdraws or amends its bid or impairs or derogates from the bid

in any respect within the period of validity of its bidor if it comes to notice that the

information /documents furnished in its bid is incorrect, false, misleading or forged. In

addition to the aforesaid grounds, the Successful Bidders’ EMD will also be forfeited

without prejudice to other rights of Nodal Authority, if it fails to furnish the required

Performance Security within the specified period or fails to sign the contract in

accordance with this RFP.

1.5.4.3 Submission of Bids

The Bidder shall submit the bid in One Large Envelope superscripted with Bid Reference Number

along with Name and Communication Address of the Bidder. The bid shall be made in 2 (Two)

SEPARATE SEALED ENVELOPES, all placed within the large envelope, each superscripted with Bid

Reference Number along with Name and Communication Address of the Bidder. The original bid

documents are as given below:

1.5.4.3.1 The First Sealed Envelope shall be the Technical Bid, having all documentation spirally

bound, numbered on each page, and shall be marked in bold letter as “TECHNICAL BID”.

It MUST comprise of the following for eligibility:

1.5.4.3.1.1 Forwarding Letter as per “Appendix A”, confirming performing the assignment and

confirmation regarding furnishing Performance Security in case of Award of Contract.

To be furnished by Bidder on their Letterhead

1.5.4.3.1.2 Bid Cost Receipt/ Demand Draft towards the cost of Bid document to be attached in

case bid document has been downloaded from website www.uphealth.up.nic.in &

www.dghealth.up.nic.in

To be submitted by Bidder

1.5.4.3.1.3 EMD in the form of Fixed Deposit Receipt / Bank Guarantee as per “Appendix I”. Refer

“Appendix I” - Format of Bank Guarantee for EMD for the required validity period.

To be submitted by Bidder

1.5.4.3.1.4 Particulars of the bidder as per “Appendix B”.

To be furnished by Bidder on their Letterhead along with the following documents.

1.5.4.3.1.4.1 Copy of the Certificate of Registration of CST, VAT and Service Tax, as applicable

under the provisions of Law, with the concerned Authority, valid as on date of

submission of Bid documents. In case of non-applicability of any of the

mentioned certifications of registration, the Bidder shall provide a Declaration on

its letter-head stating provisions under law for exemption.


14 | P a g e

1.5.4.3.1.5 Copy of Analytical approval (Form 37) duly renewed up to date, issued by the State

Licensing Authority.

To be furnished by Bidder

1.5.4.3.1.6 Copy of certificate indicating compliance to Schedule L-1 of Drugs & Cosmetics Rules,

1945 (GLP certificate) and Copy of accreditation from National Accreditation Board

withproper scope to undertake testing of drugs, surgical and sutures.


1.5.4.3.1.7 Documentary evidence of having analyzed Drugs /Surgical / Sutures during the last

three years as per“Appendix C”


1.5.4.3.1.8 Details of Bidder’s Laboratoryalong with supporting proofs/documents. The following

details should be included:

1.5.4.3.1.8.1 The list of personnel employed in the laboratory along with proof of their

qualifications and relevant approvals as per “Appendix D”

1.5.4.3.1.8.2 The list of instruments available in the laboratory as per “Appendix E”

1.5.4.3.1.8.3 Micro Biological facilities available in the laboratory as per “Appendix F”

1.5.4.3.1.8.4 List of Reference Samples along with their date of procurement and

quantities.

1.5.4.3.1.8.5 Any other relevant details of the laboratory


1.5.4.3.1.9 A Duly notarized declaration from the Bidder in the format given in “Appendix G” to the

effect that the firm has neither been declared as defaulter nor blacklisted/debarred by

any Competent Authority of Government of India or its Organizations or Government of

any State or its Organizations or any PSU and should MANDATORILY make a declaration

in case it has been, in the past or present, directly involved or been a party to any

previous / ongoing CBI litigation or litigations involving criminal indictment / offence in

a Court of Law. Refer proforma in “Appendix H”.

To be furnished by the Bidder on a Non – Judicial Stamp Paper of Rs. 100 duly attested by Executive Magistrate / Public Notary

1.5.4.3.1.10 A Duly notarized valid Power of Attorney in favour of signatory to submitted bid

documents, as per the Board Resolution or applicable provisions under Articles and

Memorandum of Association. Refer “Appendix J” for Proforma for Power of Attorney.

To be furnished by the Bidder on a Non – Judicial Stamp Paper of Rs. 100 duly attested by Executive Magistrate / Public Notary


15 | P a g e

1.5.4.3.2 The Second Sealed Envelope shall contain the financial Bid and shall be marked in bold

letters as “FINANCIAL BID”. The rates quoted should be inclusive of all taxes but exclusive

of service tax and shall be mentioned in the format as per attached “Appendix K” only. A

compact disc (CD) with Appendix K in excel and pdf format should also be enclosed.

To be furnished by Bidder on their Letterhead

1.5.4.3.3 The Bidder’s Bid shall contain no interlineations or overwriting except as necessary to

correct errors, in which cases such correction must be initialed by the person or persons

signing the bid.

1.5.4.3.4 In case of discrepancy in the quoted prices, the price written in words will be considered

as final and valid.

1.5.4.3.5 Please Note that Prices should not be indicated in the Technical Bid but should only be

indicated in the Financial Bid.

1.5.4.3.6 The outer (larger) envelope thus prepared should also indicate clearly the name, address,

telephone number, E-mail ID and fax number of the bidder to enable the Bid to be

returned unopened in case it is declared "Late".

1.5.4.3.7 All the pages of the Bid must be sequentially numbered and must contain the list of

contents with page numbers. Any deficiency in the documentation may result in the

rejection of the Bid.

1.5.4.3.8 The Original Bid shall be prepared in indelible ink. It shall contain no interlineations or

overwriting, except as necessary to correct errors made by the bidder itself. Any such

corrections must be initialed by the person (or persons) who sign(s) the Bids.

1.5.4.3.9 Cover Page and Forwarding Letter of the bid shall be initialed and stamped by the person

or persons who sign the bid.

1.5.4.4 Bid Preparation Costs

The bidder shall be responsible for all costs incurred in connection with participation in the RFP

process, including, but not limited to, costs incurred in conduct of informative and other diligence

activities, participation in meetings/discussions/presentations, preparation of Bid, in providing any

additional information required by Nodal Authority to facilitate the evaluation process, and in

negotiating a definitive contract or all such activities related to the bid process.

Nodal Authority will in no case be responsible or liable for those costs, regardless of the conduct or

outcome of the bidding process.


16 | P a g e

1.5.4.5 Language

The Bid should be filled by the Bidder in English language only. If any supporting documents

submitted are in any language other than English, translation of the same in English language is to be

duly attested by the Bidders. For purposes of interpretation of the Bid, the English translation shall

govern.

1.5.4.6 Late Bids

1.5.4.6.1 Bids received after the due date and the specified time (including the extended period if

any) for any reason whatsoever, shall not be entertained and shall be returned

unopened.

1.5.4.6.2 The bids submitted by telex/telegram/fax/e-mail etc. shall not be considered. No

correspondence will be entertained on this matter.

1.5.4.6.3 Nodal Authority shall not be responsible for any postal delay or non-receipt/ non-delivery

of the documents. No further correspondence on the subject will be entertained.

1.5.4.6.4 Nodal Authority reserves the right to modify and amend any of the above-stipulated

condition/criterion depending upon project priorities vis-à-vis urgent commitments.

1.5.5 Evaluation Process

1.5.5.1 Nodal Authority will constitute a BidEvaluation Committee to evaluate the responses of

the bidders.

1.5.5.2 The bids will be scrutinized by the Bid Evaluation Committee appointed by the Nodal

Authority to determine whether they are complete and meet the essential and important

requirements, conditions set out by this RFP and whether the bidder is eligible and

qualified as per criteria laid down in the Bid Enquiry Documents. The bids, which do not

meet the aforesaid requirements and/or do not provide requisite supporting documents /

documentary evidence required to meet eligibility criteria are liable to be treated as non-

responsive and may be ignored or rejected.

1.5.5.3 The decision of the Nodal Authority as to whether the bidder is eligible and qualified or not

and whether the bid is responsive or not shall be final and binding on the bidders. No

correspondence will be entertained outside the process of negotiation/ discussion with the

Bid Evaluation Committee.

1.5.5.4 Financial bids of only those bidders, who qualify on technical bid, will be considered and

opened.

1.5.5.5 The Bid Evaluation Committee may co-opt representatives of one or more relevant

Departments Agencies/Entities as may be deemed necessary.


17 | P a g e

1.5.5.6 The Bid Evaluation Committee may ask for meetings with the Bidders to seek clarifications

on their Bids

1.5.5.7 The Bid Evaluation Committee reserves the right to reject any or all Bids on the basis of any

deviations.

1.5.5.8 Bid Opening

1.5.5.8.1 The Bids submitted up to on or before stipulated date and time, as indicated in Bid Data

Sheet, will be opened at office of the director general medical & health u.p lucknow

(c.m.s.d. section) as per date and time indicated in Bid Data Sheet, by Selection

Committee and/or Nodal Authority or any other Officer(s) authorized by Nodal

Authority, in the presence of such of those Bidders or their representatives who may be

present at the time of opening.

1.5.5.8.2 The representatives of the bidders should be advised to carry the identity card or a letter

of authority from their respective bidding firms to identify their bonafides for attending

the opening of the Bid.

1.5.5.9 Bid Validity

The bids shall remain valid for acceptance for a period of 120 days from the opening of Price Bid

which will be opened within 180 days from the date of opening of Technical Bid, i.e. total bid validity

shall be 300days. The Nodal Authority may request the bidder to extend the bid validity (If required )

before expiry of bid validity period as deemed fit. Contract will be valid for duration of 01 (one) Year.

The Nodal Authority reserves the right to extend the Term for a period of 06 (six) months on the

same terms and conditions, or those mutually agreed between the Nodal Authority and Selected

Bidder / Service Provider, subject to the Nodal Authority’s obligations at law.

1.5.5.10 BidScrutiny

1.5.5.10.1 Initial Bid scrutiny will be held and incomplete details as given below will be treated as

non-responsive. If Bids

1.5.5.10.1.1 Are not submitted in as specified in the RFP document

1.5.5.10.1.2 Received without the Letter of Authorization (Power of Attorney)

1.5.5.10.1.3 Are found with suppression of details

1.5.5.10.1.4 With incomplete information, subjective, conditional offers and partial offers submitted

1.5.5.10.1.5 Submitted without the documents requested, as set out under Section 1.5

1.5.5.10.1.6 Have non-compliance with any of the clauses stipulated in the RFP

1.5.5.10.1.7 With lesser validity period


18 | P a g e

1.5.5.10.2 All responsive Bids will be considered for further processing as below:

Nodal Authority will prepare a list of responsive bidders, who comply with all the Terms

and Conditions of this bid. All eligible bids will be considered for further evaluation by a

Selection Committee according to the Evaluation process defined in this RFP document.

The decision of this Committee will be final in this regard.

1.5.5.10.3 Evaluation for Eligibility: The bids will be evaluated for Eligibility to bid based on

documents submitted. The following documents will be examined:

1.5.5.10.3.1 Bid Document Cost, EMD (Appendix I) – Non submission of these documents will lead to

summary rejection of the bid and the bid will not be evaluated further. In case the

bidder is eligible for exemption of EMD, DOCUMENTARY EVIDENCE FOR EXEMPTION OF

EMD needs to be submitted.

1.5.5.10.3.2 Submission of Eligibility Documents with respect to Technical Eligibility requirement as

provided under Section 1.6.1.

Non submission of Technical Eligibility documents will lead to the rejection of the bids.

1.5.5.10.4 Technical Evaluation of the bids- The eligible bidders will then be evaluated for Technical

responsiveness as indicated in Section 1.6.1

1.5.5.10.5 The Technically Responsive Bidders may be then asked for opening of Financial Bid. The

Financial bid evaluation will be based on the relevant stated Bid parameter (Rate for

complete analysis of one sample of each product, exclusive of Service Tax). Any

conditional bid, deviating from the bid conditions, will be rejected.

1.5.5.10.6 The Financial Bids of technically qualified/responsive bidders will be opened and after

scrutiny thereof, including inspection of the laboratory, if required, the acceptable rates

for analysis will be decided and communicated.

1.5.5.11 Infirmity / Non-Conformity

The Nodal Authority may waive minor infirmity and/or non-conformity in a bid, provided it does not

constitute any material deviation. The decision of the Nodal Authority as to whether the deviation is

material or not, shall be final and binding on the bidders.

1.5.5.12 Bid Clarification

Wherever necessary, the Nodal Authority may, at its discretion, seek clarification from the Bidders

seeking response by a specified date. If no response is received by this date, the Nodal Authority

shall evaluate the offer as per available information.


19 | P a g e

1.6 Criteria for Evaluation

1.6.1 Technical Qualification Criteria

1.6.1.1 The Bidder shall be a sole provider (Company including OPC

/Society/Trust/LLP/Partnership) The Service Provider should be registered as a legal entity

such as company registered under Companies Act, Partnership Act, Societies Registration

Act, Trust Act or an equivalent law applicable in the region/state/ country.

1.6.1.2 The analytical testing laboratory shall be situated in Uttar Pradesh and neighboring

states/UTs – Delhi, Haryana, Madhya Pradesh, Himachal Pradesh, Uttarakhand, Rajasthan,

Punjab, Chandigarh, Bihar , Jharkhand and Chhattisgarh.

1.6.1.3 The analytical testing laboratory of the Bidder should be approved under Rule 150B of

Drugs & Cosmetics Act, 1940 and follows all rules under it for the testing of Drugs and

medical devices

1.6.1.4 The analytical testing laboratory of the Biddershould be accredited with National

Accreditation Board, New Delhi for testing of Drugs, Surgical and Suture Items with proper

scope of accreditionand should comply with Schedule L-1 of Drugs and Cosmetic Rules,

1945 (GLP Certificate).

1.6.1.5 The analytical testing laboratory of the Bidder should have a minimum three years of

experience of testing of similar products. Documentary evidence of having analyzed Drugs

/Surgical / Sutures for the last three years with a statement in the Proforma as given in

Appendix C (The decision of the Nodal Authority as to whether the assignment is similar or

not and whether the bidders possess required experience or not, shall be final and binding

on the bidders.)

1.6.1.6 The license of the analytical testing laboratory of the Bidder shouldnot have been

suspended during last three years on account of misreporting. (Appendix G).

1.6.1.7 The analytical testing laboratory of the Bidder should have minimum two functional HPLCs.

1.6.1.8 The Bidders are not blacklisted by the Nodal Authority or by any State Govt. or its

organizations by Govt. of India or its organizationsin last three years (Appendix G).

1.6.1.9 The bidder shall declare all ongoing CBI/criminal litigations it is involved in with any

Government Agency/ State/Central departmentin last three years (Appendix G).

1.6.1.10 Neither the firm nor its personnel should have been convicted in last three years under the

provisions of Drugs and cosmetics Acts, 1940 or Rules framed there under (Appendix G)


20 | P a g e

1.6.1.11 Bidder should not have been involved in theft or in non-payment of government dues or

taxes in last three years (Appendix G).

1.6.2 Technically Responsive Bid(s)

All bids meeting the criteria set out in Section 1.6.1 shall be considered as Technically Responsive

and eligible for Financial Bid opening.

1.6.3 Financial Bid Evaluation

1.6.3.1 The Financial Bids of technically qualified/responsive bidders will be opened and after

scrutiny thereof, including inspection of the laboratory, if required, the acceptable rates for

analysis will be decided and communicated to technically qualified bidders.

1.6.3.2 The Financial bid evaluation will be based on the relevant stated Bid parameter (Rate for

complete analysis of one sample of each product, exclusive of service tax). Any conditional

bid, deviating from the bid conditions, will be rejected.Rate quoted by the bidder should

be for complete analysis of the product and not for individual tests that might have to be

performed. List of products is indicated in Appendix K

1.6.3.3 The price quoted shall be firm and shall be quoted in the format as per attached Appendix

K only.

1.6.3.4 Errors & Rectification: Arithmetical errors will be rectified on the following basis: “If there

is a discrepancy between the unit price and the total price that is obtained by multiplying

the unit price and quantity, the unit price shall prevail and the total price shall be

corrected. If there is a discrepancy between words and figures, the amount in words will

prevail”.

1.7 Empanelment Process

1.7.1 Right to Accept Any Bid and to Reject Any or All Bid(s)

Nodal Authority reserves the right to accept or reject any Bid, and to annul the bidding process /

Public procurement process and reject all Bids at any time prior to award of contract, without

thereby incurring any liability to the affected bidder or bidders or any obligation to inform the

affected bidder or bidders of the grounds for Nodal Authority action.

1.7.2 Notification of Award


21 | P a g e

1.7.2.1 All the technically qualified bidders shall be invited to match the rate quoted by L1 bidder

and on agreement they shall also be empaneled.

1.7.2.2 The Nodal Authority shall issue the Notice for Award or Letter of Intent/Award of the

Contract to the successful bidder within the bid validity period.

1.7.2.3 The successful bidder will be required to sign and submit the contract unconditionally

within 21 days of receipt of such communication.

1.7.2.4 The Letter of Award (LOA / LOI) will be issued by Director General Medical and Health,

Department of Medical Health & Family, Government of Uttar Pradesh.

1.7.2.5 In case the bidding process / public procurement process has not been completed within

the stipulated period, Nodal Authority, may like to request the bidders to extend the

validity period of the bid.

1.7.2.6 The notification of award will constitute the formation of the Contract. Upon the successful

bidder's furnishing of Performance Security, Nodal Authority will notify each unsuccessful

bidder and return their EMD.

1.7.3 Modification to Contract

The Contract when executed by both the parties shall constitute the entire Contract between the

parties in connection with the jobs / services and shall be binding upon the parties. Modification, if

any, to the contract shall be in writing and with the consent of both the parties.

1.7.4 Performance Security

1.7.4.1 The successful bidder shall furnish a Performance Security in the shape of a FDR/Bank

Guarantee issued by a Nationalized Bank/Scheduled Indian Bank in favor of Director

General of Medical & Health Services, Uttar Pradesh, Lucknow for an amount as specified

in the Bid Data Sheet. The Bank Guarantee shall be as per proforma at “Appendix I” and

will remain in force upto and including 180 (One Hundred and Eighty) days after the period

of contract validity. This shall be submitted within 21 days of receiving of Notice for Award

of Contract, failing which the EMD may be forfeited and the Contract may be cancelled.

1.7.4.2 If the Selected Bidder / Service Provider violates any of the terms and conditions of

contract, the Performance Security shall be liable for forfeiture, wholly or partly, as

decided by the Nodal Authority and the contract may also be cancelled.

1.7.4.3 The Nodal Authority will release the Performance Securitywithout any interest to the

Selected Bidder / Service Provider on successful completion of Contractual term and/or its

obligations.


22 | P a g e

1.7.5 Signing of Contract

1.7.5.1 After the Nodal Authority notifies the successful bidder that its Bid has been accepted,

Nodal Authority shall enter into a contract, incorporating all clauses, pre-bid clarifications

and the Bid of the bidder between Nodal Authority and the successful bidder.

1.7.5.2 The individual Contracts will be signed between Director General Medical and Health,

Department of Medical Health & Family Welfare, Government of Uttar Pradesh and

selected bidder.

1.7.5.3 The Implementing, Monitoring Authority and Payment Authority will be Director General

Medical and Health, Department of Medical Health & Family Welfare, Government of Uttar

Pradesh.

1.7.6 Compliance of Minimum Wages Act and other Statutory Requirements

The Service Provider shall comply with all the provisions of Minimum Wages Act and other

applicable labor laws. The bidder shall also comply with all other statutory provision including but

not limited to provisions regarding medical education and eligibility criteria of human resources used

by the Service Provider for providing the services, biomedical waste management, bio-safety,

occupational and environmental safety, Drugs & Cosmetics Act, 1940 and requirements for NABL

accredition.

1.7.7 Income Tax Deduction at Source

Income tax deduction at source shall be made at the prescribed rates from the Service Provider’s

invoices / bills. The deducted amount will be reflected in the requisite Form, which will be issued at

the end of the financial year.


23 | P a g e

1.8 Scope of Work

1.8.1 General Project Overview

The Service Provider will provide the services as per the Drugs and Cosmetics Act, 1940 for analysis

of drugs, surgical and sutures items as provided in Annexure K.

1.8.2 Work Description

The obligations of the Service Provider under this service contract shall include following service

activities and commitments.

1.8.2.1 The testing of drugs, surgical and suture items will be based on the validation of the

protocols as per ICH guidelines.The calibration of the equipment used in the analysis will

be carried out on regular schedules against national /international standards.

1.8.2.2 Chemical, biological, mechanical and physical data including print-outs,

validation/calibration records etc.; must be on records made available as and when

requested.

1.8.2.3 The laboratory should have all necessary instruments/equipments/machines for testing of

drugs with minimum two functional HPLCs.

1.8.2.4 The Service Provider shall perform all the tests mentioned in IP/BP/USP/ISO/BIS/Drugs &

Cosmetics Act. etc., (as the case may be) for each and every sample. The results obtained

in the test should be mentioned in numerical value (wherever possible).

1.8.2.5 If any sample is received in a damaged condition by the laboratory, the sample should not

be analyzed and the information should be sent immediately Director General, Medical &

Health U.P., Lucknow by fax or e-mail.

1.8.2.6 Analytical lab, which has already tested the batch (for manufacturer), the samples will not

be sent to the same lab for testing.

1.8.2.7 The laboratory will not be permitted to outsource any test from other laboratory. Sub

Letting is strictly prohibited.

1.8.2.8 All the samples tested by the laboratory should be preserved at least for three months.

1.8.2.9 Nodal Authority, Contract Signing Authority or his authorized representative(s) shall have

the right to inspect the laboratory before opening of price bid and subsequently as and

when considered appropriate and based on the finding, the bidder may be disqualified or

de-empaneled, as the case may be.


24 | P a g e

1.8.2.10 Test Reports

1.8.2.10.1 On empanelment, the laboratory should furnish test reports within:

1.8.2.10.1.1 10 days from the receipt of the sample in case of Tablets, Capsules, Pessaries,

Ointments, Powder and Liquid Oral Preparations.

1.8.2.10.1.2 21 days from the receipt of the sample in the case of I.V. Fluids and injectable and other

items requiring test for sterility.

1.8.2.10.2 Every test report must have remarks either as “Standard Quality” or “Not of Standard

Quality” or “Misbranded” or “Spurious”.

1.8.2.10.3 Reports should be attached along with Spectra / Chromatography data sheets if

applicable and it will be considered incomplete if spectra or chromatograms are not

attached.

1.8.2.10.4 Reports should have S.No, Description of tests , Specifications and Results obtained ad

should be signed by authorized approved Technical person.

1.8.2.10.5 “COMPLIES” or “PASSES” in the result column of the report is treated as incomplete

report, if the result has some numerical value.

1.8.2.11 All test reports should be submitted to Director General, Medical & Health U.P., Lucknow

in triplicate.

1.8.3 Operations & Performance Requirements

1.8.3.1 Penalty due to Non-Adherence to Timelines:


25 | P a g e

1.8.3.1.1 If the Service Provider requires an extension in time for submission of test report, on

account of occurrence of any hindrance, it shall apply in writing for extension on

occurrence of hindrance but not after the stipulated date of furnishing the test report.

1.8.3.1.2 The Director General, Medical & Health U.P., Lucknow may extend the testing period

with or without liquidated damages in case they are satisfied that the delay in the

submission of test reports is on account of any hindrances.

1.8.3.1.3 In case of delay in furnishing the test report(s), a penalty due to Non-Adherence to the

timeline shall be applied to Service Provider. A penalty as per the below percentage of

each delay will be levied on the monthly payment of each such cases which have non-

adherence to the timeline:

1.8.3.1.3.1.1 Delay upto one fourth period of the prescribed testing period; 2.5%

1.8.3.1.3.1.2 Delay exceeding one fourth but not exceeding half of the prescribed testing period; 5%

1.8.3.1.3.1.3 Delay exceeding half but not exceeding three fourth of the prescribed testing period;

7.5%

1.8.3.1.3.1.4 Delay exceeding three fourth of the prescribed testing period; 10%

Note: Fraction of a day in reckoning period of delay in furnishing the test reportshall be

eliminated if it is less than half a day. The maximum amount of liquidated damages shall be

10%.

1.8.3.2 If the Bidder/Service Provider, as the case may be, is found by the Contract signing

Authority /Nodal Authority to be engaged in misreporting or in violation of conditions of

the contract, such Bidder/ Service provider shall not be eligible to participate in any bid or

RFP issued by the Nodal Authority / Contract Signing Authority for a period of 5 (five) years

from the date such Bidder/ Service provider, as the case may be, is found to have engaged

in misreporting or in violation of conditions of the contract. The bidder/ service provider

shall also be liable for action under criminal law and the matter will be notified to the

concerned Authority for Drug control for suitable action under Drugs and Cosmetics Act

and Rules.

1.9 Payment Terms

1.9.1 The Director General Medical and Health, Department of Medical Health & Family Welfare,

Government of Uttar Pradesh will be the Paying Authority. The Paying Authority

appointedAuthorized Representative(s) will verify the payment claims / invoices of the

Service Provider.

1.9.1.1 The Service Provider will submit the invoice on monthly basis


26 | P a g e

1.9.1.2 The Service Provider can submit the claims for verification duly accompanied by evidences

of services provided, on fortnightly basis to the Authorized Representative(s) for

verification purpose.

1.9.1.3 100% Payment will be made as per Invoice supported by final submitted report of each

drug /surgical/suture items.

1.9.1.4 After verification of invoices / claims by the Authorized Representative(s), the Paying

Authority will make the payment within 30 days of verification of the Invoices or after 30

days of resolution of dispute, whichever is later, for all invoices raised.

1.9.1.5 The payment will be subject to all Statutory Taxes, Tax Deducted at Source (TDS), as per

Applicable taxes and laws.

1.9.2 The Service Provider hereby acknowledges and agrees that it is not entitled to anyrevision of

the Payment Terms or other relief from the Paying Authority except in accordance with the

express provisions of this Agreement.

1.9.3 The Paying Authority shall make no advance payment to the Service Provider towards the

cost of analysis.

1.9.4 The Paying Authority shall make no payment to the Service Provider, for the incomplete

analysis or incomplete report submission.Deliberate omission of any critical test will be

viewed seriously and shall invite action against the laboratory as deemed fit Director

General, Medical and Health, UP.

1.9.5 Penalties would apply on payments, as defined in this RFP document, due to non-

conformance to the Operations & Maintenance Performance Requirements

1.10 Other Terms and Conditions of the RFP and Contract

1.10.1 Downstream Work

The Nodal Authority does not guarantee, support or state any the possibility of any downstream

work arising of this contract. Downstream work and its procurement/bidding process strictly follows

the Government of India defined Conflict of Interest clauses. However , if a new drug is introduced

within the contract period, a limited tender process will be conducted between the empaneled

laboratories to finalize its price.

1.10.2 Fraud and Corrupt Practices


27 | P a g e

1.10.2.1 The Bidders and their respective officers, employees, agents and advisers shall observe the

highest standard of ethics during the Selection Process. Notwithstanding anything to the

contrary contained in this RFP, the Nodal Authority shall reject a Bid without being liable in

any manner whatsoever to the Bidder, if it determines that the Bidder has, directly or

indirectly or through an agent, engaged in corrupt practice, fraudulent practice, coercive

practice, undesirable practice or restrictive practice (collectively the “Prohibited Practices”)

in the Selection Process. In such an event, the Nodal Authority shall, without prejudice to

its any other rights or remedies, forfeit and appropriate the Bid Security or Performance

Security, as the case may be, as mutually agreed genuine pre-estimated compensation and

damages payable to the Nodal Authority for, inter alia, time, cost and effort of the

Authority, in regard to the RFP, including consideration and evaluation of such Bidder’s Bid.

1.10.2.2 Without prejudice to the rights of the Nodal Authority under Clause above and the rights

and remedies which the Nodal Authority may have under the LOI or the Agreement, if a

Bidder/Service Provider, as the case may be, is found by the Nodal Authority to have

directly or indirectly or through an agent, engaged or indulged in any corrupt practice,

fraudulent practice, coercive practice, undesirable practice or restrictive practice during

the Selection Process, or after the issue of the LOI or the execution of the Agreement, such

Bidder or Service Provider shall not be eligible to participate in any Bid or RFP issued by the

Nodal Authority during a period of 5 (five) years from the date such Bidder or Service

Provider, as the case may be, is found by the Nodal Authority to have directly or through

an agent, engaged or indulged in any corrupt practice, fraudulent practice, coercive

practice, undesirable practice or restrictive practice, as the case may be. The bidder/

service provider shall also be liable for action under criminal law and the matter will be

notified to the concerned Authority for Drug control for suitable action under Drugs and

Cosmetics Act and Rules.

1.10.2.2.1 For the purposes of this Section, the following terms shall have the meaning hereinafter

respectively assigned to them:


28 | P a g e

1.10.2.2.1.1 “corrupt practice” means (i) the offering, giving, receiving, or soliciting, directly or

indirectly, of anything of value to influence the action of any person connected with the

Selection Process (for avoidance of doubt, offering of employment to or employing or

engaging in any manner whatsoever, directly or indirectly, any official of the Nodal

Authority who is or has been associated in any manner, directly or indirectly with the

Selection Process or the LOI or has dealt with matters concerning the Agreement or

arising there from, before or after the execution thereof, at any time prior to the expiry

of one year from the date such official resigns or retires from or otherwise ceases to be

in the service of the Nodal Authority, shall be deemed to constitute influencing the

actions of a person connected with the Selection Process); or (ii) save as provided herein,

engaging in any manner whatsoever, whether during the Selection Process or after the

issue of the LOA or after the execution of the Agreement, as the case may be, any

person in respect of any matter relating to the Project or the LOA or the Agreement,

who at any time has been or is a legal, financial or technical consultant/ adviser of the

Nodal Authority in relation to any matter concerning the Project;

1.10.2.2.1.2 “fraudulent practice” means a misrepresentation or omission of facts or disclosure of

incomplete facts, in order to influence the Selection Process;

1.10.2.2.1.3 “coercive practice” means impairing or harming or threatening to impair or harm,

directly or indirectly, any persons or property to influence any person’s participation or

action in the Selection Process;

1.10.2.2.1.4 “undesirable practice” means (i) establishing contact with any person connected with or

employed or engaged by Nodal Authority with the objective of canvassing, lobbying or

in any manner influencing or attempting to influence the Selection Process; or (ii) having

a Conflict of Interest; and

1.10.2.2.1.5 “restrictive practice” means forming a cartel or arriving at any understanding or

arrangement among Bidders with the objective of restricting or manipulating a full and

fair competition in the Selection Process.

1.11 Conflict of Interest

1.11.1.1 A bidder shall not have a conflict of interest that may affect the Selection Process or the

Solution delivery (the “Conflict of Interest”). Any Bidder found to have a Conflict of Interest

shall be disqualified. In the event of disqualification, the Nodal Authority shall forfeit and

appropriate the EMD, if available, a mutually agreed genuine pre-estimated compensation

and damages payable to the Nodal Authority for, inter alia, the time, cost and effort of the

Nodal Authority including consideration of such Bidder’s Bid, without prejudice to any

other right or remedy that may be available to the Nodal Authority hereunder or

otherwise.


29 | P a g e

1.11.1.2 The Nodal Authority requires that the Service Providerprovides solutions which at all times

hold the Nodal Authority’s interests’ paramount, avoid conflicts with other assignments or

its own interests, and act without any consideration for future work. The Service Provider

shall not accept or engage in any assignment that would be in conflict with its prior or

current obligations to other clients, or that may place it in a position of not being able to

carry out the assignment in the best interests of the Nodal Authority.

1.11.1.3 Without limiting the generality of the above, a Bidder shall be deemed to have a Conflict of

Interest affecting the Selection Process, if:

1.11.1.3.1 the Bidder, or Associates (or any constituent thereof) and any other Bidder, or Associate

(or any constituent thereof) have common controlling shareholders or other ownership

interest; provided that this disqualification shall not apply in cases where the direct or

indirect shareholding or ownership interest of an Bidder, or Associate (or any shareholder

thereof having a shareholding of more than 5 per cent of the paid up and subscribed

share capital of such Bidder or Associate, as the case may be) in the other Bidder or

Associate is less than 5% (five per cent) of the subscribed and paid up equity share capital

thereof. For the purposes of this Clause, indirect shareholding held through one or more

intermediate persons shall be computed as follows:

1.11.1.3.2 where any intermediary controlled by a person through management control or

otherwise, the entire shareholding held by such controlled intermediary in any other

person (the “Subject Person”) shall be taken into account for computing the

shareholding of such controlling person in the Subject Person; where a person does not

exercise control over an intermediary, which has shareholding in the Subject Person, the

computation of indirect shareholding of such person in the Subject Person shall be

undertaken on a proportionate basis; provided, however, that no such shareholding shall

be reckoned under this Sub-clause if the shareholding of such person in the intermediary

is less than 26% (twenty six per cent) of the subscribed and paid up equity shareholding

of such intermediary; or

1.11.1.3.2.1 a constituent of such Bidder is also a constituent of another Bidder; or

1.11.1.3.2.2 such Bidder or its Associate receives or has received any direct or indirect subsidy or

grant from any other Bidder or its Associate; or

1.11.1.3.2.3 such Bidder has the same legal representative for purposes of this Application as any

other Bidder; or

1.11.1.3.2.4 such Bidder has a relationship with another Bidder, directly or through common third

parties, that puts them in a position to have access to each other’s information about,

or to influence the Application of either or each of the other Bidder; or


30 | P a g e

1.11.1.3.2.5 there is a conflict among this and otherservices delivery assignments of the Bidder

(including its personnel and other members, if any) and any subsidiaries or entities

controlled by such Bidder or having common controlling shareholders. The duties of the

Service Provider will depend on the circumstances of each case. While providing services

andrelated solutions to the Nodal Authority for this particular assignment, the Service

Provider shall not take up any assignment that by its nature will result in conflict with

the present assignment; or

1.11.1.3.2.6 A firm hired to provide Services for the execution of a project, and its Members or

Associates, will be disqualified from subsequently providing goods or works or services

related to the same project;

1.12 Damages for Mishap/Injury

The Nodal Authority shall not be responsible for damages of any kind or for any

mishap/injury/accident caused to any personnel/property of the bidder while performing duty in the

premises as provided by the Nodal Authority. All liabilities, legal or monetary, arising in that

eventuality shall be borne by the Service Provider.

1.13 Termination of Contract

1.13.1.1 The Nodal Authority may terminate the contract under following circumstances: If the

successful bidder withdraws its bid after its acceptance or fails to submit the required

Performance Securities for the initial contract and or fails to fulfill any other contractual

obligations. In that event, the Nodal Authority will have the right to purchase the services

from next eligible bidder and the extra expenditure on this account shall be recoverable

from the defaulter. The Earnest Money and the Performance Security deposited by the

defaulter shall also be recovered to pay the balance amount of extra expenditure incurred

by the Nodal Authority.

1.13.1.2 The following conditions will be treated as failure to fulfill the key contractual obligation:

1.13.1.2.1 Failure to follow Standard Operating Procedures (SOPs) for performing the tests.

1.13.1.2.2 Non-compliance of minimum essential standards.

1.13.1.2.3 Criminal Indictment and excess and/or forged billing to the Nodal Authority/ Paying

Authority

1.13.1.2.4 Insolvency


31 | P a g e

1.13.1.3 The Service Provider will be served a notice of termination by the Nodal Authority and will

be require to respond within 30 days failing which the services will be treated as

Terminated.

1.13.1.4 In that event, the Nodal Authority will have the right to purchase the services from next

eligible bidder and the extra expenditure on this account shall be recoverable from the

defaulter. The earnest money and the performance security deposited by the defaulter

shall also be recovered to pay the balance amount of extra expenditure incurred by the

Nodal Authority.

1.14 Arbitration

1.14.1.1 If dispute or difference of any kind shall arise between the Nodal Authority and the Service

Provider in connection with or relating to the contract, the parties shall make every effort

to resolve the same amicably by mutual consultations. 1.14.1.2 If the parties fail to resolve their dispute or difference by such mutual consultations within

thirty days of commencement of consultations, then either the Nodal Authority or the

Service Provider may give notice to the other party of its intention to commence

arbitration, as hereinafter provided. The applicable arbitration procedure will be as per the

Arbitration and Conciliation Act, 1996 of India and the rules there under. Any statutory

modification thereof for the time being in force shall be deemed to apply to the arbitration

proceedings under this clause. Arbitral Tribunal shall consist of three Arbitrators. Each

Party shall appoint one Arbitrator and both Arbitrator shall appoint Presiding Arbitrator. If

the arbitrator to whom the matter is initially referred is transferred or vacates his office or

is unable to act for any reason, he / she shall be replaced by another person, appointed by

the party appointing the outgoing Arbitrator, to act as the new Arbitrator. Such person

shall be entitled to proceed with the matter from the stage at which it was left by his

predecessor. The Arbitrator shall give reasoned award in case the amount of claim in

reference exceeds Rupees 1 Lakh (Rs.1,00,000/-)

1.14.1.3 Work under the contract, notwithstanding the existence of any such dispute or difference,

shall continue during arbitration proceedings and no payment due or payable by the Nodal

Authority or the Service Provider shall be withheld on account of such proceedings unless

such payments are the direct subject of the arbitration.

1.14.1.4 Reference to arbitration shall be a condition precedent to any other action at law. 1.14.1.5 Venue of Arbitration: The venue of arbitration shall be Lucknow.

1.14.2 Applicable Law and Jurisdiction of Court

The contract shall be governed by and interpreted in accordance with the laws of India for the time

being in force. The Court located at Lucknow shall have jurisdiction to decide any dispute arising out


32 | P a g e

of in respect of the contract. It is specifically agreed that no other Court shall have jurisdiction in the

matter.


33 | P a g e

Appendix A: Forwarding Letter

(To be submitted by Bidder on their Letterhead)

Date: ________________________ To Director General Medical and Health,

Department of Medical Health & Family,

Government of Uttar Pradesh

Lucknow-226001

Subject: Forwarding Letter – RFP for Empanelment of Approved Analytical Testing Laboratories for Analysis of Drugs, Surgical & Sutures Items, Bid Reference Number _______________________ Dear Sir/Ma’am,

1. We M/s ____________________________ are submitting herewith our bid for

Empanelment of Analytical Testing Laboratories for Analysis of Drugs, Surgical & Sutures

Items in the state.

We are enclosing Demand Draft No _________________, Dated ___________ (Amount Rs

________________________) towards Bid Document Cost/Fee (ifdocument has been

downloaded from website) and FD/BG No ______________________ Dated ___________

(Amount Rs ________________________) towards Earnest Money Deposit (EMD), drawn on

_______________ Bank in favour of Director General of Medical & Health Services, Uttar

Pradesh payable at Lucknow.

2. We agree to accept all the Terms & Condition stipulated in your Bid enquiry. We also agree

to submit Performance Security as per Section 1.7.5 of Bid Enquiry document.

3. We agree to keep our Price offer valid for the period stipulated in your Bid Enquiry.

Enclosures: 1. 2. 3.

Name and Signature of the Authorized Signatory: _______________________ Name of the Bidder: __________________________


34 | P a g e

Seal of the Bidder: _________________


35 | P a g e

Appendix B: Bidder’s Information

(To be furnished by Bidder on their Letterhead)

1. Name of the Bidder:

Full Registered Address:

Phone/Mobile Number:

Fax Number:

Email ID:

2. Details of the Bidder:

Date of Inception:

Approval No. & Date:

Issued by:

Valid up to:

3. Details of Certification:

Particulars Details

Certificate of Analytical approval (issued by the State Licensing Authority)

Date of Issue

Name and Designation of Issuing Authority

Date of Renew

Schedule L-1 Certificate (GLP Certificate)

Certificate No.

Date of Issue

NABL Accreditation

Accreditation No.

Scope of Accreditation

Validity of Accreditation

Other Registration Number (if Applicable)

PAN No.

Service Tax Registration No.

EPF Registration No.

ESI Registration No.

Sales Tax Registration No.

VAT Registration No.

Note: (i) Kindly attach attested copy of the certification; (ii) For Other Registration Number (If

Applicable): In case of non-applicability of any of the mentioned Certifications of Registration, the

Bidder shall provide a Declaration on its letter-head stating provisions under law for exemption.

4. Details of Branches (if any):

S.No. Branch Name Branch Address Telephone

Number Mobile

Number Fax

Number Email Id

1.

2.

..


36 | P a g e

Note: Kindly add extra rows as per requirement.

5. Type of Entity: OPC/Company/Society/Trust/LLP/Partnership or Any Institution formed

under an act of Parliament or State/UT Legislature of India

6. Whether the Bidder has its own Manufacturing Unit: Yes/No

(If Yes, provide Details of Manufacturing Unit such as Address, Licence Number etc.)

7. Copy of CA Certified or Audited Financial / Account Statements for the last 3 (three) Financial Years (2013-14, 2014-15 and 2015-16).

8. Copy of the Income Tax Returns Acknowledgement for the last 3 (three) Financial Years (2013-14, 2014-15 and 2015-16)

9. Brief write-up about the Bidder. (use extra sheet if necessary)

10. Details of Bidder’s Representative(s):

Particulars Details

Authorized Signatory

Name

Specimen of Signature

Approved Technical Staff who are authorized to Sign the Test Reports

Name

Specimen of Signature


Date __________________________ Place __________________________ Name and Signature of the Authorized Signatory: _______________________ Name of the Bidder: __________________________ Seal of the Bidder: _________________


37 | P a g e

Appendix C: Performance Statement

(For a period of Last 3 years)


Name of the Bidder: M/s ________________________________ Address: _________________________________________________________________________

S.No. Types of Sample Analyzed Number of Samples Analyzed during

2013-14 2014-15 2015-16

1. Tablets / Capsules / Pessaries

2. Injectable

3. Liquid Oils

4. Ointments / Creams / Gels

5. Others (Drugs)

6. Surgical (Specify item names)

7. Sutures (Specify types)

Note: Attach extra sheet for above Performa if required.

Name and Signature of the Authorized Signatory: _______________________ Name of the Bidder: __________________________ Seal of the Bidder: _________________


38 | P a g e

Appendix D: Personnel Details



Details of Technical Staff approved by State Licensing Authority:

S.No. Name of Personnel Designation Highest

Qualification No. of years of

Experience Experience Domain*

1.

2.

..


*Kindly mention experience relevant to analysis of Drugs/Surgical/Sutures.



39 | P a g e

Appendix E: List of Equipment/Instrument/Apparatus available in Lab



Details of sophisticated Equipment / Instrument / Apparatus available in the Lab:

S.No. Name of the Equipment / Instrument / Apparatus

Make & Description

Date of Installation

Date of Last Validation

Approved for testing of Drugs from State Licensing Authority

since _____*

1.

2.

..


*Kindly mention Date (in DD/MM/YYYY format) on which approval has been received.

S.No. Types of Sample Maximum Capacity (in Samples per month)

1. Tablets / Capsules / Pessaries

2. Injectable

3. Liquid Oils

4. Ointments / Creams / Gels

5. Others (Drugs)

6. Surgical Items

7. Sutures (Specify types)




40 | P a g e

Appendix F: Microbiological Facilities


FACILITIES IN THE MICROBIOLOGICAL SECTION


I. LIST OF STOCK CULTURES AVAILABLE:

II. LIST OF EQUIPMENT / APPARATUS AVAILABLE: Approval from State Licensing Authority to permit Microbiological Testing in the Lab

S.No. Name of the Equipment /

Apparatus Date of Make

Model / Serial No.

Date of Installation

Under AMC / CMC

Calibrated on / up to

1.

2.

..


Name and Signature of the Authorized Signatory: _______________________ Name of the Bidder: __________________________


41 | P a g e

Appendix G: Declaration by the Bidder

(To be furnished by the Bidder)

on a Non – Judicial Stamp Paper of Rs. 100 duly attested by Executive Magistrate / Public Notary

1. I, the undersigned, do hereby certify that all the statements made in our bid are true and correct.

2. The undersigned hereby certifies that neither our ________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership) M/s __________________ nor any of its Directors/President/Chairperson/Trustee has abandoned any work for the Government of Uttar Pradesh or any other State Government or Government of India during last three years prior to the date of this Bid.

3. The undersigned also hereby certifies that neither our ________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership) M/s __________________ nor any of its Directors / President / Chairperson / Trustee have been debarred / blacklisted by Government of Uttar Pradesh, or any other State Government or Government of India for any work during last three years prior to the date of this Bid.

4. The undersigned also hereby certifies that neither our ________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership) M/s __________________ nor any of its Directors / President / Chairperson / Trustee have not been involved in theft or in non-payment of Government dues or taxes during last three years prior to the date of this Bid.

5. The undersigned further certifies that a. Our ________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership) M/s

__________________ has not been criminally indicted or punished for any offence, nor is/are any criminal case(s) pending before any Competent Court during last three years prior to date of this Bid; and/or

b. The Directors / President / Chairperson / Trustee of our ________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership) M/s __________________ criminally indicted or convicted of any offence nor is/are any criminal case(s) or pending before any Competent Court during last three years prior to date of this Bid.

c. We have not been found guilty and are not found to be involved in any pending /ongoing CBI or Criminal Litigations. In case of any pending /ongoing litigation(s) of the aforementioned nature, involving our ________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership), we agree to declare the same.

6. The undersigned hereby authorize(s) and request(s) any bank, person, firm, Competent Authority or corporation to furnish pertinent information deemed necessary and requested by Director General of Medical & Health Services, Uttar Pradesh, to verify this statement or regarding my (our) competence and general reputation. a. The undersigned understands and agrees that further qualifying information may be

requested, and agrees to furnish any such information at the request of the Director General Medical and Health, Department of Medical Health & Family, Government of Uttar Pradesh

7. We M/s _______________ having our registered office at ____________________ and the approved drug testing laboratory at _______________________ do hereby declare that, we have carefully read all the conditions of Bid Document of Director General Medical and Health, Department of Medical Health & Family, Government of Uttar Pradesh for the bid for “RFP for Empanelment of Approved Analytical Testing Laboratories for Analysis of Drugs, Surgical & Sutures Items” and shall abide by all the conditions set forth therein.


42 | P a g e

8. We further declare that, we possess valid approval for testing of all the Drugs / Surgical / Sutures for which Price Bid have been submitted by us as per Appendix K and permission on Form 37 have been obtained for testing of these items from State Licensing Authority where ever applicable and has not been suspended in past three years on account of misreporting.

9. That the approval to test drugs/surgical & sutures have been obtained on Form 37 bearing No. _____ which is valid/renewed up to _________________.

10. That we are _____________ (Please mention: OPC / Company / Society / Trust / LLP / Partnership) and following are the details of Partners/Directors:

S.No. Name of Partner /

Director Age Present and Permanent

Address

Signed by an Authorized Signatory of the Bidder: ____________________

Title of Officer: ________________________

Name of the Bidder: ____________________ Date: ______________ Place:_____________________________


43 | P a g e

Appendix H: Litigation Declaration Proforma

(If Applicable, to be furnished by the Bidder on their Letterhead, wherever applicable)

S. No. Particulars Inputs / Remarks / Details

1. Case Name

2. Case Number

3. Government Order No. and details, if applicable

4. Name of the Court

5. Jurisdiction in which Case was Filed

6. Name(s) of Litigant(s)

7. Describe Nature of Litigation

8. Outcome of the Case

9. Any Additional Information

(Attach extra sheet for above Performa if required). Name and Signature of the Authorized Signatory: _______________________

Name of the Bidder: __________________________

Seal of the Bidder: _________________


44 | P a g e

Appendix I: Proforma for Bank Guarantee for EMD & Performance Security

Format for Bank Guarantee for Earnest Money Deposit (EMD)

(To be issued by any Indian Scheduled Commercial Bank)

Whereas M/s ___________________________________________ (hereinafter called the “Bidder”)

has submitted their offer dated _____________ for the supply of under “RFP for Empanelment of

Approved Analytical Testing Laboratories for Analysis of Drugs, Surgical & Sutures Items”

(hereinafter called the “Project”) against Nodal Authority’s Bid Reference Number

___________________

KNOW ALL MEN by these presents that WE M/s ____________________________ of __________

having registered office at ____________________________ are bound unto Director General of

Medical & Health Services, Uttar Pradesh (hereinafter called the “Nodal Authority”) in the sum of

Rs. ____________________ (Rupees ______ only) for which payment will and truly to be made in

favour of Director General of Medical & Health Services, Uttar Pradesh, the Bank binds itself, its

successors and assigns by these presents.

Sealed with Common Seal of the said bank this ______ day of ________ 20_____.

THE CONDITIONS OF THIS OBLIGATION ARE:

1) If the Bidder withdraws or amends, impairs or derogates from the Bid in any respect within the Period of Validity of this Bid.

2) If the Bidder having been notified of the acceptance of his Bid by the Nodal Authority during the Period of its Validity, a. Fails to furnish the Performance Security for the due performance of the Contract. b. Fails or refuses to accept/execute the Contract.

We undertake to pay the Nodal Authority up to the above amount upon receipt of its first

written demand, without the Nodal Authority having to substantiate its demand, provided that in

the demand the Nodal Authority will note that amount claimed by it is due to its owing to the

occurrence of one or both the two conditions, specifying the occurred condition or conditions.

This guarantee will remain in force up to and including 45 (Forty-Five) days after the period

of Bid validity and any demand in respect of should reach the Bank not later than the above date.

Signature of the Authorized Officer of the Bank: _________________________________

Name and Designation of the Officer: _________________________________

Seal, Name and Address of the Bank/Branch: _________________________________


45 | P a g e

Format for Bank Guarantee for Performance Security

(Tobeissuedby any IndianScheduledCommercialBank)

Date: __________________

To

Director General Medical and Health,

Department of Medical Health & Family,

Government of Uttar Pradesh

Lucknow-226001

Dear Sir/Ma’am,

1. We understand that __________ (the “Service Provider”) has entered into a Service Agreement dated __________ (the “Agreement”), with the Nodal Authority, whereby the Service Provider has undertaken to provide the Services, subject to and in accordance with provisions of the Agreement.

2. The Agreement requires the Service Provider to furnish a Performance Security tothe Nodal Authority in a sum of Rs. __________ (Rupees__________ Lakh) (the “Guarantee Amount”) as security for due and faithfulperformance of its obligations, under and in accordance with the Agreement, during theTerm as per the provisions of the Agreement.

3. We __________, through our Branch at __________ (the “Bank”) have agreed to furnish this Bank Guarantee by way of Performance Security

NOW, THEREFORE, the Bank hereby, unconditionally and irrevocably, guarantees and affirmsas

follows:

1. The Bank hereby unconditionally and irrevocably guarantees the due and

faithfulperformance of the Service Provider’s obligations during the Term, underand in

accordance with the Agreement, and agrees and undertakes to pay to the Nodal

Authority, upon its mere first written demand, andwithout any demur, reservation,

recourse, contest or protest, and without anyreference to the Service Provider, such sum

or sums up to an aggregate sum of theGuarantee Amount as the Nodal Authority shall

claim, without the Nodal Authoritybeing required to prove or to show grounds or reasons

for its demand and/or for thesum specified therein.

2. A letter from the Nodal Authority, under the hand of an Officer dulyauthorized by the

Nodal Authority, that the Service Provider has committed default in the due and faithful

performance of all or any of itsobligations under and in accordance with the Agreement

shall be conclusive, final and binding on the Bank. The Bank further agrees that the Nodal

Authority shall be the sole judge as to whether the Service Provider is in defaultin due and

faithful performance of its obligations during the Term underthe Agreement and its


46 | P a g e

decision that the Service Provider is in default shall be final, andbinding on the Bank,

notwithstanding any differences between the Nodal Authority and the Service Provider, or

any dispute between thempending before any court, tribunal, arbitrators or any other

authority or body, or bythe discharge of the Service Provider for any reason whatsoever.

3. In order to give effect to this Guarantee, the Nodal Authority shall be entitled to act as if

the Bank were the principal debtor and any changein the constitution of the Service

Provider and/or the Bank, whether by their absorptionwith any other body or corporation

or otherwise, shall not in any way or manner affectthe liability or obligation of the Bank

under this Guarantee.

4. It shall not be necessary, and the Bank hereby waives any necessity, for the Nodal

Authority to proceed against the Service Provider before presenting to the Bank its

demand under this Guarantee.

5. The Nodal Authority shall have the liberty, withoutaffecting in any manner the liability of

the Bank under this Guarantee, to vary at anytime, the terms and conditions of the

Agreement or to extend the time or period forthe compliance with, fulfilment and/ or

performance of all or any of the obligations ofthe Service Provider contained in the

Agreement or to postpone for any time, and fromtime to time, any of the rights and

powers exercisable by the Nodal Authority against the Service Provider, and either to

enforce or forbear fromenforcing any of the terms and conditions contained in the

Agreement and/or thesecurities available to the Nodal Authority , and the Bank shall not

be releasedfrom its liability and obligation under these presents by any exercise by

theNodal Authority of the liberty with reference to thematters aforesaid or by reason of

time being given to the Service Provider or any otherforbearance, indulgence, act or

omission on the part of the Nodal Authority or of any other matter or thing whatsoever

which under any lawrelating to sureties and guarantors would but for this provision have

the effect ofreleasing the Bank from its liability and obligation under this Guarantee and

the Bankhereby waives all of its rights under any such law.

6. This Guarantee is in addition to and not in substitution of any other guarantee orsecurity

now or which may hereafter be held by the Nodal Authority in respect of or relating to the

Agreement or for the fulfilment,compliance and/or performance of all or any of the

obligations of the Service Providerunder the Agreement.

7. Notwithstanding anything contained hereinbefore, the liability of the Bank under

thisGuarantee is restricted to the Guarantee Amount and this Guarantee will remain in

force for the period specified in paragraph 8 below and unless a demand or claim inwriting

is made by the Nodal Authority on the Bank underthis Guarantee, not later than 6 (six)

months from the date of expiry of thisGuarantee, all rights of the Nodal Authority under

thisGuarantee shall be forfeited and the Bank shall be relieved from its

liabilitieshereunder.


47 | P a g e

8. The Performance Security shall cease to be in force and effect till thesubsistence of the

Agreement and provided the Service Provider is not inbreach of this Agreement. On

successful completion of Term and uponrequest made by the Service Provider for release

of the Performance Securityalong with the particulars required hereunder, duly certified

by a statutory auditor ofthe Service Provider, the Nodal Authority shall release

thePerformance Security forthwith.

9. The Bank undertakes not to revoke this Guarantee during its currency, except with

theprevious express consent of the Nodal Authority in writing,and declares that it has the

power to issue this Guarantee and the undersigned has fullpowers to do so on behalf of

the Bank.

10. Any notice by way of request, demand or otherwise hereunder may be sent by

postaddressed to the Bank at its above referred Branch, which shall be deemed to

havebeen duly authorized to receive such notice and to effect payment thereof

forthwith,and if sent by post it shall be deemed to have been given at the time when it

ought tohave been delivered in due course of post and in proving such notice, when given

bypost, it shall be sufficient to prove that the envelope containing the notice was

postedand a certificate signed by an officer of the Nodal Authority that the envelope was

so posted shall be conclusive.

11. This Guarantee shall come into force with immediate effect and shall remain in forceand

effect for a period of _________ months or until it is released earlier by the Nodal

Authority pursuant to the provisions of the Agreement.

Signed and sealed this ________ Day of ________ 20_____.

SIGNED, SEALED AND DELIVERED For and on behalf ofthe BANK

by:

Signature:

Name:

Designation:

Address:


48 | P a g e

Appendix J: Format for Power of Attorney for Signing of Proposal

(To be furnished by the Bidder)

On a Non – Judicial Stamp Paper of Rs. 100 duly attested by Executive Magistrate / Public Notary

POWER OF ATTORNEY

Know all men by these present, we M/s ____________________ (Name and Address of the

Registered office of the Bidder) do hereby constitute, appoint and authorise Mr. / Ms.

__________________R/o _______________________________ (Name and Address of Residence)

who is presently employed with us and holding the position of ______________ as our Authorised

Representative, to do in our name and on our behalf, all such acts, deeds and things necessary in

connection with or incidental to the bid for “RFP for Empanelment of Approved Analytical Testing

Laboratories for Analysis of Drugs, Surgical & Sutures Items” (the “Project”), including signing and

submission of all documents and providing information / responses to Director General of Medical

& Health Services, Uttar Pradesh, representing us in all matters in connection with our bid for the

said Project.

We hereby agree to ratify all acts, deeds and things lawfully done by our said attorney pursuant to

this Power of Attorney and that all acts, deeds and things done by our aforesaid attorney shall and

shall always be deemed to have been done by us.

This Power of Attorney shall be effective, binding, and operative till ___________, if not revoked

earlier or as long as the said Attorney is in the service of the Company, whichever is earlier.

For: _________________(Signature)

(Name, Title and Address)

Accept: _________________(Signature)

(Name, Title and Address of the authorised representative)

Notes:

1. To be executed by the Single Entity.

2. The mode of execution of Power of Attorney should be in accordance with the procedure, if any,

laid down by the applicable law and the charter documents of the executant(s) and when it is so

required the same should be under common seal affixed in accordance with the required

procedure.


49 | P a g e

3. Also, wherever required, the executant(s) should submit for verification the extract of the charter

documents and documents such as a resolution / Power of attorney in favour of the Person

executing this Power of Attorney for the delegation of power hereunder on behalf of the

executant(s).

4. For a Power of Attorney executed and issued overseas, the document shall be authenticated by

the Indian Embassy and notarised in the jurisdiction where the Power of Attorney is being

executed. However, a Power of Attorney executed in a country that has signed The Hague

Legalization Convention, 1961 is not required to be authenticated by the Indian Embassy if it

carries a conforming Apostille certificate.


50 | P a g e

Appendix K: Financial Bid

Terms and conditions of the Price offerings:

1. The Financial Bid Price quoted by the Bidder shall be the “Testing Charge” (which shall be inclusive of all the Applicable Taxes but exclusive of Service Tax). 2. Quote as per the PRICE SCHEDULE provided herein. 3. Each Page of this Appendix shall be duly Signed by the Authorized Signatory of the Bidder and shall be Sealed with Seal of the Bidder.

4. PRICE SCHEDULE: FOR LIST OF DRUGS

S No.

Code

Name Formulation Strength /Size Pharmacopeia

Name

Testing Charge

(A)

Service Tax (B)

Rate (inclusive All taxes)

(A+B)

1 M-1 ACECLOFINAC Tablet 100 mg IP

2 M-2 ACECLOFINAC S.R. Tablet 200mg USP

3 M-3 ASPRIN ENTERIC COATED Tablet 150 mg IP

4 M-4 ASPRIN ENTERIC COATED Tablet 75 mg IP

5 M-5 DICLOFENAC POTASSIUM(Enteric Coated) Tablet 50mg IP

6 M-6 DICLOFENAC DIETHYLAMINE 1PERCENT

METHYL SALICYLATE 10 PERCENT MENTHOL 5 PERCENT

GEL 1%W/W 10% 5% IP

7 M-7 DICLOFENAC SODIUM(Enteric Coated) Tablet 100 mg SR IP

8 M-8 DICLOFENAC SODIUM(Enteric Coated) Tablet 50 mg IP

9 M-9 IBUPROFEN Syrup 100 mg/5 ml IP

10 M-10 IBUPROFEN Tablet 200 mg IP

11 M-11 IBUPROFEN Tablet 400 mg IP

12 M-12 KETOPROFEN Plaster 30mg IP


51 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

13 M-13 METHYL SALICYLATE 30 PERCENT MENTHOL 10 PERCENT CAMPHOR

GEL 30gm IP

14 M-14 OXACEPROL Capsule 200mg IP

15 M-15 PARACETAMOL Drop 150mg/ml IP

16 M-16 PARACETAMOL Syrup 25 mg/ ml IP

17 M-17 PARACETAMOL Tablet 500 mg IP

18 M-18 PARACETAMOL Tablet 650mg IP

19 M-19 PARACETAMOL DISPERSIBLE Tablet 125 mg IP

20 M-20 PARACETOMOL SUPPOSITORY Tablet 170 mg IP

21 M-21 PARACETOMOL SUPPOSITORY Tablet 80 mg IP

22 M-22 PHLOUROGLUCINOL+

TRIMETHYLPHLOROGLUCINOL TABLET 80mg IP

23 M-23 PIROXICAM Capsule 20 mg IP

24 M-24 TRAMADOL HYDROCHLORIDE Capsule 50 mg IP

25 M-25 ALLUMINIUM HYDROXIDE Gel 3.5% to 4.4% W/w IP

26 M-26 ALLUMINIUM HYDROXIDE Tablet 500 mg IP

27 M-27 DEXARABEPRAZOLE Tablet 10mg IP

28 M-28 DEXARABEPRAZOLE DOMPERIDONE Tablet 10mg,30mgSR IP

29 M-29 ESOMEPRAZOLE Tablet 40 mg IP

30 M-30 ESOMEPRAZOLE MAGNESIUM TRITHYDRATE Tablet 20 mg IP

31 M-31 OMEPRAZOLE Capsule 20 mg. IP

32 M-32 PANTOPRAZOLE Tablet 40 mg IP

33 M-33 RABEPRAZOLE SODIUM DOMPERIDONE Tablet 20mg+30 mg IP

34 M-34 RABEPRAZOLE SODIUM Tablet 20 mg IP


52 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

35 M-35 RANITIDINE HYDROCHLORIDE Tablet 150 mg IP

36 M-36 RANITIDINE HYDROCHLORIDE Tablet 300 mg IP

37 M-37 SUCRALFATE WITH OXETACAINE SUSPENSION 1 gm/20mg/10ml IP

38 M-38 DICYCLOMINE HYDROCHLORIDE Tablet 20 mg IP

39 M-39 DICYCLOMINE HYDROCHLORIDE Tablet 10 mg IP

40 M-40 DICYLOMINE HCL WITH ACTIVATED

DIMEHICONE Drop 10 mg+40 mg/ml IP

41 M-41 HYOSCINE BUTYL BROMIDE Tablet 10 mg IP

42 M-42 MEFENAMIC ACID WITH DICYCLOMINE HCL Tablet 500 mg+20 mg FDC

43 M-43 URSODEOXYCHOLIC ACID Tablet 150 mg IP

44 M-44 URSODEOXYCHOLIC ACID Tablet 300 mg IP

45 M-45 Abacavir Lamivudine Tablet 600mg+300mg USP

46 M-46 Abacavir Lamivudine Tablet 60mg+30mg USP

47 M-47 ACYCLOVIR Cream 5% W/w IP

48 M-48 ACYCLOVIR Tablet 200 mg IP



51 M-51 AMOXYCILLIN AND POTASSIUM CLAVULANATE

ORAL SUSPENSION dry syrup 200 mg+ 28.5 mg/5 ml IP

52 M-52 AMOXYCILLIN FOR ORAL SUSPENSION dry syrup 25 mg/ml IP

53 M-53 AMOXYCILLIN TRIHYDRATE Capsule 250 mg IP

54 M-54 AMOXYCILLIN TRIHYDRATE Capsule 500 mg IP

55 M-55 AMOXYCILLIN TRIHYDRATE Syrup 25 mg/ml USP


53 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

56 M-56 AMOXYCILLIN TRIHYDRATE EQUIVALENT TO

AMOXYCILLIN AND CLAVULANATE POTASSIUM EQUIVALENT TO CLAVULANIC ACID

Tablet 500 mg + 125 mg IP

57 M-57 AMOXYCILLIN TRIHYDRATE WITH CLOXACILLIN Capsule 250 mg+250 mg USP

58 M-58 AMOXYCILLIN TRIHYDRATE WITH CLOXACILLIN Tablet 125 mg + 125 mg USP

59 M-59 AMOXYCILLINE TRIHYDRATE WITH

CLAVULANATE Tablet 250 mg+125 mg USP

60 M-60 ATAZANAVIR Capsule 300mg IP

61 M-61 Atazanavir Ritonavir Tablet 300mg+100mg IP

62 M-62 AZITHROMYCIN SUSPENSION 100mg/5ml USP

63 M-63 AZITHROMYCIN Tablet 250 mg IP


65 M-65 AZITHROMYCIN Tablet 1 gm IP


67 M-67 CEFADROXIL dry syrup 125 mg/5 ml IP

68 M-68 CEFADROXIL Tablet 500 mg IP

69 M-69 CEFADROXIL DISPERSIBLE Tablet 125 mg IP

70 M-70 CEFADROXIL Tablet 250 mg IP

71 M-71 CEFIXIME TRIHYDRATE dry surup 50mg/5ml IP

72 M-72 CEFIXIME TRIHYDRATE Tablet 100 mg IP



75 M-75 CEFPODOXIME Syrup 125 mg/5 ml IP

76 M-76 CEFPODOXIME Tablet 100 mg IP


54 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

77 M-77 CEFPODOXIME Tablet 200 mg IP

78 M-78 CEFPODOXIME PROXETIL WITH CLAVULANIC

ACID Tablet 200mg+125mg IP

79 M-79 CEFUROXIME AXETIL Tablet 250 mg IP

80 M-80 CEFUROXIME AXETIL Tablet 500 mg IP

81 M-81 CEFUROXIME AXETIL DISPERSABLE Tablet 125 mg IP

82 M-82 CEPHALEXIN Capsule 250 mg IP

83 M-83 CEPHALEXIN Capsule 500 mg IP

84 M-84 CEPHALEXIN drop 100mg/ml

85 M-85 CIPROFLOXACIN HYDROCHLORIDE Tablet 250 mg IP



88 M-88 CLOBAZAM Capsule 10mg IP

89 M-89 CLOBAZAM Tablet 5mg IP

90 M-90 CLOBAZAM Tablet 20mg IP

91 M-91 CLOTRIMAZOLE Tablet 100 mg IP

92 M-92 CLOXACILLIN SODIUM Capsule 250 mg IP

93 M-93 Darunavir Tablet 600mg IP

94 M-94 DOXYCYCLINE HYDROCHLORIDE Capsule EQUIVALENT OF 100mg

DOXYCYCLINE IP

95 M-95 DOXYCYCLINE HYDROCHLORIDE Capsule EQUIVALENT OF 200mg

DOXYCYCLINE IP

96 M-96 EFAVIRENZ Tablet 50mg IP

97 M-97 Efavirenz Capsule 200mg IP

98 M-98 Efavirenz Tablet 600mg USP

99 M-99 ENTECAVIR TABLET 0.5mg IP


55 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

100 M-100

ENTECAVIR TABLET 1mg IP

101 M-101

ERYTHROMYCIN Tablet 250 mg IP

102 M-102

ERYTHROMYCIN DISPERSABLE Tablet 125 mg IP

103 M-103

ERYTHROMYCIN ESTOLATE SUSPENSION 125 mg/5 ml IP

104 M-104

FLUCONAZOLE Tablet 150 mg IP

105 M-105

FLUCONAZOLE Tablet 50 mg IP

106 M-106

GARENOXACIN Tablet 200mg IP

107 M-107

GLICLAZIDE +METFORMIN TABLET 80+500mg IP

108 M-

108 ITRACONZOLE CAPSULE 100mg IP

109 M-109

LEVOFLOXACIN Tablet 500 mg IP

110 M-110

LINEZOLID Tablet 600mg IP

111 M-111

Lopinavir Ritonavir TABLET 100mg+25mg USP

112 M-112

Lopinavir Ritonavir Tablet 200mg+50mg USP

113 M-113

Lopinavir Ritonavir Syrup 80mg+20mg USP

114 M-114

Nevirapine Tablet 50mg

115 M-115

AMOXYCILLIN DISPERSIBLE SCORED TABLET 250mg IP

116 M-116

Nevirapine Tablet 200mg IP

117 M-117

Nevirapine Syrup 10mg/ml IP


56 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

118 M-118

NORFLOXACIN Syrup 100 mg/5 ml

119 M-119

NORFLOXACIN Tablet 200 mg IP

120 M-120


121 M-121


122 M-122

NORFLOXACIN DISPERSABLE Tablet 100 mg IP

123 M-123

OFLOXACIN Tablet 200 mg IP

124 M-124

OFLOXACIN Tablet 400 mg IP

125 M-125

Oseltamivir PHOSPHATE Capsule 75mg IP

126 M-

126 Oseltamivir PHOSPHATE Capsule 45mg IP

127 M-127

Oseltamivir PHOSPHATE Capsule 30mg IP

128 M-128

Oseltamivir PHOSPHATE Syrup 15mg/ml IP

129 M-129

Raltegravir TABLET 400mg IP

130 M-130

Ritonavir Tablet 100mg IP

131 M-131

ROXYTHROMYCIN Tablet 150 mg IP

132 M-132

ROXYTHROMYCIN Tablet 300 mg IP

133 M-133

SOFOSBUVIR TABLET 400mg IP

134 M-134

Stavudine Lamivudine Disp Tablet 6mg+30mg IP

135 M-135

Stavudine Lamivudine Nevirapin Disp Tablet 6mg+30mg+50mg IP


57 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

136 M-136

Stavudine Lamivudine Tablet 30mg+150mg IP

137 M-137

Stavudine Lamivudine Nevirapine Tablet 30mg+150mg+ 200mg USP

138 M-138

TENOFOVIR +LAMIVUDINE Tablet 300mg + 300mg IP

139 M-139

TENOFOVIR +LAMIVUDINE+EFAVIRENZ Tablet 300mg + 300mg+600 IP

140 M-140

TERBENAFINE HYDROCHLORIDE Tablet 250mg IP

141 M-141

TRIMETHHOPRIM WITH SULPHAMETHOXOZOLE DISPERSABLE

Tablet 20 mg+100 mg IP

142 M-142

TRIMETHHOPRIM WITH SULPHAMETHOXOZOLE DISPERSABLE

Tablet 40 mg+200 mg IP

143 M-

143 TRIMETHOPRIM WITH SULPHAMETHOXOZOLE SUSPENSION 40mg+200mg/5 ml IP

144 M-144

TRIMETHOPRIM WITH SULPHAMETHOXOZOLE Tablet 160mg+800mg IP

145 M-145

TRIMETHOPRIM WITH SULPHAMETHOXOZOLE Tablet 80 mg+400 mg IP

146 M-146

Zidovudine Syrup 10mg/mL IP

147 M-147

Zidovudine Lamivudine Tablet 300mg+150mg (FDC)

148 M-148

Zidovudine Lamivudine Nevirapine Tablet 300mg+150mg+ 200mg IP

149 M-149

Zidovudine Lamivudine Tablet 60mg+30mg FDC

150 M-150

Zidovudine Lamivudine Nevirapin Tablet 60Mg+30mg+50mg FDC

151 M-151

CALCIUM DOBESILATE MONOHYDRATE TABLET 500mg IP

152 M-152

DABIGATRAN ETEXILATE Capsule 110 mg and 150 mg IP


58 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

153 M-153

GLICLAZIDE TABLET ER600 IP

154 M-154

HEPARIN SODIUM Ointment 200 iu/gm IP

155 M-155

PURIFIED FLAVONOID FRACTION OF RUTACAE MICRONIZED

TABLET 500mg IP

156 M-156

WARFARIN SODIUM Tablet 5 mg IP

157 M-157

CARBAMAZEPINE Tablet 100 mg IP

158 M-158

CARBAMAZEPINE Tablet 200 mg IP

159 M-159

CARBAMAZEPINE Tablet 200 mg CR IP

160 M-160

CARBAMAZEPINE Tablet 400 mg CR IP

161 M-161

CARBAMAZEPINE Syrup 100mg/ml IP

162 M-162

CARBAMAZEPINE Tablet 400mg IP

163 M-163

PHENOBARBITONE Tablet 30 mg IP

164 M-164

PHENOBARBITONE Tablet 60 mg IP

165 M-165

PHENOBARBITONE SODIUM Syrup 20 mg/5 ml IP

166 M-166

PHENYTOIN SODIUM SUSPENSION 25 mg/ml IP

167 M-167

PHENYTOIN SODIUM Tablet 100 mg IP

168 M-168

SODIUM VALPROATE Syrup 40mg/ml IP

169 M-169

SODIUM VALPROATE Tablet 200 mg IP

170 M-170

SODIUM VALPROATE Tablet 300 mg CR IP


59 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

171 M-171

SODIUM VALPROATE Tablet 500 mg CR IP

172 M-172

TOPIRAMATE Tablet 25 mg IP

173 M-173

VALPORIC ACID Syrup 40 mg/ ml IP

174 M-174

DAPAGLIFLOZIN Tablet 5 mg IP

175 M-175

GLIBENCLAMIDE Tablet 2.5 mg IP

176 M-176

GLIBENCLAMIDE Tablet 5 mg IP

177 M-177

GLIBENCLAMIDE Tablet 10 mg IP

178 M-178

GLICLAZIDE Tablet 10 mg IP

179 M-

179 GLICLAZIDE Tablet 60 mg MR IP

180 M-180

GLICLAZIDE Tablet 80 mg IP

181 M-181

GLIMEPRIDE Tablet 1 mg IP

182 M-182


183 M-183

GLIMEPRIDE Tablet 3 mg. IP

184 M-184


185 M-185

GLIPIZIDE Tablet 5 mg IP

186 M-186

GLIPIZIDE Tablet 10mg IP

187 M-187

CACIUM ELEMENTAL CAPSULE

elemental form150 mg (in the form of calcium hydroxide and calcium

oxide pretreated with heated algae)

IP


60 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

188 M-188

LINAGLIPTIN Tablet 5 mg BP

189 M-189

METFORMIN HYDROCHLORIDE Tablet 500 mg IP

190 M-190

METFORMIN HYDROCHLORIDE Tablet 1000 mg SR IP

191 M-191

PIOGLITAZONE HCL Tablet 15 mg IP

192 M-192

PIOGLITAZONE HCL Tablet 30 mg IP

193 M-193

SAXAGLIPTIN Tablet 5mg IP

194 M-194

SAXAGLIPTIN WITH METFORMIN HCL Tablet 5mg+500mg IP

195 M-195

SITAGLIPTIN PHOSPHATE Tablet 50 mg IP

196 M-196

SITAGLIPTIN PHOSPHATE Tablet 100 mg IP

197 M-197

VILDAGLIPTIN WITH METFORMIN HCL Tablet 50 mg+500 mg EP

198 M-198

VILDAGLIPTIN Tablet 50 mg EP

199 M-199

VOGLIBOSE Tablet 0.2 mg IP

200 M-200

VOGLIBOSE Tablet 0.3 mg. IP

201 M-201

BROMHEXINE HYDROCHLORIDE Tablet 8mg USP

202 M-202

CETIRIZINE DIHYDROCHLORIDE Syrup 1 mg/ ml IP

203 M-203

CETIRIZINE DIHYDROCHLORIDE Tablet 10 mg IP

204 M-204

CHLORPHENIRAMINE MALEATE Tablet 4 mg IP

205 M-205

DEFLAZACORT Tablet 12 mg. IP


61 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

206 M-206

DEFLAZACORT Tablet 24 mg. IP

207 M-207

DEFLAZACORT Tablet 30 mg IP

208 M-208

DEFLAZACORT Tablet 6 mg IP

209 M-209

DESLORATADINE DISPERSIBLE Tablet 5 mg IP

210 M-210

FEXOFENADINE HYDROCHLORIDE Tablet 120 mg IP

211 M-211

FEXOFENADINE HYDROCHLORIDE Tablet 180 mg IP

212 M-212

HYDROXIZINE HCL Syrup 10 mg/5 ml IP

213 M-213

HYDROXIZINE HCL Tablet 25 mg IP

214 M-

214 LEVOCETIRIZINE DIHYDROCHLORIDE Tablet 5 mg IP

215 M-215

MONTELUKAST SODIUM Tablet 4 mg IP

216 M-216


217 M-217


218 M-218

PROMETHAZINE HYDROCHLORIDE+PHOLCODINE

Syrup 1.5mg/ml+1.5mg/ml IP

219 M-219

ALBENDAZOLE SUSPENSION 100 mg/5 ml NHM

220 M-220

ALBENDAZOLE SUSPENSION 200 mg/5 ml NHM

221 M-221

ALBENDAZOLE Tablet 200 mg NHM

222 M-222

ALBENDAZOLE Tablet 400 mg NHM

223 M-223

DIETHYLCARBAMAZINE CITRATE Tablet 100 mg NHM


62 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

224 M-224

DIETHYLCARBAMAZINE CITRATE Tablet 50 mg NHM

225 M-225

IVERMECTIN Tablet 12 mg. IP

226 M-226

IVERMECTIN Tablet 6 mg IP

227 M-227

MEBENDAZOLE Tablet 100 mg IP

228 M-228

PIPERAZINE CITRATE Syrup 750 mg /5 ml IP

229 M-229

PYRANTEL PALMOATE Tablet 250 mg IP

230 M-230

CLOFAZIMINE Capsule 100 mg NLEP

231 M-231

CLOFAZIMINE Capsule 50 mg NLEP

232 M-

232 DIAMINODIPHENYL SULPHONE Tablet 50 mg NLEP

233 M-233

ACT 05 TO 08 YEAR(ARTESUNATE ,SULPHADOXINE+PYRIMETHAMINE,PRIMAQUINE

PHOSPHATE ) Tablet

100 mgX3 TAB, 750mg+37.5 mg X 1 TAB 7.5mgX2TAB

NVBDCP

234 M-234


PHOSPHATE ) Tablet

150 mg,X3 TAB 500mg +25mgX 2 TAB 7.5mg X 4 TAB

NVBDCP

235 M-235

ACT ADULT(ARTESUNATE ,SULPHADOXINE+PYRIMETHAMINE,PRIMAQUINE

PHOSPHATE ) Tablet

200 mgX3 TAB, 750mg+37.5 mg X 1 TAB 7.5mgX6TAB

NVBDCP

236 M-236

ARTEMETHER Capsule 40mg NVBDCP

237 M-237

ARTEMETHER WITH LUMEFATRINE SUSPENSION 20mg+12mg/5ml NVBDCP

238 M-238

ARTEMETHER WITH LUMEFATRINE Tablet 20 mg+120 mg NVBDCP

239 M-239

ARTEMETHER WITH LUMEFATRINE Tablet 40mg+240mg NVBDCP


63 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

240 M-240

ARTEMETHER WITH LUMEFATRINE Tablet 80mg+480mg NVBDCP

241 M-241

ARTEROLANE MALEATE WITH PIPERAQUINE PHOSPHATE

Tablet 150mg+750mg NVBDCP

242 M-242

ARTESUNATE Tablet 50 mg NVBDCP

243 M-243

CHLOROQUINE PHOSPHATE Syrup 50 mg/5 ml NVBDCP

244 M-244

CHLOROQUINE PHOSPHATE Tablet 250 mg NVBDCP

245 M-245

MEFLOQUINE Tablet 250 mg NVBDCP

246 M-246

PRIMAQUINE PHOSPHATE Tablet 15 mg NVBDCP

247 M-247

PRIMAQUINE PHOSPHATE Tablet 7.5 mg NVBDCP

248 M-248

PRIMAQUINE PHOSPHATE Tablet 2.5 mg NVBDCP

249 M-249

ETHAMBUTOL HYDROCHLORIDE Tablet 1000 mg IP

250 M-250


251 M-251


252 M-252


253 M-253

ISONIAZID Tablet 100 mg IP

254 M-254

ISONIAZID Tablet 300 mg IP

255 M-255

PYRAZINAMIDE Tablet 500 mg IP

256 M-256

PYRAZINAMIDE Tablet 750 mg IP

257 M-257

RIFAMPICIN Capsule 150 mg IP


64 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

258 M-258

RIFAMPICIN Capsule 450mg IP

259 M-259

RIFAMPICIN Capsule 600mg IP

260 M-260

RIFAMPICIN SUSPENSION 20 mg/ ml IP

261 M-261

RIFAMPICIN ISONIAZIDE CAPSULE/TABLET 450MG/300MG FDC

262 M-262

RIFAMPICIN ISONIAZIDE ETHAMBUTOL PYRAZINAMIDE

KIT 450MG+300MG+800MG+2(750MG) IP

263 M-263

BETAHISTINE DIHYDROCHLORIDE Tablet 16 mg IP

264 M-264

BETAHISTINE DIHYDROCHLORIDE Tablet 24mg IP

265 M-265

CINNARIZINE Tablet 25 mg IP

266 M-266

CINNARIZINE Tablet 75 mg IP

267 M-267

DOMPERIDONE SUSPENSION 1 mg/ml IP

268 M-268

DOMPERIDONE Tablet 10 mg IP

269 M-269

DOXYLAMINE SUCCINATE WITH PYRIDOXINE HCL

Tablet 10 mg/ 10 mg IP

270 M-270

GRANISETRON HYDROCHLORIDE Syrup 1 mg/ml IP

271 M-271

ONDANSETRON HCL Syrup 2 mg base/5 ml IP

272 M-272

ONDANSETRON HCL Syrup 4 mg base/5 ml IP

273 M-273

ONDANSETRON HCL Tablet 4 mg IP

274 M-274

ONDANSETRON HCL Tablet 8mg IP

275 M-275

PROMETHAZINE HYDROCHLORIDE Syrup 5 mg/5 ml IP


65 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

276 M-276

PROMETHAZINE HYDROCHLORIDE Tablet 10 mg IP

277 M-277

PROMETHAZINE HYDROCHLORIDE Tablet 25mg IP

278 M-278

AMIODARONE HYDROCHLORIDE Tablet 200 mg IP

279 M-279

AMIODARONE HYDROCHLORIDE Tablet 100 mg USP

280 M-280

AMLODIPINE BESYLATE Tablet 10 mg IP

281 M-281

AMLODIPINE BESYLATE Tablet 5 mg IP

282 M-282

ATENOLOL Tablet 50 mg IP

283 M-283

ATORVASTATIN CALCIUM Tablet 10 mg IP

284 M-

284 ATORVASTATIN CALCIUM Tablet 20 mg IP

285 M-285

ATORVASTATIN CALCIUM Tablet 40 mg IP

286 M-286

CARVEDILOL Tablet 12.5 mg IP

287 M-287


288 M-288


289 M-289

DIGOXIN Syrup 0.05 mg/ml IP

290 M-290

DIGOXIN Tablet 0.25 mg IP

291 M-291

DIGOXIN Tablet 0.5 mg IP

292 M-292

DILTIAZEM HYDROCHLORIDE Tablet 30 mg IP

293 M-293

DILTIAZEM HYDROCHLORIDE Tablet 60 mg IP


66 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

294 M-294

DILTIAZEM HYDROCHLORIDE Tablet 90mg modified release IP

295 M-295

DILTIAZEM HYDROCHLORIDE Tablet 120 mg modified release IP

296 M-296

ENALPRIL MALEATE Tablet 2.5 mg IP

297 M-297

ENALPRIL MALEATE Tablet 5 mg IP

298 M-298

FENOFIBRATE Tablet 70 mg IP

299 M-299

FENOFIBRATE Tablet 140 mg IP

300 M-300

GLYCERYL TRINITRATE Tablet 6.4mg IP

301 M-301

GLYCERYL TRINITRATE SUBLINGUAL Tablet 0.5mg IP

302 M-302

GLYCERYL TRINITRATE Tablet 0.3mg IP

303 M-303

GLYCERYL TRINITRATE Tablet 2.6 mg IP

304 M-304

HYDROCHLORTHIAZIDE Tablet 12.5mg IP

305 M-305

ISOSORBIDE 5 MONONITRATE Tablet 10 mg IP

306 M-306

ISOSORBIDE 5 MONONITRATE Tablet 20 mg IP

307 M-307

ISOSORBIDE DINITRATE Tablet 5 mg IP

308 M-308

ISOSORBIDE DINITRATE Tablet 10 mg IP

309 M-309

ISOSORBIDE DINITRATE Tablet 20 mg SR

310 M-310

LOSARTAN POTASSIUM Tablet 50 mg IP

311 M-311

LOSARTAN POTASSIUM WITH HYDROCHLOROTHIAZIDE

Tablet 50 mg+12.5 mg IP


67 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

312 M-312

METHYLDOPA Tablet 250 mg IP

313 M-313

METOPROLOL TARTARATE Tablet 100 mg IP

314 M-314


315 M-315


316 M-316

NEBIVOLOL HYDROCHLORIDE Tablet 5 mg IP

317 M-317

NEBIVOLOL HYDROCHLORIDE Tablet 2.5 mg IP

318 M-318

NIFEDIPINE Capsule 5 mg IP

319 M-319

NIFEDIPINE Capsule 10mg IP

320 M-

320 NIFEDIPINE Tablet 5 mg IP

321 M-321

NIFEDIPINE Tablet 10mg IP

322 M-322

NIFEDIPINE Tablet 20 mg

323 M-323

PERINDOPRIL ERBUMINE TABLET 4mg USP

324 M-324

PERINDOPRIL ERBUMINE +AMLODEPINE TABLET 4mg+5mg IP

325 M-325

PERINDOPRIL ERBUMINE +INDAPAMIDE TABLET 4mg+1.2mg IP

326 M-326

PERINDOPRIL ERBUMINE +INDAPAMIDE TABLET 8mg+2.5mg IP

327 M-327

RAMIPRIL Capsule 2.5 mg IP

328 M-328

ROSUVASTIN CALCIUM Tablet 5 mg IP

329 M-329

ROSUVASTIN CALCIUM Tablet 10mg IP


68 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

330 M-330

ROSUVASTIN CALCIUM Tablet 20 mg IP

331 M-331

S AMLODIPINE BESYLATE Tablet 2.5mg IP

332 M-332

S AMLODIPINE BESYLATE Tablet 5mg IP

333 M-333

TELMISARTAN Tablet 40 mg IP

334 M-334

TELMISARTAN Tablet 80 mg IP

335 M-335

VERAPAMIL HCL Tablet 40 mg IP

336 M-336

VERAPAMIL HCL Tablet 80 mg IP

337 M-338

BUDESONIDE INHALER 100mcg IP

338 M-

339 BUDESONIDE Rotacap 100 mcg IP

339 M-340

BUDESONIDE LEVALBUTEROL RASPULES 1mg+1mg IP

340 M-341

FLUTICASONE Rotacap 250 mcg IP

341 M-342

FLUTICASONE PROPIONATE ROTACAP Rotacap 100 mcg IP

342 M-343

INHALER BECLOMETHASONE DIPROPIONATE AEROSOL

Inhaler 100 mcg/meterd dose IP

343 M-344

BECLOMETHASONE DIPROPIONATE AEROSOL Inhaler 200 mcg/meterd dose IP

344 M-345

BECLOMETHASONE DIPROPIONATE AEROSOL Inhaler 50 mcg/meterd dose IP

345 M-346

SALBUTAMOL AEROSOL Inhaler 100 mcg/meterd dose IP

346 M-347

SALMETROL 25 MCG WITH FLUCTICASONE 250 MCG

Inhaler 25 mcg + 250 mcg IP

347 M-348

SALMETROL 25 MCG WITH FLUCTICASONE125 MCG

Inhaler 25mcg+125mcg IP


69 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

348 M-349

SALMETROL 50 MCG WITH FLUCTICASONE250 MCG

Inhaler 50mcg+250mcg IP

349 M-350

IPRATROPIUM BROMIDE RASPULE 500mg IP

350 M-351

IPRATROPIUM BROMIDE Rotacap 40 mcg IP

351 M-352

IPRATROPIUM BROMIDE Solution 250 mcg/ml IP

352 M-353

LEVOSALBUTAMOL Syrup 1 mg/5 ml IP

353 M-354

LEVOSALBUTAMOL 1.25mg IPRATROPIUM BROMIDE 500mcg

Raspule 1.25mg+500mcg IP

354 M-355

SALBUTAMOL Raspule 2.5mg/2.5ml IP

355 M-356

SALBUTAMOL Rotacap 100 mcg IP

356 M-

357 SALBUTAMOL Solution 5 mg/ml IP

357 M-358

SALBUTAMOL SOLUTION FOR NEBULIZATION Solution 3 ml=2.5 mg IP

358 M-359

SALBUTAMOL SULPHATE Tablet 2 mg IP

359 M-360

SALBUTAMOL SULPHATE Tablet 4 mg IP

360 M-361

SALBUTAMOL SULPHATE Tablet 8mg IP

361 M-362

SALMETROL 50 AND FLUTICASONE 250 ROTACAP 50 mcg + 250 mcg IP

362 M-363

THEOPHYLLINE WITH ETOPHYLLINE Tablet 69 mg+231 mg IP

363 M-364

DEFERASIROX DISPERSIBLE Tablet 125MG IP

364 M-365

DEFERASIROX Tablet 250 mg IP

365 M-366

TRANEXAMIC ACID TABLET 250mg IP


70 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

366 M-367

TRANEXAMIC ACID TABLET 500mg IP

367 M-368

TRANEXAMIC ACID MEFENAMIC ACID TABLET 500mg 250mg FDC

368 M-369

ETHAMSYLATE Tablet 250 mg IP

369 M-370

ETHAMSYLATE Tablet 500 mg IP

370 M-371

CYCLOPHOSPHAMIDE Tablet 50 mg IP

371 M-372

HYDROXYUREA Tablet 1000 mg IP

372 M-373

HYDROXYUREA Tablet 500 mg IP

373 M-374

TAMOXIFEN CITRATE Tablet 10 mg IP

374 M-375

TAMOXIFEN CITRATE Tablet 20 mg IP

375 M-376

PREDENISOLONE Tablet 10 mg IP

376 M-377


377 M-378


378 M-379

ACETAZOLAMIDE Tablet 250 mg IP

379 M-380

FRUSEMIDE Tablet 40 mg IP

380 M-381

INDAPAMIDE Tablet 2.5 mg IP

381 M-382

INDAPAMIDE SR Tablet 1.5 mg IP

382 M-383

SPIRONOLACTONE Tablet 25 mg IP

383 M-384

SPIRONOLACTONE Tablet 50 mg IP


71 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

384 M-385

SPIRONOLACTONE WITH FRUSEMIDE Tablet 50 mg + 20 mg FDC

385 M-386

TORASEMIDE Tablet 5mg IP

386 M-387

TORASEMIDE Tablet 10 mg IP

387 M-388


388 M-389


389 M-390

ACECLOFINAC PARACETAMOL CHLOROZOXAZONE

Tablet 100mg\500mg\250mg FDC

390 M-391

ALLOPURINOL Tablet 100 mg IP

391 M-392

EPERISONE TABLET 150mg

392 M-

393 ETORICOXIB Tablet 120 mg IP

393 M-394

ETORICOXIB Tablet 90 mg IP

394 M-395

FABUXOSTAT Tablet 40mg IP

395 M-396

HYDROXY CHLOROQUINE SULPHATE Tablet 200mg IP

396 M-397

LEFLUNOMIDE Tablet 10 mg IP

397 M-398

LEFLUNOMIDE Tablet 20 mg IP

398 M-399

METHOCARBAMOL Tablet 500mg IP

399 M-400

SERRATIOPEPTIDASE Tablet 5 mg IP

400 M-401

SERRATIOPEPTIDASE Tablet 10mg IP

401 M-402

SULPHASALAZINE Tablet 500 mg


72 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

402 M-403

THIOCOLCHICOSIDE Tablet 8mg IP

403 M-404

ACTIVE CHARCOAL Tablet BP

404 M-405

BUPROPION HCL Tablet 150mg IP

405 M-406

DISULFIRAM Tablet 2500mg IP

406 M-407

FUROZOLADINE DISPERSIBLE Tablet 100 mg

407 M-408

METRONIDAZOLE Tablet 200 mg IP

408 M-409

METRONIDAZOLE Tablet 400 mg IP

409 M-410

METRONIDAZOLE BENZOATE SUSPENSION 40mg/ml

410 M-411

ORAL REHYDRATION SALTS CITRATE (W.H.O. Formula)

sachet

ORS 20.5Gm. Each sachet Contains Sodium Chloride IP 2.6g Potassium Chloride IP 1.5g Sodium Citrate IP 2.9g 2.9g Anhydrous Dextorse IP 13.5g

for making 1 ltr

IP

411 M-412

ORNIDAZOLE Tablet 500 mg IP

412 M-413

RACECADOTRIL Capsule 100 mg IP

413 M-

414 RACECADOTRIL Tablet 10 mg IP

414 M-415

SACCHAROMYCES BOULARDII Capsule 250mg

415 M-416

SECNIDAZOLE Tablet 1000 mg IP

416 M-417

SPORES OF POLY ANITBIOTIC RESISTANT BACILLUS CLAUSII

Capsule 2 billion spores IP


73 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

417 M-418

SPORES OF POLY ANITBIOTIC RESISTANT BACILLUS CLAUSII

SUSPENSION 2 billion spores IP

418 M-419

TINIDAZOLE Tablet 300 mg IP

419 M-420

TINIDAZOLE Tablet 500 mg IP

420 M-421

ALLYLOSTRENOL Tablet 5 mg USP

421 M-422

CABERGOLINE TABLET 0.25mg IP

422 M-423


PHOSPHATE ) Tablet

50 mg,X3 TAB 500mg +25mgX 1 TAB 7.5mg X 1 TAB

NVBDCP

423 M-424

CLOMIPHENE CITRATE Tablet 25 mg IP

424 M-425

CLOMIPHENE CITRATE Tablet 50 mg IP

425 M-426

CLOTRIMAZOLE VAGINAL Tablet 100 mg (WITH APPLICATOR) IP

426 M-427


427 M-428


428 M-429

CONJUGATED OESTROGENS Tablet 0.625 mg IP

429 M-430

CONJUGATED OESTROGENS Tablet 1.25 mg IP

430 M-431

DANAZOL Capsule 100 mg IP

431 M-432


432 M-433


433 M-434

DINOPROSTONE Tablet 0.5 mg IP


74 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

434 M-435

DYDROGESTERONE Tablet 10 mg IP

435 M-436

DYDROGESTERONE Tablet 5 mg IP

436 M-437

ETHINYLOESTRADIOL Tablet 0.01 mg IP

437 M-438

ETHINYLOESTRADIOL Tablet 0.05 mg IP

438 M-439

ETHINYLOTSTRADIOL WITH NORGESTREL Tablet 0.25 mg+0.05mg IP

439 M-440

ETHINYLOUSTRADIOL WITH LEVONORGESTREL Tablet 0.03 mg+0.15 mg IP

440 M-441

ISOXUPRIME HYDROCHLORIDE Tablet 10 mg IP

441 M-442

ISOXUPRIME HYDROCHLORIDE Tablet 20 mg IP

442 M-

443 LABETALOL HCL Tablet 100 mg IP

443 M-444

LABETALOL HCL Tablet 200 mg IP

444 M-445

LABETALOL HCL Tablet 50 mg IP

445 M-446

LEVONORGESTROL Tablet 1.5 mg IP

446 M-447

MEDROXYPROGESTRONE Tablet 10 mg IP

447 M-448

METHYLERGOMETRINE MALEATE Tablet 0.125 mg IP

448 M-449

MIFEPRISTONE Tablet 200 mg IP

449 M-450

MISOPROSTOL Tablet 200 mcg IP

450 M-451


451 M-452



75 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

452 M-453

NORETHISTERONE Tablet 5 mg IP

453 M-454

PGE 2 DINOPROSTONE Gel 0.5 mg IP

454 M-455

POVIDINE IOIDINE VAGINAL Tablet 200 mg with applicator IP

455 M-456

PROGESTERON SOFT GELATIN MICRONISED Capsule 100 mg IP

456 M-457


457 M-458


458 M-459

RITODRINE HYDROCHLORIDE Tablet 10 mg IP

459 M-460

SULBUTIAMINE TABLET 200mg IP

460 M-461

XANTHINOL NICOTINATE Tablet 150 mg IP

461 M-462

XANTHINOL NICOTINATE (RETARD TABLET) Tablet 500 mg IP

462 M-463

BUDESONIDE HCL nasal spray 100 mcg IP

463 M-464

BUDESONIDE HCL nasal spray 200 mcg IP

464 M-465

Chloramphenicol 5% w/v Benzocaine 1%w/v Ear Drop 5% w/v+ 1% w/v IP

465 M-466

ACT 00 TO 01 YEAR(ARTESUNATE ,SULPHADOXINE+PYRIMETHAMINE, )

Tablet 25 mgX3 TAB 250mg +12.5mgX 1

TAB NVBDCP

466 M-467

CIPROFLOXACIN HYDROCHLORIDE Eye Drop 0.3% w/v IP

467 M-468

CLOTRIMAZOLE Ear Drop 1% W/v IP

468 M-469

Clotrimazole 1%+ Lignocaine HCL2% w/v Ear Drop 1%+2%w/v IP


76 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

469 M-470

FLUTICASONE PROPIONATE nasal spray 100 mcg IP

470 M-471


471 M-472


472 M-473

Gentamicin Sulphate 0.3%w/v+ Betamethasone0.1%w/v

Ear Drop 0.3% w/v+0.1% w/v IP

473 M-474

LIGNOCAINE HCL SPRAY 15% W/W IP

474 M-475

PARADICHLOROBENZEN 2% CHLOROBUTOL TURPENTINE OIL BENZOCAINE

EAR DROP 2%, 5%, 15%, 2.7%,W/V IP

475 M-476

SODIUM CHLORIDE Nasal Drop 0.009 IP

476 M-477

Xylometazoline HCL Nasal Drop 0.05%w/v IP

477 M-478

ACYCLOVIR eye ointment 3% w/w IP

478 M-479

ATROPINE SULPHATE eye ointment 1.0% w/w atropine sulphate IP

479 M-480

ATROPINE SULPHATE Eye Drop 1% W/v IP

480 M-481

CARBOXYMETHYL CELLULOSE SODIUM Eye Drop 0.5% W/v IP

481 M-482

CARBOXYMETHYL CELLULOSE SODIUM Eye Drop 1% W/v IP

482 M-483

CHLORAMPHENICOL eye applicap 1% W/w IP

483 M-484

CHLORAMPHENICOL Eye Drop 0.5% W/v IP

484 M-485

CYCLOPENTOLATE HCL EYE DROP 1%W/V IP

485 M-486

DEXAMETHASONE WIYH NEOMYCIN EYE DROP 0.1%+0.5% IP


77 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

486 M-487

FLUCONAZOLE Eye Drop 0.3% w/v IP

487 M-488

FLURBIPROFEN SODIUM Eye Drop 0.03% w/v IP

488 M-489

GENTAMYCIN EYE/Ear Drop 0.003 IP

489 M-490

LIGNOCAINE HCL TOPICAL 4%W/W BP

490 M-491

METHYLCELLULOSE SOLUTION FOR INTRA OPERATING USE

Solution 0.02 IP

491 M-492

MOXIFLOXACIN HYDROCHLORIDE Eye Drop 0.5% W/v IP

492 M-493

NAPHZOLINE NITRATE BORIC ACID SODIUM CHLORIDE ZINC SULPHATE

Eye Drop 0.056% w/v+1.25% w/v+0.5%

w/v+0.12% w/v FDC

493 M-494

PHENYLEPHRINE HYDROCHLORIDE Eye Drop 10% w/v IP

494 M-495

PILOCARPINE NITRATE Eye Drop 1% W/v IP

495 M-496

PILOCARPINE NITRATE Eye Drop 2% W/V IP

496 M-497

POTASSIUM IODIDE SODIUM CHLORIDE EYE DROP 1%w/v 0.83%w/v IP

497 M-498

PREDENISOLONE SODIUM PHOSPHATE Eye Drop 1.0% w/v IP

498 M-499

SULPHACETAMIDE SODIUM Eye Drop 10% w/v IP

499 M-500


500 M-501


501 M-502

TIMOLOL MALEATE Eye Drop 0.25% W/v IP

502 M-503

TIMOLOL MALEATE Eye Drop 0.5% W/v IP


78 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

503 M-504

TOBRAMYCIN Eye Drop 0.3% w/v IP

504 M-505

TROPICAMIDE Eye Drop 1%W/V IP

505 M-506

TRYPAN BLUE Dye 0.6mg/ml IP

506 M-507

CHOLINE SALICYLATE BEZALKONIUMCHLORIDE LIGNOCAINE HYDROCHLORIDE

Gel 8.7%W/W,0.01%W/W,2%W/W FDC

507 M-508

CHLORHEXIDINE GLUCONATE SOLUTION Solution 0.2% w/v IP

508 M-509

POVIDINE IOIDINE LIQUID 1%W/V IP

509 M-510

CLOTRIMAZOLE ORAL MOUTH PAINT Solution 1%W/V IP

510 M-511

B COMPLEX Tablet

VITAMIN B1 5 MG THIAMINE HYDROCHLORIDE VITAMIN B2

5MG RIBOFLAVIN VITAMIN B6 2MG PYRIDOXINE

HYDROCHLORIDE VITAMIN B3 NICOTINAMIDE 50 MG VITAMIN B5 CALCIUM PANTOTHENATE 5

MG

IP

511 M-512

BIOTIN (B7) Tablet 5 mg

512 M-513

CALCITRIOL SOFT GELATIN CAPSULE Capsule 0.25 mcg IP

513 M-

514 CALCIUM CARBONATE WITH VITAMIN D3 Tablet 1250mg+250IU IP

514 M-515

CALCIUM CARBONATE WITH VITAMIN D3 SUSPENSION 625+125IU/5ml IP

515 M-516

CALCIUM CARBONATE WITH ALPHA CALCIDOL Capsule 625 mg+0.25 mcg IP

516 M-517

CALCIUM LACTATE Tablet 300 mg NHM


79 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

517 M-518

CHOLECALCIFEROL Nano Spray/Drop 60000IU/spray IP

518 M-519

DEFERASIROX Tablet 500MG IP

519 M-520

ETHAMSYLATE +TRANEXANIC ACID Tablet 250mg+250MG IP

520 M-521

BARIUM SULPHATE MIXED READY TO USE SUSPENSION

SUSPENSION 95% w/v IP

521 M-522

FOLIC ACID (B9) Tablet 400mcg IP

522 M-523

IDEBENONE Tablet 30 mg IP

523 M-524

IRON AND FOLIC ACID IFA LARGE CONTAINING DRIED FERROUS SULPHATE EQ TO FERROUS

IRON 100 MG AND FOLIC ACID 1/2 MG Tablet

100 mg+0.5 mg RED SUGAR COATED

NHM

524 M-525

IRON AND FOLIC ACID IFA LARGE CONTAINING DRIED FERROUS SULPHATE EQ TO FERROUS

IRON 45 MG AND FOLIC ACID 0.4MG Tablet

45 mg+0.4 mg PINK IFA WIFS JUNIOR

NHM

525 M-526

IRON AND FOLIC ACID IFA SMALL CONTAINING DRIED FERROUS SULPHATE EQ TO FERROUS

IRON 20 MG AND FOLIC ACID 01 MG Tablet 20 mg + 0.1 mg NHM

526 M-527

IRON AND FOLIC ACID CONTAINING DRIED FERROUS SULPHATE IP

Tablet

equivalent to ferrous iron 100 mg & folic acid 0.5 mgIFA WIFS LARGE

BLUE COLOURED INDIGO CARMINE

NHM

527 M-528

IRON WITH FOLIC ACID Syrup 20 mg+100 mcg/ml NHM

528 M-529

IRON WITH FOLIC ACID Syrup 20 mg+100 mcg/ml NHM

529 M-530

RIBOFLAVIN (B2) Tablet 100mg IP

530 M-531

PYRIDOXINE HYDROCHLORIDE (B6) Tablet 100 mg IP


80 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

531 M-532

NIACINAMIDE (B3) Tablet 500 mg IP

532 M-533

CALCIUM PANTOTHENATE (B5) Tablet 500 mg IP

533 M-534

POVIDIONE IODINE SOLUTION Solution 7.5% w/v IP

534 M-535

METHYLECOBALAMINE FOR SUBLINGUAL USE Tablet 1500 mcg BP

535 M-536

METHYLCOBALAMINE (B12) Tablet 500 mcg IP

536 M-537

THIAMINE HYDROCHLORIDE (B1) Tablet 100mg IP

537 M-538

STREPTOCOCCUS FAECALIS+CLOSTRIDIUM BUTYRICUM+BACILLUS MESENTERICUS

Capsule

60 MIllions spores 4 Millions Spores 2 Millions Spores

100 Millions Sproes

IP

538 M-539

STREPTOCOCCUS FAECALIS+CLOSTRIDIUM BUTYRICUM+BACILLUS MESENTERICUS

SYRUP

30 MIllions spores 2 Millions Spores 1 Millions Spores 50 Millions Sproes

IP

539 M-540

VITAMIN A AS ALL TRANS ISOMER OF RETINOL 30 MGSOFT GELATIN APPLICAP

APPLICAP 100000 IU IP

540 M-541

DISODIUM HYDROGEN CITRATE Syrup 1.53G/5ML IP

541 M-542

ZINC SULPHATE DISPERSIBLE Tablet eq. to elemental zinc 20mg NHM

542 M-

543 BISACODYL ENTERIC COATED Tablet 5 mg IP

543 M-544

BISACODYL ENTERIC COATED Tablet 10 mg IP

544 M-545

ENEMA GLYCERIN SODIUM CHLORIDE TUBE 15% W/w+15% W/v IP

545 M-546

LACTULOSE Syrup 3.325gm/5ml IP


81 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

546 M-547

PARAFFIN LIQUID 100%v/v IP

547 M-548

PARAFFIN LIQUID 100%v/v IP

548 M-549

ALPRAZOLAM Tablet 0.25 mg IP

549 M-550

ALPRAZOLAM Tablet 0.5 mg IP

550 M-551

AMISULPRIDE Tablet 50 mg IP

551 M-552

AMISULPRIDE Tablet 100 mg IP

552 M-553

AMISULPRIDE Tablet 200mg IP

553 M-554

AMITRIPTYLINE HCL Tablet 10mg IP

554 M-

555 AMITRIPTYLINE HCL Tablet 25mg USP

555 M-556

AMITRIPTYLINE HYDROCHLORIDE Tablet 50 mg IP

556 M-557

AMITRIPTYLINE HYDROCHLORIDE Tablet 75 mg IP

557 M-558

ARIPIPRAZOLE Tablet 10 mg IP

558 M-559

ARIPIPRAZOLE Tablet 15 mg IP

559 M-560

ATOMOXETINE Tablet 10mg USP

560 M-561

ATOMOXETINE Tablet 25mg USP

561 M-562

BLONANSERIN Tablet 8mg IP

562 M-563

CEPHALEXIN Dry Syrup 125mg/5ml IP

563 M-564

CHLORPROMAZINE Tablet 100mg IP


82 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

564 M-565

CLOMIPRAMINE Tablet 25mg IP

565 M-566

CLOMIPRAMINE Tablet 50mg

566 M-567

CLONAZEPAM Tablet 0.25 mg IP

567 M-568

CLONAZEPAM Tablet 0.5 mg IP

568 M-569

CLONAZEPAM Tablet 2 mg IP

569 M-570

CLOZAPINE Tablet 100mg IP

570 M-571

CLOZAPINE Tablet 75mg IP

571 M-572

DESVENLAFAXINE SUCCINATE Tablet 25mg IP

572 M-

573 DESVENLAFAXINE SUCCINATE Tablet 50mg IP

573 M-574

DIVALPROEX SODIUM Tablet 250mg IP

574 M-575


575 M-576


576 M-577


577 M-578

DIAZEPAM Tablet 5 mg IP

578 M-579

DONEPEZIL HYDROCHLORIDE Tablet 10mg IP

579 M-580

DONEPEZIL HYDROCHLORIDE Tablet 5mg IP

580 M-581

DOTHIEPIN HYDROCHLORIDE Tablet 25mg IP

581 M-582

DOTHIEPIN HYDROCHLORIDE Tablet 100mg IP


83 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

582 M-583

DULOXEITINE HYDROCHLORIDE Tablet 20 mg IP

583 M-584

DULOXEITINE HYDROCHLORIDE Tablet 30 mg IP

584 M-585

ESCITALOPRAM Tablet 5 mg IP

585 M-586

ESCITALOPRAM Tablet 10 mg IP

586 M-587

ESCITALOPRAM Tablet 20mg IP

587 M-588

ETIZOLAM Tablet 0.25mg IP

588 M-589

ETIZOLAM Tablet 0.5mg IP

589 M-590

ETIZOLAM Tablet 1mg IP

590 M-

591 FLUNARIZINE Tablet 10 mg IP

591 M-592

FLUNARIZINE Tablet 5mg IP

592 M-593

CLONAZEPAM Tablet 1 mg IP

593 M-594

FLUOXETINE HYDROCHLORIDE Capsule 20 mg IP

594 M-595

FLUOXETINE HYDROCHLORIDE Capsule 40 mg IP

595 M-596

FLUPHENAZINE DECANOATE Tablet 25mg IP

596 M-597

FLUVOXAMINE MALEATE Tablet 100mg IP

597 M-598

HALOPERIDOL Tablet 0.25 mg IP

598 M-599


599 M-600



84 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

600 M-601

HALOPERIDOL Tablet 5mg IP

601 M-602

HALOPERIDOL Tablet 10mg IP

602 M-603

IMIPRAMINE Tablet 25mg IP

603 M-604

IMIPRAMINE Tablet 75mg IP

604 M-605

LAMOTRIGINE Tablet 100mg IP

605 M-606


606 M-607


607 M-608

LEVETIRACETAM Tablet 250mg IP

608 M-

609 LEVETIRACETAM Tablet 500mg IP

609 M-610

LEVODOPA CARBIDOPA Tablet 100mg/10mg FDC

610 M-611

LEVODOPA WITH CARBIDOPA Tablet 250 mg/25 mg FDC

611 M-612

LITHIUM CARBONATE Tablet 300mg BP

612 M-613

LITHIUM CARBONATE SR Tablet 400 mg BP

613 M-614

LORAZEPAM Tablet 1mg IP

614 M-615

LORAZEPAM Tablet 2 mg IP

615 M-616

LORAZEPAM Tablet 3mg IP

616 M-617

MEMATINE HYDRO CHLORIDE Tablet 5mg IP

617 M-618

MEMATINE HYDRO CHLORIDE Tablet 10mg IP


85 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

618 M-619

MIRTAZAPINE Tablet 7.5mg IP

619 M-620

MIRTAZAPINE Tablet 30 mg IP

620 M-621

MIRTAZAPINE Tablet 15mg IP

621 M-622

NICERGOLINE Tablet 5 mg USP

622 M-623

NALTREXONE HCL Tablet 50mg IP

623 M-624

NITRAZEPAM Tablet 5mg IP

624 M-625

NITRAZEPAM Tablet 10mg IP

625 M-626

OLANZAPINE Tablet 2.5 mg IP

626 M-

627 OLANZAPINE Tablet 5 mg IP

627 M-628

OLANZAPINE Tablet 10mg IP

628 M-629

OLANZAPINE Tablet 20 mg

629 M-630

OXCARBAZEPINE Tablet 300mg IP

630 M-631

PAROXETINE HCL Tablet 25mg

631 M-632

PAROXETINE HCL Tablet 10mg IP

632 M-633


633 M-634


634 M-635

PIRACETAM Tablet 800mg IP

635 M-636

PRAMIPEXOLE DIHYDROCHLORIDE Tablet 0.5mg IP


86 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

636 M-637

PROPANOLOL HYDROCHLORIDE Tablet 10mg IP

637 M-638


638 M-639


639 M-640

PROCHLORPERAZINE MALEATE Tablet 5 mg IP

640 M-641

QUETIAPINE FUMARATE Tablet 200mg IP

641 M-642

QUETIAPINE FUMARATE Tablet 100mg IP

642 M-643

QUETIAPINE FUMARATE Tablet 50 mg IP

643 M-644

QUETIAPINE FUMARATE Tablet 25 mg IP

644 M-

645 RISPERIDONE Tablet 1 mg IP

645 M-646

RISPERIDONE Tablet 2 mg IP

646 M-647

RISPERIDONE Tablet 3 mg. IP

647 M-648

RISPERIDONE Tablet 4 mg IP

648 M-649

RIVASTIGMINE Tablet 1.5mg IP

649 M-650

RIVASTIGMINE Tablet 3mg IP

650 M-651

RIVASTIGMINE Tablet 4.5mg

651 M-652

SERTRALINE HYDROCHLORIDE Tablet 25mg IP

652 M-653

SERTRALINE HYDROCHLORIDE Tablet 50 mg IP

653 M-654

SERTRALINE HYDROCHLORIDE Tablet 100 mg IP


87 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

654 M-655

THIORIDAZINE Tablet 25mg IP

655 M-656

THIORIDAZINE Tablet 50mg IP

656 M-657

TIANEPTINE Tablet 12.5mg IP

657 M-658

TIAPRIDE Tablet 50mg IP

658 M-659

TOPIRAMATE Tablet 100mg IP

659 M-660

TOPIRAMATE Tablet 50mg IP

660 M-661

TRIFLUOPERAZINE HYDROCHLORIDE Tablet 5mg IP

661 M-662

TRIFLUOPERAZINE HYDROCHLORIDE Tablet 10mg IP

662 M-

663

TRIFLUOPERAZINE TRIHEXYPHENIDYL HCL

CHLORPROMAZINE Tablet 5 mg + 2 mg + 50mg FDC

663 M-664

TRIHEXYPHENIDYL HYDROCHLORIDE Tablet 2 mg IP

664 M-665

TRIHEXYPHENIDYL HYDROCHLORIDE Tablet 5mg IP

665 M-666

ZOLPIDEM TARTARATE Tablet 5 mg IP

666 M-667

ZOLPIDEM TARTARATE Tablet 10 mg IP

667 M-

668 ZONISAMIDE Tablet 100mg IP

668 M-669

BENZYL BENZOATE APPLICATION application 25% w/w IP

669 M-670

BETAMETHASONE SODIUM PHOSPHATE Cream 0.1% W/w IP

670 M-671

BETAMETHASONE SODIUM PHOSPHATE Cream 0.05% W/w IP


88 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

671 M-672

CLINDAMYCIN GEL 1% W/W IP

672 M-673

CLOTRIMAZOLE Cream 1% W/w IP

673 M-674

CLOTRIMAZOLE Cream 2% w/w IP

674 M-675

CLOTRIMAZOLE Powder 1% W/w

675 M-676

Beclomethasone Dipropionate; Lidocaine Hydrochloride ; Phenylephrine Hydrochloride

Cream 0.025%+2.5%+0.1% IP

676 M-677

Beclomethasone Dipropionate; Lidocaine Hydrochloride ; Phenylephrine Hydrochloride

Ointment 0.05%+2.5%+0.1% IP

677 M-678

COAL TAR KETACONAZOLE Solution 4% w/v+2% w/v IP

678 M-

679 COAL TAR lotion 5% w/v IP

679 M-680

CLOTRIMAZOLE BECLOMETHASONE DIPROPIONATE

Cream 0.1% W/w+0.025% W/w IP

680 M-681

FRAMYCETIN SULPHATE Cream 1% W/w IP

681 M-682

FRAMYCETIN SULPHATE Cream 1% W/w IP

682 M-683

FRAMYCETIN SULPHATE DEXAMETHASONE ACETATE

CREAM 1%W/W+0.1%w/w IP

683 M-

684 FUSIDIC ACID OINT Ointment 0.02 IP

684 M-685

GAMA BENZENE HEXACHLORIDE LOTION lotion 1% W/v IP

685 M-686

METHYLROSANILINIUM CHLORIDE(GENTION VIOLET) SOLUTION/PAINT

Solution 0.25% W/v IP


89 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

686 M-687

METHYLROSANILINIUM CHLORIDE(GENTION VIOLET) SOLUTION/PAINT

Solution 0.5% w/w IP

687 M-688

GRISEOFULVIN Tablet 125mg IP

688 M-

689 GRISEOFULVIN Tablet 250mg IP

689 M-690

GRISEOFULVIN Tablet 375mg IP

690 M-691

HYDROCORTISONE CREAM Cream 0.005 IP

691 M-692

HYDROCORTISONE CREAM Cream 0.01 IP

692 M-693

ISOTRETINOIN Capsule 20 mg IP

693 M-694

METHOXASALEN Tablet 10 mg IP

694 M-695

METRONIDAZOLE Gel 1% W/w IP

695 M-696

MICONAZOLE NITRATE Gel 2% w/w IP

696 M-697

MUPIROCIN CREAM 2% W/W IP

697 M-698

RECOBINANT HUMAN EPIDERMAL GROWTH FACTOR GEL

GEL 15mg IP

698 M-699

NEOMYCINE+POLYMYXINE B SULPHATE & BACITRACIN ZINC

POWDER 3400Units+5000Units+400Units IP

699 M-

700 PERMETHRIN Cream 5% W/w IP

700 M-701

PODOPHYLINE TINCTURE lotion 25% w/v IP

701 M-702

POVIDIONE IODINE Powder 5% W/w IP

702 M-703

POVIDIONE IODINE SOLUTION Solution 10% eq. to 1% iodine IP


90 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

703 M-704

POVIDIONE IODINE SOLUTION Solution 5% w/v IP

704 M-705

POVIDONE IODINE Ointment 10% w/v IP

705 M-706

POVIDONE IODINE Ointment 5% W/w IP

706 M-707

POVIDONE IODINE Solution 5% w/v IP

707 M-708

SALICYLIC ACID WITH BETAMETHASONE Ointment 3% W/w+0.64% W/w

708 M-709

SILVER SULPHADIAZINE Cream 1% W/w IP

709 M-710

SILVER SULPHADIAZINE Cream 1% W/w IP

710 M-711

SILVER SULPHADIAZINE+CHLORHEXIDINE GLUCONATE+RECOMBINANT HUMAN

EPIDERMAL GROWTH FACTOR Cream

1% W/w 0.2%

10mcg/gm IP

711 M-712

TRIOXSALEN TABLET 25mg IP

712 M-713

CARBIMAZOLE Tablet 20 mg IP

713 M-714

CARBIMAZOLE Tablet 5 mg IP

714 M-715

CARBIMAZOLE Tablet 10 mg

715 M-

716 IODINE LIQUID 8 mg/ 5 ml

716 M-717

THYROXINE SODIUM Tablet 0.05 mg IP

717 M-718

THYROXINE SODIUM Tablet 0.1 mg IP

718 M-719

DISODIUM HYDROGEN CITRATE LIQUID 1.53 gm/5 ml IP


91 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

719 M-720

DUTASTERIDE Tablet 0.5 mg IP

720 M-721

TAMSULOSIN HCL Tablet 0.2 mg IP

721 M-722

TAMSULOSIN HCL Tablet 0.4 mg. IP

722 M-723

AMINO ACID CAPSULE

(L-Leucine 18.3mg, L-Isoleucine 5.9mg, L-Lysine Hcl25mg, L-

Phenylalanine 5mg, L-threomine 8.3mg, L-valine 6.7mg, L-

Tryptophan 10.1mg, L-Methionine 18.4mg, Copper Suphate

Pentahydrate 1mg, Managanese Sulphate monohydrate 4.6mg, Light Magnesium Oside 30mg,

Selenium75mcg)

FDC

723 M-724

L ORNITHINE L ASPARTATE Tablet 150mg

724 M-725

PEPSIN FUNGAL DIASTASE THIAMINE HCL RIBOFLAVIN PYRIDOXINE HCL

CYANOCOBALAMINE PANTOTHENOL D NICOTINAMIDE

CAPSULE 125mg 18.75mg 2mg 1mg 1.5mcg

1mcg 1.5mg 15mg IP

725 M-726

VITAMIN A SOFTGEL 25000IU IP

726 M-727

ASCORBIC ACID Tablet 100 mg IP

727 M-728

ASCORBIC ACID Tablet 500 mg IP


92 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

728 M-729

B COMPLEX Capsule

VITAMIN B1 5 MG THIAMINE HYDROCHLORIDE VITAMIN B2 5MG RIBOFLAVIN VITAMIN B6

2MG PYRIDOXINE HYDROCHLORIDE VITAMIN B3

NICOTINAMIDE 50 MG VITAMIN B5 CALCIUM PANTOTHENATE 5

MG

IP

729 M-730

Multi Vitamin (Therapeutic) SYRUP

Containing :Thiamine Hydrochloride 2.5 mg/5 ml, Riboflavine 2.5 mg/ 5 ml,

Pyridoxine Hydrochloride1.0 mg/5 ml, Cyanocobalamine5.0 mcg/5 ml

,Niacinamide25.0 mg/5 ml with dosage instructions-one teaspoonful twice daily

NHM

730 M-731

LACTOBASCILLUS SPOROGENES Capsule 60 millions spores IP

731 M-732

VITAMIN A AND VITAMIN D3 SOFT GELATIN CAP Capsule 5000 iu+400 iu IP

732 M-733

VITAMIN A PALMIPATE Arachis oil base LIQUID 100000 IU/ml IP

733 M-734

VITAMIN A SOFT GELATIN CAP Capsule 50000 iu IP

734 M-735

PROCHLORPERAZINE MALEATE Tablet 10 mg IP

735 M-736

VITAMIN E (TOCOPHEROL ) SOFT GELATIN CAP Capsule 600 mg IP

736 M-737


737 M-738

VITAMIN D Capsule 60000IU IP

738 M-739



93 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

739 M-740

CARBON DIOXIDE GAS NA IP

740 M-741

HALOTHANE LIQUID 0.1%W/W THYMOL IP

741 M-742


742 M-743


743 M-744

ISOFLURANE LIQUID 5 mg/5 ml IP

744 M-745

LIGNOCAINE GEL Gel 2%W/V IP

745 M-746

NITROUS OXIDE IP GAS NA IP

746 M-747

OXYGEN IP GAS 0.93 IP

747 M-

748 INDOMETHACIN SR Capsule 75mg IP

748 M-749

INDOMETHACIN Capsule 25mg IP

749 M-750

Turpentine Oil I.P. LIQUID IP

750 M-751

ACETYLSALICYLIC ACID TABLET 300mg ENTERIC COATED

Effervescent IP

751 M-752

ACETYLSALICYLIC ACID TABLET 500mg ENTERIC COATED

Effervescent IP

752 M-753

MEFENAMIC ACID CAPSULE 250mg IP

753 M-754

MEFENAMIC ACID CAPSULE 500mg IP

754 M-755

TRAMADOL CAPSULE 100mg IP

755 M-756

ACETYLSALICYLIC ACID TABLET 100mg ENTERIC COATED IP

756 M-757

OMEPRAZOLE CAPSULE 10mg IP


94 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

757 M-758

RANITIDINE SYRUP 75mg/ml IP

758 M-759

FLAVOXATE HYDROCHLORIDE TABLET 100mg IP

759 M-760

AMOXYCILLIN SYRUP 250mg/5ml IP

760 M-761

AMOXYCILLIN WITH CLAVLANIC ACID SUSPENSION 200mg+28.5mg/5ml IP

761 M-762

AMOXYCILLIN WITH CLAVLANIC ACID DRY SYRUP 125mg+31.5mg/5ml IP

762 M-763

CEFADROXYL TABLET 1G IP

763 M-764

CEFIXIME SYRUP 100mg/5ml IP

764 M-765

CLOXACILLIN CAPSULE 500mg IP

765 M-

766 CLOXACILLIN SYRUP 125mg/5ml IP

766 M-767

AZITHROMYCIN SYRUP 200mg/5ml IP

767 M-768

CIPROFLOXACIN SUSPENSION 250mg/5ml IP

768 M-769

SPIRAMYCIN TABLET 3 Million I U IP

769 M-770

SPIRAMYCIN TABLET 1.5 Million I U IP

770 M-771

FLUCONAZOLE TABLET 100mg IP

771 M-772


772 M-773


773 M-774

FLUCONAZOLE SYRUP 50mg/5ml IP

774 M-775

ACYCLOVIR SYRUP 400mg/5ml IP


95 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

775 M-776

RIBAVIRIN CAPSULE 200mg IP

776 M-777

TENOFOVIR TABLET 300mg IP

777 M-778

WARFERIN TABLET 1mg IP

778 M-779


779 M-780


780 M-781

MORPHINE TABLET 10mg IP

781 M-782

CARBAMAZEPINE SYRUP 200mg/ml IP

782 M-783

DIAZEPAM SYRUP 2mg/5ML IP

783 M-

784 DIAZEPAM SUPPOSITORY 5mg IP

784 M-785

LORAZEPAM TABLET 1mg IP

785 M-786

LORAZEPAM TABLET 2mg IP

786 M-787

PHENYTOIN TABLET 50mg IP

787 M-788

PHENYTOIN TABLET 300mg IP

788 M-789

PHENYTOIN TABLET 300mg ER IP

789 M-790

PHENYTOIN SYRUP 30mg/5ml IP

790 M-791

SODIUM VALPROATE TABLET 300mg IP

791 M-792

SODIUM VALPROATE TABLET 500mg IP

792 M-793

METFORMIN HYDROCHLORIDE TABLET 750mg IP


96 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

793 M-794

CLOMIPHENE CITRATE TABLET 100mg IP

794 M-795

CHLORPHENIRAMINE MALEATE SYRUP 2mg/5ML IP

795 M-796

EBASTINE TABLET 10mg IP

796 M-797

EBASTINE TABLET 20mg IP

797 M-798

ALBENDAZOLE TABLET 400mg IP

798 M-799

MEBENDAZOLE SYRUP 100mg/5ml IP

799 M-800

DIETHYLCARBAMAZINE CITRATE SYRUP 120mg/5ml IP

800 M-801

DIETHYLDIPHENYLSULPHONE TABLET 25mg IP

801 M-

802 DIETHYLDIPHENYLSULPHONE TABLET 100mg IP

802 M-803

PRAZIQUANTEL TABLET 600mg IP

803 M-804

ARTEMETHER WITH LUMEFATRINE SYRUP 80mg+480mg/5ml IP

804 M-805

CHLOROQUINE TABLET 150mg IP

805 M-806

QUININE TABLET 300mg IP

806 M-807

RIFAMPICIN CAPSULE 300mg IP

807 M-808

CLOPIDOGREL TABLET 75mg IP

808 M-809

ISOSORBIDE MONONITRATE TABLET 30mg SR IP

809 M-810

ISOSORBIDE MONONITRATE TABLET 60mgSR IP

810 M-811

METOPROLOL TABLET 25mg SR IP


97 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

811 M-812

METOPROLOL TABLET 50mg SR IP

812 M-813

AMLODEPINE BESYLATE TABLET 2.5mg IP

813 M-814

ATENOLOL TABLET 100mg IP

814 M-815

METHYLDOPA TABLET 500mg IP

815 M-816

RAMIPRIL TABLET 5mg IP

816 M-817

TELMISARTAN TABLET 20mg IP

817 M-818

TADALAFIL TABLET 2.5mg IP

818 M-819

TADALAFIL TABLET 5mg IP

819 M-

820 SILDENAFIL TABLET 5mg IP

820 M-821

SILDENAFIL TABLET 20mg IP

821 M-822

BUDESONIDE RASPULE 0.5mg/ml IP

822 M-823

BUDESONIDE WITH FORMOTEROL INHALER 100mcg+6mcg/DOSE IP

823 M-824


824 M-825


825 M-826

SALBUTAMOL SYRUP 2mg/5ML IP

826 M-827

TIOTROPIUM INHALER 9mcg/DOSE IP

827 M-828

TIOTROPIUM INHALER 18mcg/DOSE IP

828 M-829

METHOTREXATE TABLET 5mg IP


98 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

829 M-830

METHOTREXATE TABLET 7.5mg IP

830 M-831

METHOTREXATE TABLET 10mg IP

831 M-832

AZATHIOPRINE TABLET 50mg IP

832 M-833

DEXAMETHASONE TABLET 0.5mg IP

833 M-834

PREDNISOLONE SYRUP 5mg/ml IP

834 M-835

PREDNISOLONE SYRUP 15mg/ml IP

835 M-836

HYDROCORTISONE TABLET 5mg IP

836 M-837

HYDROCORTISONE TABLET 10mg IP

837 M-

838 METHYLPREDNISOLONE TABLET 8mg IP

838 M-839

METHYLPREDNISOLONE TABLET 16mg IP

839 M-840

METHYLPREDNISOLONE TABLET 32mg IP

840 M-841

HYDROCHLOROTHIAZIDE TABLET 25mg IP

841 M-842

FRUSEMIDE SYRUP 10mg/ml IP

842 M-843

HYDROCHLOROTHIAZIDE TABLET 50mg IP

843 M-844

ALLOPURINOL TABLET 300mg IP

844 M-845

COLCHICINE TABLET 0.5mg IP

845 M-846

HYDROXYCHLOROQUINE TABLET 400mg IP

846 M-847

TIZANIDINE HYDROCHLORIDE TABLET 4mg IP


99 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

847 M-848

Lornoxicam Tab 16mg SR

848 M-849

NEOSTIGMINE TABLET 15mg IP

849 M-850

NICOTINE GUM 2mg IP

850 M-851

NICOTINE GUM 4mg IP

851 M-852

NICOTINE PATCH 114mg IP

852 M-853

NITROFURANTOIN SUSPENSION 25mg/5ml IP

853 M-854

SECNIDAZOLE Tab 2gm I.P.

854 M-855

ETHINYLESTRADIOL WITH NORETHISTRONE TABLET 0.035mg+1mg IP

855 M-856

DINOPROSTONE GEL 0.5mg IP

856 M-857

MISOPROSTOL Tab 400mcg I.P.

857 M-858

Sertaconazole Nitrate Vaginal Tab with

Applicator 500mg

858 M-859

XYLOMETAZOLINE NASAL DROPS 0.001 IP

859 M-860

FLUORESCEIN SODIUM EYE DROPS 0.01 IP

860 M-861

CIPROFLOXACIN OINTMENT 0.003 IP

861 M-862

POVIDONE IODINE EYE DROPS 0.006 IP

862 M-863

PREDNISOLONE EYE DROPS 0.001 IP

863 M-864

PROPARACAINE HYDROCHLORIDE EYE DROPS 0.005 IP

864 M-865

PILOCARPINE EYE DROPS 0.04 IP


100 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

865 M-866

HOMATROPINE EYE DROPS 0.02 IP

866 M-867

PHENYLEPHRINE EYE DROPS 0.05 IP

867 M-868

FERROUS FUMERATE TABLET 200mg EQUIVALENT TO 65mg

FERROUS ION IP

868 M-869

FERROUS GLUCONATE TABLET 300mg EQUIVALENT TO 35 mg

FERROUS ION IP

869 M-870

FERROUS SULPHATE TABLET 200mg EQUIVALENT TO 60mg

FERROUS ION IP

870 M-871

POTASSIUM CHLORIDE SYRUP 500mg/5ml IP

871 M-872

CALCIUM CARBONATE TABLET 250mg IP

872 M-873

CALCIUM CARBONATE TABLET 500mg IP

873 M-874

POTASSIUM CHLORIDE TABLET 20 milliequivalents SR IP

874 M-875

BISACODYL SUPPOSITORY 5mg IP

875 M-876

PROPANOLOL HYDROCHLORIDE TABLET 80mg IP

876 M-877

RISPERIDONE SYRUP 1mg/ml IP

877 M-878

FLUOXETINE CAPSULE 10mg IP

878 M-879

FLUOXETINE CAPSULE 60mg IP

879 M-880

CLOMIPRAMINE CAPSULE 10mg IP

880 M-881

CLOMIPRAMINE CAPSULE 75mg IP

881 M-882

ERYTHROMYCIN OINTMENT 0.005 IP


101 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

882 M-883

CALAMINE LOTION

CALAMINE 150G ZINC OXIDE 50G BENTONITE 30G SODIUM CITRATE

5G LIQUIFIED PHENOL 5ML GLYCERINE 50ML AQUA 1L

IP

883 M-884

BENZOYL PEROXIDE GEL 0.025 IP

884 M-885

PERMETHRIN LOTION 0.01 IP

885 M-886

Gama Benzene Hexachloride +Benzoczine CREAM 1%+2% I.P.

886 M-887

LEVOTHYROXINE TABLET 12.5mcg IP

887 M-888

LEVOTHYROXINE TABLET 25mcg IP

888 M-889


889 M-

890 LEVOTHYROXINE TABLET 75mcg IP

890 M-891


891 M-892


892 M-893

PHYTOMENADIONE TABLET 10mg IP

893 M-894

CHOLECALCIFEROL SYRUP 400 IU/ml IP

894 M-895

CHOLECALCIFEROL TABLET 1000 IU IP

895 M-896

PYRIDOXINE TABLET 10mg IP

896 M-897

PYRIDOXINE TABLET 50mg IP

897 M-898

MIDAZOLAM TABLET 7.5mg IP

898 M-899

MIDAZOLAM TABLET 15mg IP


102 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

899 M-900

MIDAZOLAM SYRUP 2mg/ML IP

900 M-901

SEVOFLURANE LIQUID IP

901 M-902

PRILOCAINE WITH LIGNOCAINE CREAM 2.5%+2.5% IP

902 M-903

CETRIMIDE SOLUTION 0.2 IP

903 M-904

CETRIMIDE SOLUTION 0.2 IP

904 M-905

POTASSIUM PERMANGANATE POWDER CRYSTALS FOR SOLUTION IP

905 M-906

Dextrose Monohydrate POWDER 1 IP

906 M-907

ETHYL ALCOHAL LIQUID 0.7 IP

907 M-

908 ETHYL ALCOHAL LIQUID 0.7 IP

908 M-909

Formalin LIQUID IP

909 M-910

Paraffin I.PWhite Soft. GEL IP

910 M-911

Glycerin I.P. LIQUID IP

911 M-912


912 M-913


913 M-914


914 M-915

Hydrogen Peroxide Solution I.P. LIQUID 6% w/v IP

915 M-916


916 M-917



103 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

917 M-918


918 M-919


919 M-920


920 M-921

Chlorine Water LIQUID 10% w/v

921 M-922

Boric Acid I.P. POWDER IP

922 M-923


923 M-924


924 M-925

Acriflavin powder POWDER IP

925 M-

926

CALCIUM SULPHATE HEMIHYDRATE(Plaster of

Paris) I.P. POWDER IP

926 M-927

CALCIUM SULPHATE HEMIHYDRATE(Plaster of Paris) I.P.

POWDER 2

927 M-928

Magnesium Sulphate I.P. POWDER IP

928 M-929

Magnesium Sulphate I.P. POWDER IP

929 M-930

Lysol I.P. LIQUID IP

930 M-931


931 M-932


932 M-933

Tab. Sodium Dichloroisocyanurate TABLET 33mg available Chlorine 20 mg

suitable for 5 litres IP

933 M-934

Tab. Sodium Dichloroisocyanurate TABLET 8.68 gms available chlorine 5000

mg suitable for 1000 litres of water IP


104 | P a g e

S No.

Code


Name

Testing Charge

(A)

Service Tax (B)


(A+B)

934 M-935

Tab. Sodium Dichloroisocyanurate TABLET 67 mg available chlorine 40 mg suitable for 10 litres of water

IP

935 M-936

Tab. Sodium Dichloroisocyanurate TABLET 1.67 gms available chlorine 1000

mg suitable for 200 litres IP

936 M-937

Tab. Sodium Dichloroisocyanurate TABLET 167mg available Chlorine 100 mg

suitable for 20 litres IP

937 M-938

1 Tab Azithromycin (1 gm) /2 Tab Azithromycin (500mg) & 1 Tab Cefixme (400mg)

Kit-1 1 gm 500mg

400mg IP

938 M-939

1 Tablet Secnidazole (2 gm) / 2 Tablet Secnidazole (1 gm) &

Tab Fluconazole (150 mg) Kit-2

2 gm 1 gm 150mg

IP

939 M-940

Injection Benzathine Pencillin (2.4 MU) + & 1 Tablet Azithromycin (1gm) + distilled water (10

ml) Kit-3 2.4 MU 1gm 10ml IP

940 M-941

28 Tablet /Capsules of Doxycycline (100mg) &

1 Tablet Azithromycin (1 gm)/ 2 Tablet Azithromycin (500mg)

Kit-4 100mg 1gm

500mg IP

941 M-942

21 Tablet of Acyclovir (400mg) Kit-5 400mg IP

942 M-943

1 Tab Cefixme (400mg) & 28 Tablet of Metronidazole (400mg) & 28 Tablet

of Doxycycline (100mg) Kit-6

400mg 400mg 100mg

IP

943 M-944

42 Tablet of Doxycycline (100mg) & 1 Tablet Azithromycin (1 gm)

Kit-7 100mg 1gm IP


105 | P a g e

5. PRICE SCHEDULE: FOR LIST OF INJECTABLES

S No.

Code Name Formulation Strength /Size Pharmacopeia

Name Testing

Charge (A) Service Tax

(B)

Rate (inclusive All taxes) (A+B)

1 I-1 ACECLOFINAC Injection 150mg/ml

2 I-2 DICLOFENAC SODIUM Injection 25 mg/ml IP

3 I-3 KETOROLAC TROMETHAMINE Injection 30 mg/ml USP

4 I-4 PARACETAMOL Injection 150mg/ml IP

5 I-5 PARACETAMOL

MANNITOL/CYSTIENE Injection 10mg/ml BP

6 I-6 PARACETAMOL

MANNITOL/CYSTIENE Injection 10mg/ml BP

7 I-7 PENTAZOCINE LACTATE Injection 30 mg/ml IP

8 I-8 PHLOROGLUCINOL+

TRIMETHYLPHLOROGLUCINOL Injection 40mg/0.4mg BP

9 I-9 TRAMADOL HYDROCHLORIDE Injection 50mg/ ml IP

10 I-10 NANDROLONE DECANOATE Injection 50 mg./ml. IP

11 I-11 NANDROLONE PHENYL

PROPIONATE Injection 25 mg/ml IP

12 I-12 NANDROLONE PHENYL

PROPIONATE Injection 50 mg./ml. IP

13 I-13 OMEPRAZOLE Injection 40mg USP

14 I-14 PANTOPRAZOLE Injection 4 mg/ml IP

15 I-15 RANITIDINE HYDROCHLORIDE Injection 25mg/ ml IP

16 I-16 DICYCLOMINE HYDROCHLORIDE Injection 10 mg/ml USP

17 I-17 DROTAVERINE HYDROCHLORIDE Injection 20mg/ml IP

18 I-18 HYOSCINE BUTYLE BROMIDE Injection 20mg/ml IP

19 I-19 AMIKACIN SULPHATE Injection 100 mg/2ml IP




106 | P a g e

S No.


Name Testing


(B)


22 I-22 AMOXYCILLIN SODIUM Injection 250 mg IP

23 I-23 AMOXYCILLIN SODIUM Injection 500 mg IP

24 I-24 AMOXYCILLINE TRIHYDRATE WITH

CLAVULANATE POTASSIUM Injection 1 gm+200mg IP

25 I-25 AMOXYCILLINE TRIHYDRATE WITH

CLAVULANATE POTASSIUM Injection 500MG+100mg IP

26 I-26 AMPICILLIN SODIUM Injection 100 mg IP



29 I-29 ANIDULAFUNGIN Injection 100mg USP

30 I-30 BENZATHINE PENICILLIN SODIUM Injection 12 lacs IU IP



33 I-33 CEFOPERAZONE WITH SULBACTUM Injection 500 mg+500 mg IP

34 I-34 CEFOPERAZONE SODIUM Injection 250 mg IP

35 I-35 CEFOPERAZONE SODIUM Injection 500 mg IP

36 I-36 CEFOPERAZONE SODIUM Injection 1 gm IP

37 I-37 CEFOTAXIME SODIUM Injection 1 gm IP

38 I-38 CEFOTAXIME SODIUM Injection 125 mg IP



41 I-41 CEFPIROME SULPHATE Injection 1 gm IP

42 I-42 CEFTAZIDIME PENTAHYDRATE Injection 250 mg IP

43 I-43 CEFTAZIDIME PENTAHYDRATE Injection 500 mg IP

44 I-44 CEFTAZIDIME PENTAHYDRATE Injection 1 gm IP

45 I-45 CEFTAZIDIME PENTAHYDRATE Injection 2gm IP


107 | P a g e

S No.


Name Testing


(B)


46 I-46 CEFTRIAXONE SODIUM Injection 1 gm IP

47 I-47 CEFTRIAXONE SODIUM Injection 500 mg IP

48 I-48 CEFTRIAXONE SODIUM Injection 250mg IP

49 I-49 CEFTRIAXONE SODIUM Injection 125 mg IP

50 I-50 CIPROFLOXACIN HYDROCHLORIDE Injection 2 mg/ml BP

51 I-51 CLINDAMYCIN PHOSPHATE Injection 150mg/ml IP

52 I-52 GENTAMICIN SULPHATE Injection 10 mg/ml IP

53 I-53 GENTAMICIN SULPHATE Injection 40 mg/ml IP

54 I-54 IMIPENEM WITH CILASTATIN Injection 250 mg+250 mg IP

55 I-55 IMIPENEM WITH CILASTATIN Injection 500 mg+500 mg IP

56 I-56 LEVOFLOXACIN IN 5% DEXTROSE Injection 500 mg/100 ml USP

57 I-57 LINCOMYCIN HYDROCHLORIDE Injection 300 mg USP

58 I-58 LINEZOLID Injection 2mg/ml USP

59 I-59 METRONIDAZOLE Injection 5 mg/ml IP

60 I-60 PIPERACILLIN WITH TAZOBACTAM

SODIUM Injection 4gm + 500mg USP

61 I-61 TIGECYCLINE Injection 50 mg USP

62 I-62 VANCOMYCIN HCL Injection 500 mg IP

63 I-63 ALTEPLASE Injection 100 mg(58millioni IU) USP

64 I-64 ALTEPLASE Injection 50 mg(29millioni IU) USP

65 I-65 ALTEPLASE Injection 20 mg USP

66 I-66 HEPARIN SODIUM Injection 10000 IU USP

67 I-67 DALTEPARIN LOW MOL WT

HEPARIN Injection 2500IU USP

68 I-68 ENOXAPARIN LOW MOL WT

HEPARIN Injection 60mg//0.6ml USP

69 I-69 STREPTOKINASE Injection 1500000 IU IP


108 | P a g e

S No.


Name Testing


(B)


70 I-70 FOSPHENYTOIN SODIUM Injection 75mg/ml

71 I-71 FOSPHENYTOIN SODIUM Injection 75mg/ml

72 I-72 LEVETIRACETAM Injection 100 mg/ml USP

73 I-73 PHENOBARBITONE SODIUM Injection 100 mg/ml BP

74 I-74 PHENYTOIN SODIUM Injection 50 mg./ml. BP

75 I-75 INSULIN HUMAN ULTRA LENTE Injection 40 IU/ml IP

76 I-76 INSULIN NEUTRAL WITH INSULIN

ISOPHANE Injection 25%/75% 100IU/ml BP

77 I-77 INSULIN HUMAN SOLUBLE Injection 40 IU/ml BP

78 I-78 INSULIN HUMAN SOLUBLE with

INSULIN HUMAN NEUTRAL PROTAMINE HAGEDORN

Injection 30%70%40 IU/ml BP

79 I-79 INSULIN GLARGINE Injection 100IU/ml BP

80 I-80 INSULIN GLULISINE Injection 100 IU/ml USP

81 I-81 INSULIN LISPRO Injection 100IU/ml BP

82 I-82 INSULIN LISPRO WITH INSULIN

PROTAMINE Injection 25%/75% 100IU/ml BP

83 I-83 INSULIN LISPRO WITH INSULIN

PROTAMINE Injection 50%, /50%100IU/ml BP

84 I-84 INSULIN SOLUBLE WITH INSULIN

ISOPHANE Injection 50%, /50%100IU/ml IP

85 I-85 INSULIN SOLUBLE WITH INSULIN

ISOPHANE Injection 50%, /50%40IU/ml IP

86 I-86 PHENIRAMINE MALEATE Injection 22.75 mg/ml IP

87 I-87 ARTEETHER Injection 75 mg/ml IP

88 I-88 ARTESUNATE Injection 60 mg IP

89 I-89 CHLOROQUINE PHOSPHATE Injection 40mg/ml IP

90 I-90 CHLOROQUINE PHOSPHATE Injection 40 mg/ml IP

91 I-91 QUININE DIHYDROCHLORIDE Injection 300 mg/ml IP


109 | P a g e

S No.


Name Testing


(B)


92 I-92 STREPTOMYCIN SULPHATE Injection 0.75G eq. streptomycin IP

93 I-93 STREPTOMYCIN SULPHATE Injection 1G eq. streptomycin IP

94 I-94 METOCLOPRAMIDE HYDROCHLORIDE

Injection 5 mg/ml USP

95 I-95 METOCLOPRAMIDE

HYDROCHLORIDE Injection 5 mg/ml USP

96 I-96 ONDANSETRON Injection 2 mg/ml IP

97 I-97 ONDANSETRON Injection 2 mg/ml IP

98 I-98 PROCHLORPERAZINE Injection 12.5mg/ml BP

99 I-99 PROMETHAZINE HYDROCHLORIDE Injection 25 mg/ml USP

100 I-100 AMIODARONE HYDROCHLORIDE Injection 50 mg./ml. IP

101 I-101 DILTIAZEM HYDROCHLORIDE Injection 5 mg/ml USP

102 I-102 DOBUTAMINE HYDROCHLORIDE Injection 12.5 mg./ml. USP

103 I-103 DOBUTAMINE HYDROCHLORIDE Injection 50 mg./ml. USP

104 I-104 DOPAMINE HYDROCHLORIDE Injection 40 mg/ml USP

105 I-105 LIGNOCAINE HCL Injection 1%W/v BP

106 I-106 LIGNOCAINE HCL Injection 2%w/v BP

107 I-107 LIGNOCAINE IN DEXTROSE Injection 5%W/V in 7.5%Dextrose BP

108 I-108 LIGNOCAINE HCL WITH

ADRENALINE Injection

LIGNOCAINE HCL 20mg/ml ADRENALINE BITARTATE Eq. TO

Adrenaline 5mcg/ml BP

109 I-109 LIGNOCAINE HCL WITH SODIUM

CHLORIDE Injection 21.3mg+6mg/ml BP

110 I-110 MEPHENTERMINE SULPHATE Injection 30 mg/ml IP

111 I-111 MEPHENTERMINE SULPHATE Injection 15 mg/ml IP

112 I-112 TENECTEPLASE Injection 30 mg(6000IU) BP

113 I-113 TENECTEPLASE Injection 40 mg(8000iu) BP


110 | P a g e

S No.


Name Testing


(B)


114 I-114 TENECTEPLASE Injection 50 mg(10000IU) BP

115 I-115 VERAPAMIL HYDROCHLORIDE Injection 2.5 mg/ml IP

116 I-116 GLYCERYL TRINITRATE Injection 5 mg/ml IP

117 I-117 ADRENALINE BI TARTRATE Injection 1 mg/ml IP

118 I-118 AMINOPHYLLINE DIHYDRATE Injection 25 mg/ml IP

119 I-119 BOVINE LUNG SURFACTANT SUSPENSION 25mg/ml USP

120 I-120 DOXAPRAM HYDROCHLORIDE Injection 20 mg/ml USP

121 I-121 THEOPHYLLINE WITH

ETOPHYLLINE Injection 25.3mg+84.7 mg/ml IP

122 I-122 TRANEXAMIC ACID Injection 100mg/ml IP

123 I-123 ANTI HAEMOPHYLIC FACTOR IX Injection 500 IU USP

124 I-124 ANTI HAEMOPHYLIC FACTOR VIII Injection 500 IU USP

125 I-125 DESFERRIOXAMINE MESILATE Injection 500mg IP

126 I-126 ETHAMSYLATE Injection 125 mg/ml BP

127 I-127 HAEMOCOAGULASE Injection 1 christensen unit/ml IP

128 I-128 PROTAMINE SULPHATE Injection 10 mg/ ml BP

129 I-129 BLEOMYCIN SULPHATE Injection 15Unit Of Bleomycin

130 I-130 BLEOMYCIN SULPHATE Injection 30Unit Of Bleomycin

131 I-131 BORTEZOMIB Injection 3.5mg USP

132 I-132 BORTEZOMIB Injection 2mg USP

133 I-133 CARBOPLATIN Injection 10mg/ml BP

134 I-134 CARBOPLATIN Injection 10mg/ml BP

135 I-135 CISPLATIN Injection 1 mg/ml BP

136 I-136 CISPLATIN Injection 1 mg/ml IP

137 I-137 CYCLOPHOSPHAMIDE Injection 1G USP


111 | P a g e

S No.


Name Testing


(B)


138 I-138 CYCLOPHOSPHAMIDE Injection 2G USP

139 I-139 CYCLOPHOSPHAMIDE Injection 200 mg USP

140 I-140 CYCLOPHOSPHAMIDE Injection 500 mg USP

141 I-141 POTASSIUM CHLORIDE Injection 150mg/ml IP

142 I-142 DOCETAXEL TRIHYDRATE Injection 40mg/ml IP

143 I-143 DOCETAXEL TRIHYDRATE Injection 20mg/ml IP

144 I-144 DOXORUBICIN HCL LIPOSOMAL Injection 2 mg/ml USP



147 I-147 GOSERLIN ACETATE Injection 3.6mg

148 I-148 ETOPOSIDE PHOSPHATE Injection 100 mg BP

149 I-149 FLUOROURACIL Injection 50 mg/ml USP

150 I-150 FLUOROURACIL Injection 50 mg/ml USP

151 I-151 GOSERLIN ACETATE Injection 10.8mg

152 I-152 METHOTREXATE Injection 25mg/ml USP

153 I-153 OXALIPLATIN Injection 5 mg / ml USP

154 I-154 PACLITAXEL Injection 100 mg IP

155 I-155 PACLITAXEL Injection 260 mg IP

156 I-156 VINCRISTINE SULPHATE Injection 1 mg/ml IP

157 I-157 BETAMETHASONE SODIUM

PHOSPHATE Injection 4 mg/ml BP

158 I-158 DEXAMETHASONE SODIUM

PHOSPHATE Injection 4 mg/ml IP

159 I-159 HYDROCORTISONE SODIUM

SUCCIINATE Injection 100 mg IP

160 I-160 HYLAN GF20 Injection 8mg/ml USP

161 I-161 METHYLPREDNISOLONE ACETATE Injection 80mg\ml USP


112 | P a g e

S No.


Name Testing


(B)


162 I-162 METHYLPREDNISOLONE ACETATE Injection 20mg/ml USP

163 I-163 METHYLPREDNISOLONE ACETATE Injection 40mg\ml USP

164 I-164 METHYLPREDNISOLONE

SUCCINATE SODIUM Injection 1gm/ml USP


SUCCINATE SODIUM Injection 125mg/ml USP


SUCCINATE SODIUM Injection 500mg/ml USP

167 I-167 TRIAMCINOLONE ACETONIDE Injection 40mg/ml IP

168 I-168 FRUSEMIDE Injection 10 mg/ml IP

169 I-169 TORASEMIDE Injection 10 mg/ml IP

170 I-170 ABATACEPT Injection 250mg USP

171 I-171 METHOCARBAMOL Injection 100mg/ml IP

172 I-172 NALOXONE HCL Injection 1mg/ml IP

173 I-173 NALOXONE HCL(NEONATAL) Injection 20MCG/ML USP

174 I-174 NALOXONE HCL Injection 400MCG USP

175 I-175 NEOSTEGMINE METHYL SULPHATE Injection 0.5 mg/ml BP

176 I-176 NEOSTEGMINE METHYL SULPHATE Injection 0.5 mg/ml IP

177 I-177 PRALIDOXIME CHLORIDE Injection 1G USP

178 I-178 DEHYDROEMETINE DIHYDROCHLORIDE

Injection 30 mg/ml IP

179 I-179 TINIDAZOLE Injection 2mg/ml IP

180 I-180 AQUA EXTRACT OF FRESH HUMAN

PLECENTA Injection 0.1 gm/2 ml IP

181 I-181 CAMYLOFIN DIHYDROCHLORIDE Injection 25mg/ml BP

182 I-182 CARBOPROST TROMETHAMINE Injection 250 mcg/ml IP

183 I-183 DEPOT MEDROXY PROGESTERONE

ACETATE Injection 150 mg/ml IP


113 | P a g e

S No.


Name Testing


(B)


184 I-184 DEPOT MEDROXY PROGESTERONE

ACETATE Injection 400 mg/ml IP

185 I-185 HUMAN CHORIONIC

GONADOTROPIN Injection 5000 IU BP

186 I-186 IMMUNOGLOBULIN HUMAN ANTI-D

MONOCLONAL Injection 300mcg IP


MONOCLONAL Injection 150mcg IP

188 I-188 HYDROXYPROGESTERONE

CAPROATE Injection 250 mg/ml IP

189 I-189 HYDROXYPROGESTERONE

CAPROATE Injection 250 mg/ml IP

190 I-190 ANTI HAEMOPHYLIC FACTOR VIII Injection 250 IU USP

191 I-191 DALTEPARIN LOW MOL WT

HEPARIN Injection 5000IU USP

192 I-192 ISOXUPRIME HYDROCHLORIDE Injection 5mg/ml USP

193 I-193 LABETALOL HCL Injection 5mg/ml USP

194 I-194 LABETALOL HCL Injection 5mg/ml USP

195 I-195 MAGNESIUM SULPHATE Injection 50% w/v USP

196 I-196 MAGNESIUM SULPHATE Injection 50% w/v EQ To mg++mlMol/ml USP

197 I-197 METHYLERGOMETRINE MALEATE Injection 0.2 mg USP

198 I-198 OXYTOCIN Injection 5IU/ML IP

199 I-199 OXYTOCIN Injection 10 IU/ML USP

200 I-200 RITODRINE HYDROCHLORIDE Injection 10 mg/ml USP

201 I-201 VALETHAMATE BROMIDE Injection 8mg/ml IP

202 I-202 HYALURONIDAZE Injection 1500 IU IP

203 I-203 Hydroxypropyl methylcellulose

Ophthalmic(HPMC) Injection 2% in BalancedSaltSolution USP

204 I-204 SODIUM HYALURONATE Injection 10mg/ml IP


114 | P a g e

S No.


Name Testing


(B)


205 I-205 CALCIUM GLUCONATE Injection 100 mg IP


POLYCLONAL Injection 300mcg IP


POLYCLONAL Injection 150mcg IP

208 I-208 DARBEPOETIN INJECTION 40mcg/ml USP

209 I-209 ERYTHROPOIETIN Injection 2000 IU/ml USP

210 I-210 ERYTHROPOIETIN Injection 4000 IU USP



213 I-213 FERRIC CARBOXY MALTOSE Injection 50mg/ml BP

214 I-214 IRON DEXTRAN Injection 50 mg/ml USP

215 I-215

IRON SUCROSE CONTAINING FERRIC HYDROXIDE AS COMPLEX

WITH SUCROSE EQ TO ELEMENTAL IRON 20MG/ML


216 I-216

IRON SUCROSE CONTAINING FERRIC HYDROXIDE AS COMPLEX

WITH SUCROSE EQ TO ELEMENTAL IRON 20MG/ML


217 I-217 METHYLCOBALAMINE Injection 500 mcg/ml USP

218 I-218 PHYTOMENADIONE Vit.K Injection 1mg/ml IP

219 I-219 ERYTHROPOIETIN Injection 3000 units / ml IP

220 I-220 DIAZEPAM Injection 5 mg/ml IP

221 I-221 LORAZEPAM Injection 2 mg/ml USP

222 I-222 HALOPERIDOL LACTATE Injection 5mg/ml USP

223 I-223 PIRACETAM Injection 200 mg/15ml IP

224 I-224 ANTI SERUM POLYVALENT SNAKE

VENOM ASV Injection 10 ml USP


115 | P a g e

S No.


Name Testing


(B)


225 I-225

ANTI SERUM Polyvalent Equine Purified Concentrated Liquid of Anti

Gas Gangrene Sera(anti gas gangrene serum)

Injection 30000 IU IP

226 I-226 ANTI SERUM RABIES Injection 300 IU/ml IP

227 I-227 VACCINE RUBELLA Injection 0.5ML IP

228 I-228 Vaccine H1N1 Influenza Injection 0.5ml IP

229 I-229 Vaccine Human PapilomaVirus type

16&18(Recombinant,AS04 adjuvanted)

Injection 0.5 ml

230 I-230 HUMAN NORMAL

IMMUNOGLOBULIN Injection 10% w/v IP

231 I-231 HUMAN NORMAL

IMMUNOGLOBULIN Injection 16.5% w/v IP

232 I-232 IMMUNOGLOBULIN ANTI TETANUS Injection 1000 IU IP

233 I-233 IMMUNOGLOBULIN ANTI TETANUS Injection 250 IU IP

234 I-234 IMMUNOGLOBULINDIPHTHERIA

ANTITOXIN Injection 10000 IU BP

235 I-235 Vaccine Inactivated Hepatitis A

(Adsorbed)IP 1ML IP

236 I-236 Vaccine Inactivated Hepatitis A

(Adsorbed)IP For Paediatric/adolescent use

0.5ml IP

237 I-237 Vaccine Measles,Mumps & Rubella

MMR Injection 0.5ml IP

238 I-238 vaccine Pneumococcal

Polysaccharide conjugate (adsorbed)

Injection 0.5 ml IP

239 I-239 IMMUNOGLOBULIN ANTI-

TETANUS Injection 500IU

240 I-240 TUBERCULIN PURIFIED PROTEIN

DERIVATIVE Injection 5TU/0.1ml IP

241 I-241 VACCINE ANTI RABIES Injection 2.5 IU Per Vial IP


116 | P a g e

S No.


Name Testing


(B)


242 I-242 VACCINE ANTI RABIES Injection 2.5 IU Per Vial IP

243 I-243 VACCINE BCG Injection 33million CFU/1ml saline IP

244 I-244 VACCINE DIPHTHERIA PERTUSSIS

TETANUS Injection 0.5ml IP

245 I-245 VACCINE DIPHTHERIA TETANUS Injection 0.5ml IP

246 I-246 VACCINE GENETICALLY

ENGINEERED HEPATITIS B Injection 20mcg/ml IP





249 I-249 Vaccine H1N1 Influenza Injection 0.5ml IP

250 I-250 VACCINE JE Injection 1ml IP

251 I-251 VACCINE LIVE ATTENUATED

MEASLES VACCINE SCHWARTZ Injection 0.5ml IP

252 I-252 VACCINE MEASLES MUMPS RUBELLA VARICELLA MMRV

Injection 0.5ml IP

253 I-253 VACCINE TENTANUS TOXOID Injection 0.5ml IP

254 I-254 VACCINE YELLOW FEVER Injection 0.5ml IP

255 I-255 Varicella vaccine, Live IP 0.5 ml

256 I-256 VACCINE POLIOMYELITIS (LIVE

ATTENUATED) SALK 0.5ml

257 I-257 LEVOTHYROXINE

SODIUM(lyophilized powder) Injection 100 mcg USP


117 | P a g e

S No.


Name Testing


(B)


258 I-258 AMINO ACID Injection

(L-Lysine Hcl,19.2mg,L-methionine 6.8mg, L-tryptophan

3mg, L-leucine 10mg, L-Isoleucine6.6mg, L-

Phenylalamine 9.5mg, L-valine 6.4mg, L-Arginine Hc,. 10.9mg,

L-Histidine Hcl (Monohyd.)4.7mg, glycine 6mg,

Sorbitol 50mg/ml)

IP

259 I-259 AMINO ACID WITH TAURINE AND

WITHOUT SORBITOL Injection 50 gm/ 500 ml IP

260 I-260 DEXTRAN 70 WITH 5 PERCENT

DEXTROSE Injection 6% w/v IP

261 I-261 DEXTROSE Injection 10% w/v IP


263 I-263 DEXTROSE WITH SODIUM

CHLORIDE Injection 5% w/v +0.9%W/V IP

264 I-264 HAEMO DIALYSIS FLUID Injection

EACH 1000ml contains:- Potassium chloride IP 5.49gm

Magnesium chloride IP 3.55gm Calcium Chloride IP 7.97gm

Chloride IP 200.66gm Purified Water IP Q.S

IP

265 I-265 SODIUM CHLORIDE Injection 3% w/v USP

266 I-266 SODIUM CHLORIDE Injection 5% w/v USP

267 I-267 MANNITOL Injection 10% w/v IP




271 I-271 MANNITOL WITH GLYCERINE Injection 10gm +10gm/100ml IP



118 | P a g e

S No.


Name Testing


(B)



274 I-274 MANNITOL WITH GLYCERINE Injection 20gm + 20gm/100ml IP



277 I-277 Muliple electrolytes and dextrose

type-1 (Isolyte P) Injection

Sodium acetate trihydrate 0.32gm Potassium chloride

0.13gm Dipotassium hydrogen phosphate heptahydrate

0.026gm magnisium chloride hexahydrate 0.031gm Dextrose 5.0gm Water for injection to

100ml pH 5.0

278 I-278 Multiple electrolytes nad dextrose

type-2(Isolyte R) Injection

Sodium acetate trihydrate 0.64gm Sodium chloride

0.496gm Potassium chloride

0.0746gm calcium chloride dihydrate 0.0368 gm Magnisium chloride hexahydrate 0.0305gm sodium lactate .089gm Dextrose

5.0gm Water for injection to 100ml pH5.5


type-3(Isolyte M) Injection


0.091gm Potassium chloride 0.15gm Dipotassium hydrogen

phosphate heptahydrate 0.13gm Dextrose 5.0gm Water for

injection to 100ml pH5


type-4(Isolyte G) Injection

Sodium chloride 0.37gm Potassium chloride 0.13gm amonium chloride 0.37gm Dextrose 5.0gm Water for

injection to 100ml


119 | P a g e

S No.


Name Testing


(B)



type-5(Isolyte E) Injection


0.50gm Sodium citrate 0.074gm Potassium chloride0.074gm

Calcium chloride 0.035 Magnisium chloride hexahydrate

0.030gm Dextrose 5.0gm Water for

injection to 100ml pH 5


type-6(Isolyte S) Injection

Sodium acetate trihydrate 0.37gm Sodium chloride 0.53gm Sodium gluconate 0.5gm Potassium chloride 0.037gm Calcium chloride

0.035gm Dipotassium hydrogen phosphate heptahydrate

0.012gm magnisium chloride hexahydrate

0.030gm Water for injection to 100ml pH

7.4

283 I-283 SODIUM CHLORIDE Injection 0.9% w/v IP

284 I-284 SODIUM CHLORIDE Injection 0.9% w/v IP

285 I-285 HYDROXYETHYL STARCH WITH

SODIUM CHLORIDE Injection 6% w/v 0.9% w/v USP

286 I-286 RINGER LACTATE Injection

0.24%w/vLacticAcid (eq.0.32%w/vSod.Lac.) with0.6%w/vSod.Cl.,

0.04%w/vPot .Cl. & 0.027% w/vCal Cl

IP

287 I-287 SODIUM BICARBONATE Injection 7.5% w/v IP

288 I-288 SODIUM BICARBONATE Injection 8.4% w/v IP

289 I-289 HUMAN ALBUMIN Injection 0.2 IP


120 | P a g e

S No.


Name Testing


(B)


290 I-290 WATER FOR INJECTION Injection 5ml IP

291 I-291 WATER FOR INJECTION Injection 10ml IP

292 I-292 Polygeline Polypeptides of degraded gelatin,cross linked via urea bridges

Injection

Polygeline 3.5g(Eq.to0.63g of nitrogen) sodium chloride IP 0.85g Potassium chloride IP

0.038g calcium chloride IP 0.070 g water for inj IP

Q,s/100ml Electrolytes in M.mol/Litre

Na145 m mol per liter K 5.1m Mol per liter

Ca 6.25m Mol per liter Cl 145 m mol per liter

293 I-293 L ORNITHINE L ASPARTATE Injection 0.5 gm/ml USP

294 I-294 ATROPINE SULPHATE Injection 0.6 mg/ml IP

295 I-295 ATRACURIUM BESYLATE Injection 10 mg/ml USP

296 I-296 BUPIVACAINE HYDROCHLORIDE Injection 0.5%W/V IP

297 I-297 VECURONIUM BROMIDE Injection 4 mg BP

298 I-298 CLONIDINE HYDROCHLORIDE Injection 150 mcg IP

299 I-299 DEXMEDETOMIDINE Injection 4 mcg/ml IP



302 I-302 FENTANYL CITRATE Injection 50 mcg eq. Fentanyl /ml BP

303 I-303 FENTANYL CITRATE Injection 50 mcg eq. Fentanyl /ml BP

304 I-304 GLYCOPYRROLATE Injection 0.2 mg/ml IP

305 I-305 GLYCOPYRROLATE Injection 0.2 mg/ml IP

306 I-306 KETAMINE HYDROCHLORIDE Injection 50 mg./ml. IP

307 I-307 KETAMINE HYDROCHLORIDE Injection 10 mg/ml IP


121 | P a g e

S No.


Name Testing


(B)


308 I-308 KETAMINE HYDROCHLORIDE Injection 50 mg./ml. IP

309 I-309 LEVOBUPIVACAINE HYDROCHLORIDE


310 I-310 LEVOBUPIVACAINE HYDROCHLORIDE


311 I-311 IOHEXOL Injection 350 MG/ML IP

312 I-312 MIDAZOLAM HCL Injection 1 mg/ml IP

313 I-313 MIDAZOLAM HCL Injection 1 mg/ml IP

314 I-314 MIDAZOLAM HCL Injection 5 mg/ml USP

315 I-315 MIDAZOLAM HCL Injection 5 mg/ml USP

316 I-316 NEOSTIGMINE METHYL SULPHATE

WITH GLYCOPYRROLATE Injection 0.5 mg/ml +0.1 mg/ml FDC

317 I-317 NEOSTIGMINE METHYL SULPHATE Injection 0.5 mg/ml IP

318 I-318 NORADRENALINE TARTRATE Injection 2 mg/ ml BP

319 I-319 PROPOFOL 1 PERCENT Injection 10 mg/ml IP

320 I-320 PROPOFOL 1 PERCENT Injection 10 mg/ml IP

321 I-321 ROPIVACAINE HYDROCHLORIDE Injection 7.5 mg/ml USP



324 I-324 DEXTRAN 40 WITH 5 PERCENT

DEXTROSE Injection 10% w/v IP

325 I-325 SUCCINYLCHOLINE CHLORIDE Injection 50 mg./ml. IP

326 I-326 SUCCINYLCHOLINE CHLORIDE Injection 50 mg./ml. IP

327 I-327 THIOPENTONE SODIUM Injection 1GM IP

328 I-328 THIOPENTONE SODIUM Injection 500 mg IP

329 I-329 VECURONIUM BROMIDE Injection 10 mg BP



122 | P a g e

S No.


Name Testing


(B)


331 I-331 BENZYL PENICILLIN INJECTION 10 LAC IU IP

332 I-332 CEFAZOLIN INJECTION 500mg IP

333 I-333 CEFAZOLIN INJECTION 1G IP

334 I-334 CLOXACILLIN INJECTION 250mg IP

335 I-335 AZITHROMYCIN INJECTION 500mg IP

336 I-336 CAPREOMYCIN INJECTION 1G IP

337 I-337 ACYCLOVIR INJECTION 250mg IP

338 I-338 ACYCLOVIR INJECTION 500mg IP

339 I-339 AMPHOTERICIN B INJECTION 50mg IP

340 I-340 CEFOPERAZONE WITH

TAZOBACTUM Inj 1gm+ 125mg

341 I-341 CEFOPERAZONE WITH

TAZOBACTUM Inj 500mg+ 62.5mg

342 I-342 ENOXAPARIN INJECTION 40mg/0.4ml IP

343 I-343 HEPARIN INJECTION 1000 IU/ml IP

344 I-344 MORPHINE INJECTION 10mg/ml IP

345 I-345 MORPHINE INJECTION 15mg/ml IP

346 I-346 PHENYTOIN INJECTION 25mg/ml IP

347 I-347 SODIUM VALPROATE INJECTION 100mg/ml IP

348 I-348 DULAGLUTIDE INJECTION 0.75mg

349 I-349 DULAGLUTIDE INJECTION 1.5mg

350 I-350 ARTESUNATE INJECTION 120mg IP

351 I-351 DIGOXIN INJECTION 0.25mg/ml IP

352 I-352 STREPTOKINASE Injection 750000 IU IP

353 I-353 ADENOSINE INJECTION 3mg/ml IP

354 I-354 HYDROCORTISONE INJECTION 200mg IP


123 | P a g e

S No.


Name Testing


(B)


355 I-355 METHYLTHIONINIUM

CHLORIDE(METHYLENE BLUE) INJECTION 10mg/ml IP

356 I-356 SODIUM NITRITE INJECTION 30mg/ml IP

357 I-357 SODIUM THIOSULPHATE INJECTION 100mg/ml IP

358 I-358 PEGYLATED INTERFERON ALFA 2A INJECTION 180mcg IP




362 I-362 HYDROXYCOBALAMINE INJECTION 1mg/ml IP

363 I-363 Vaccine H1N1 Influenza Inj Multi Dose Vial (10 dose Vial)

364 I-364 Vaccine H1N1 Influenza Inj Multi Dose Vial (10 dose Vial)

365 I-365 Vaccine Anti Rabies Inj 1ml

366 I-366 DEXTROSE INJECTION 0.5 IP

367 I-367 SODIUM CHLORIDE INJECTION 0.0045 IP

368 I-368 PHYTOMENADIONE INJECTION 10mg/ml IP

369 I-369 THIAMINE INJECTION 100mg/ml IP

370 I-370 BUPIVACAINE INJECTION 0.5% WITH 7.5% GLUCOSE IP

371 I-371 LIGNOCAINE HCL WITH

ADRENALINE Injection

LIGNOCAINE HCL 10mg/ml ADRENALINE BITARTATE Eq. TO

Adrenaline 5mcg/ml IP


124 | P a g e

6. PRICE SCHEDULE: FOR LIST OF SURGICAL ITEMS

S. No.

Code Name Size/Strength Specifications Basic rate of testing

(A)

Service Tax (B)


(A+B)

1 S-1 Suture Boilable thread 1 Length 25mtrs reel.

2 S-2 Suture Boilable thread 2 Length 25mtrs reel.

3 S-3 Plain Silk Suture 1 Length 25mtrs reel.

4 S-4 Plain Silk Suture 2 Length 25mtrs reel.

5 S-5 Suture Braided Silk 1 Length 25mtrs reel.

6 S-6 Suture Braided Silk 2 Length 25mtrs reel.

10 S-10 Suture Monofilament

Polyamide 6/0

Lenghth 30 CM double armed, Needle size 6 mm Black Needle, Micropoint Spatulated


Polyamide 8/0

Lenghth 30 CM double armed, Needle size

6 mm Black Needle, Micropoint Spatulated


Polyamide 8/0

LENGTH 38 CM NEDLE SIZE 6 MM Black Double Armed Spatulated Needle Curved,


Polyamide 9/0

LENGTH 38 CM NEDLE SIZE 6 MM Black DoubleArmed Spatulated Needle Curved,


Polyamide 10/0

LENGTH 38 CM NEDLE SIZE 6 MM Black Double Armed Spatulated Needle Curved,


Polyamide 8/0

LENGTH 38 CM NEDLE SIZE 6 MM Black Double Armed Spatulated Needle Curved

Micropoint


Polyamide 9/0


Micropoint


125 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


Polyamide 10/0


Micropoint


Polypropylene Suture prolene 1/0

Length 45 CM 1/2 CIRCLE TAPER CUTTING NEEDLE 16MM












































126 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)












Length 90 CM 3/8 CIRCLETAPER CUTTING NEEDLE 30MM
















42 S-42 Suture Coated (polyglycolic

acid)Polyglactin Braided Synthetic Absorbable Suture

2 Length 45 cm.size needles 40mm.

1/2circle Taper Cutting



1 Length 45 cm.size needles 30mm. 1/2

circle,Taper Cutting



1-0 Length 45 cm.size needles 20mm.




2-0 Length 45 cm.size needles 16mm. 1/2







127 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)





































56 S-56

Suture Coated (polyglycolic









128 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

































66 S-66 Suture Chromic Catgut Suture 2 Length 76cm needles 45 mm. 1/2 circle

taper point

67 S-67 Suture Chromic Catgut Suture 1 Length 76cm needles 40 mm. 1/2 circle

taper point

68 S-68 Suture Chromic Catgut Suture 1-0 Length 76cm. needles 30 mm. 1/2

circle taper point

69 S-69 Suture Chromic Catgut Suture 2-0 Length 76cm. needles 30 mm.

,1/2 circle taper point

70 S-70 Suture Chromic Catgut Suture 3-0 Length 76cm. needles 20

mm.1/2circle taper point


129 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

71 S-71 Suture Chromic Catgut Suture 2 Length 100cm. needles 45 mm.

1/2 circle taper point



73 S-73 Suture Chromic Catgut Suture 1-0 Length 100cm. sneedles 30 mm.



,1/2 circle taper point





77 S-77 Suture Chromic Catgut Suture 1 Length 152cm. needles 40mm.



1/2 taper point

79 S-79 Suture Chromic Catgut Suture 2-0 Length 152cm. needles 30mm.

,1/2 circle taper point,



81 S-81 Plain Catgut suture 2 76 cm 3/8 Circle Round Bodied Needle, 30

mm,

82 S-82 Plain Catgut suture 1 76 cm 3/8 Circle Round Bodied Needle, 30

mm,

83 S-83 Plain Catgut suture 1-0 76 cm 3/8 Circle Round Bodied Needle, 20

mm,

84 S-84 Plain Catgut suture 2-0 76 cm 3/8 Circle Round Bodied Needle, 20

mm,


130 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

85 S-85 Plain Silk Suture 2 Length 76cm. needles 40mm. 1/2circle

cutting

86 S-86 Plain Silk Suture 1 Length 76cm needle 30mm. 1/2circle

cutting

87 S-87 Plain Silk Suture 1-0 Length 76cm. needle 16mm. 1/2circle

cutting

88 S-88 Plain Silk Suture 2-0 Length 76cm. Needle 16mm. 1/2circle

cutting


cutting


cutting

91 S-91 Plain Silk Suture 2 Length 76cm. needle 40mm. 3/8circle

cutting

92 S-92 Plain Silk Suture 1 Length 76cm. needle 30mm. 3/8circle

cutting


cutting


cutting


cutting


cutting


cutting


cutting

99 S-99 Plain Silk Suture 1-0 Length 152cm needle 20mm. 3/8circle

cutting


cutting


cutting


131 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


cutting


cutting


cutting


cutting

106 S-106 Plain Silk Suture 2-0 Length 152cm needle 16mm 1/2circle

cutting


cutting


cutting

109 S-109 Suture Braided silk 2 Length 76cm. Needle 40mm. 3/8circle,

cutting

110 S-110 Suture Braided silk 1 Length 76cm. Needle 30mm. 3/8circle,

cutting

111 S-111 Suture Braided silk 1-0 Length 76cm. Needle 20mm. 3/8circle,

cutting


cutting


cutting


cutting

115 S-115 Suture Braided silk 2 Length 76cm. Needle 40mm. 1/2circle

cutting

116 S-116 Suture Braided silk 1 Length 76cm. Needle 30mm. 1/2circle

cutting

117 S-117 Suture Braided silk 1-0 Length 76cm. Needle 20mm. 1/2circle

cutting


cutting


132 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


cutting


cutting

121 S-121 Suture Braided Silk 2 Length 152cm needle 40mm. 3/8circle,

cutting

122 S-122 Suture Braided Silk 1 Length 152cm needle 30mm. 3/8circle,

cutting

123 S-123 Suture Braided Silk 1-0 Length 152cm needle 20mm. 3/8circle,

cutting


cutting


cutting


cutting

127 S-127 Suture Braided Silk 2 Length 152cm needle 40mm. 1/2circle

cutting

128 S-128 Suture Braided Silk 1 Length 152cm needle 30mm. 1/2circle

cutting

129 S-129 Suture Braided Silk 1-0 Length 152cm needle 20mm. 1/2circle

cutting


cutting


cutting


cutting

133 S-133 Nylon suture 1/0 100cm 3/8 circleCurved cutting needle

20mm


16mm


12mm


133 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


12mm


8mm


8mm

139 S-139 Adhesive Tape 10 Cm x 5 Mt.

140 S-140 Adhesive Tape 7.5 Cm x 5 Mt.



143 S-143

Non-Woven Viscose Rayon Porous backing tape with

Synthetic Copolymer Acrylate Hypoallergic Adhesive

7.5 cms 9.14 mtrs

144 S-144 Permeable Non Woven

Hypoallergic Adhesive Tape 7.5 Cm 5 Mt

145 S-145

Semi Permeable Transparent,, Polyurethane water proof post-operative

dressing with a non adherent absorbent pad and picture

frame delivery system.

7cm x 5 cm Box of 100

146 S-146

147 S-147




10cm x 10 cm Box of 20

148 S-148



10cm x 20cm Box of 10


134 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


149 S-149

Semi Permeable

Transparent,, Polyurethane water proof post-operative



10cm x 25 cm

150 S-150

151 S-151 Oxidized Regenerated

Cellulose In Sterile Foil Pack 5cmx 7.5cm Box of 10


Cellulose In Sterile Foil Pack 10cmX 20cm Box of 10


Cellulose In Sterile Foil Pack 5cmx 35cm Box of 10

154 S-154 Hernia Mesh 7.5cmX12.5cmt Box of 10

155 S-155 Hernia Mesh 10cmX15cm Box of 10

156 S-156 Hernia Mesh 15cmx15cm Box of 10

157 S-157 Plaster of Paris bandages 10 cmX 2.7 mtr Box of 10

158 S-158 Plaster of Paris bandages 15cmX 2.7 mtr. Box of 10

159 S-159 Foley' Catheter ( without

urobag) No. 12 As per latest BIS specifications










135 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)



165 S-165 Scalp Vein Set:. FG 20 SIZE

Conforming to following specifications: 1. The set should be made of special medical grade non toxic P.V.C. flexible transparent

material with a separate air-vent 2. It should be sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O.

irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray. 3. The pack should be

sealed at the both end one cm away from each end. The sealing thickness should be

2.5 to 3 mm4. The length of tube should be 30 cm5. The adopter ((Mouth) should be made of flexible P.V.C. and leak proof at the joint of the tubing & transparent &

flexible 6. The quality of tubing should be flexible non toxic medical grade. The I.V.

needle of scalp-vein should be sharp bevel, it should be mounded in a fashion to

provide easy holding while vein puncture, all the joints in the set should be leak-

proof. 7. The needle should be provided with a flexible cap to protect the bevel of needle8. The adopter should be provided

with well fitting closing device.As per latest BIS specifications


136 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

166 S-166 Scalp Vein Set:. FG 22 SIZE











167 S-167 Intra venous cannulaWith integrated three way stop

FG 14 45mm


137 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

cock


cock FG 16 45mm


cock FG 18 45mm


cock FG20 32mm


cock FG22 32mm


cock FG24 25mm


cock FG26 25mm

174 S-174 Intra venous cannulaWith

safety guard FG 14, 45mm


safety guard FG 16 45mm


safety guard FG 18 45mm


safety guard FG20 32mm








138 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

181 S-181 I.V. infusion set with Micro

Drip Appoximately 60

drop/ml

Micro I.V. infusion set for paediatric

use.Conforming to following specifications: 1. The set should be made of special

medical grade non toxic P.V.C. flexible transparent material with a separate air-

vent 2. It should be sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray. 3. The

pack should be sealed at the both end one cm away from each end. The sealing

thickness should be 2.5 to 3 mm4. The length of tube should be 30 cm5. The adopter ((Mouth) should be made of

flexible P.V.C. and leak proof at the joint of the tubing & transparent & flexible 6. The

quality of tubing should be flexible non toxic medical grade. The I.V. needle of

scalp-vein should be sharp bevel, it should be mounded in a fashion to provide easy

holding while vein puncture, all the joints in the set should be leak-proof. 7. The needle should be provided with a flexible cap to protect the bevel of needle8. The adopter

should be provided with well fitting closing device.As per latest BIS specifications


139 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

182 S-182 I.V. infusion set with Micro

Drip Appoximately 30

drop/ml

Micro I.V. infusion set for paediatric

use.Conforming to following specifications: 1. The set should be made of special

medical grade non toxic P.V.C. flexible transparent material with a separate air-

vent 2. It should be sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray. 3. The

pack should be sealed at the both end one cm away from each end. The sealing

thickness should be 2.5 to 3 mm4. The length of tube should be 30 cm5. The adopter ((Mouth) should be made of


quality of tubing should be flexible non toxic medical grade. The I.V. needle of

scalp-vein should be sharp bevel, it should be mounded in a fashion to provide easy

holding while vein puncture, all the joints in the set should be leak-proof. 7. The needle should be provided with a flexible cap to protect the bevel of needle8. The adopter

should be provided with well fitting closing device.As per latest BIS specifications


140 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

183 S-183 I.V. infusion set Appoximately 15

drop/ml



irradiated .As per latest BIS specifications


141 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

184 S-184 CVP Manometer SET











185 S-185 Double Lumen Polyurethane

Catheter Size - 11.5 FR 12 cm


142 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)




Catheter Size - 11.5 FR 20cm



189 S-189 Tracheostomy Tube (cuffed) FG 24 . Balloon with non return valve to facilitate

inflation and deflation of the cuff









194 S-194 Tracheostomy Tube (cuffed) FG34 . Balloon with non return valve to facilitate







143 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

197 S-197 Urine Drainage Catheters FG14

. Soft, Frosted and kink resistant PVC tubing.. Atraumatic, Soft, rounded, closed

tip with two lateral eyes for efficient draiage.. Color coded plain connector for

easy identification of size.















tip with two lateral eyes for efficient

draiage.. Color coded plain connector for easy identification of size.


144 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)





203 S-203 Closed Wound Suction Unit FG 12

. Suitable for close wound drainage under negative pressure post operatively with the

option to operate one or two catheters simultaneously.. Graduated Bellow

Chamber.. Size of Bellow Chamber : 600 & 800 ml.




Chamber.. Size of Bellow Chamber : 600 ml.






145 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

206 S-206 Thoracic Drainage Catheter

with Trocar . Size : 8 FG






. Catheter is provided with trocar for easy penetration, placement and handling..

Markings provided at 5, 10, 15 & 20 cm from the last eye to help ascertain depth of placement.. Two lateral eyes for efficient drainage. Proximal end fitted with tapered

connector for easy connection to the drainage bottle.







146 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)









Markings provided at 5, 10, 15 & 20 cm from the last eye to help ascertain depth of placement.. Two lateral eyes for efficient

drainage. Proximal end fitted with tapered connector for easy connection to the

drainage bottle.


with Trocar . Size 18 FG





147 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)











drainage bottle.







148 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)











drainage bottle.







149 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)











drainage bottle.







150 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)











drainage bottle.


151 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

223 S-223 Peritoneal Dialysis Set Adult Model.

. Suitable for performing peritoneal dialysis in patients of all age groups.. Perforated open-end catheter manufactured from polypropylene.. Stainless steel trocar is

provided to facilitate smooth penetration.. Scalpel blade is provided for the incision. The Trocar and the tip of the catheter are perfectly matched to facilitate trauma free insertion.. Latex flash bulb is provided on

the junction unit for additional medication.. Complete kit comes in tray pack in peelable

pouch.

224 S-224 Peritoneal Dialysis Set Child Model.

. Suitable for performing peritoneal dialysis in patients of all age groups.. Perforated open-end catheter manufactured from polypropylene.. Stainless steel trocar is

provided to facilitate smooth penetration.. Scalpel blade is provided for the incision. The Trocar and the tip of the catheter are perfectly matched to facilitate trauma free insertion.. Latex flash bulb is provided on

the junction unit for additional medication..

Complete kit comes in tray pack in peelable pouch.

225 S-225 Gauze Than : As per Schedule

F-II of Drugs & Cosmetics Rules, 1945

60 cm x18 mtr 3mm mesh


152 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

226 S-226 Gauze Than : As per Schedule

F-II of Drugs & Cosmetics Rules, 1945

45 cm x 18 mtr 3mm mesh

227 S-227 Rolled Bandage As per

Schedule F-II of Drugs & Cosmetics Rules, 1945

7.5 Cm x 5 Mt. 1mm mesh



10 Cm x 5 Mt. 1mm mesh



15 cm x 5 Mt. 1mm mesh

230 S-230 Bandage Than As per


100 cm x20 mtr 2mm mesh

231 S-231 Bandage Than As per


45 cm x 18 mtr 2mm mesh

232 S-232 Absobent Cotton I.P. Wool 500 gm. LAYERED COTTON PACK . EVERY LAYER MUST BE SEPERATED BY A THIN PAPER

SHEET


153 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

233 S-233 Insuline Syringe Fixed Needle 1 ml, 40 U

Each syringe should separately HDPE card board packing and be Gamma sterilized

E.T.O. the washer of the syringe should be

non toxic medical grade.Needle should be properly protected. The product and package should be designed as an

integrated unit. The package should be sealed with a good heat sealing machine so

that the seal with is not less than 2 to 3 mm the body of the packing material as

well as the seal should not contain pinholes.As per latest BIS specifications

234 S-234 Mucous extractor

235 S-235 tubal rings

236 S-236 IUCD 380A

237 S-237 IUCD 375

238 S-238 BONE CEMENT 40G powder with

sterile liquid

Powder containing poly methyl methacrylate copolymer(PMMA) with Benzoylperoxide(BPO) initiator and Zirconium Dioxide(ZrO2)Antibiotic

Gentamycine and liquid containing monomer Methyl methacrylate(MMA)

withNN-Dimethylpara Toluidine(DMPT) acceleratorand Hydroquinone Stabilizer.

239 S-239 SURGICAL BONE WAX 2.5G


154 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

240 S-240 DISPOSABLE NEEDLE FG 16 As per latest BIS specifications








248 S-248 INFANT FEEDING TUBE FG 5

Conforming to following specifications: 1. The tube should be made of special

medical grade non toxic P.V.C. flexible

transparent material with a radio opaqque marker line all along 2. It should be

sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray. 3. The pack should be sealed at the both

end one cm away from each end. The sealing thickness should be 2.5 to 3 mm4. The adopter ((Mouth) should be made of


adopter should be provided with well fitting

closing device


155 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)



medical grade non toxic P.V.C. flexible transparent material with a radio opaqque

marker line all along 2. It should be sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray. 3. The pack should be sealed at the both




closing device


156 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device


157 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device


158 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device


159 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device

254 S-254 DISPOSABLE SYRINGE

WITHOUT NEEDLE 10 ml


E.T.O. the washer of the syringe should be non toxic medical grade.The product and

package should be designed as an integrated unit. The package should be

sealed with a good heat sealing machine so that the seal with is not less than 2 to 3 mm the body of the packing material as

well as the seal should not contain pinholes.As per latest BIS specifications.


160 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


WITHOUT NEEDLE 2 ml







WITHOUT NEEDLE 3 ml







161 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


WITHOUT NEEDLE 20ml







WITHOUT NEEDLE 5 ml







162 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


WITHOUT NEEDLE 50 ml






260 S-260 INSULIN NEEDLE 26Gx4mm As per latest BIS specifications



263 S-263 INSULIN NEEDLE 32G x4mm As per latest BIS specifications


163 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

264 S-264 RYLES TUBE FG 10







closing device


164 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device


165 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

266 S-266 RYLES TUBE FG14







closing device


166 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device


167 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)



medical grade non toxic P.V.C. flexible

transparent material with a radio opaqque marker line all along 2. It should be

sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray. 3. The pack should be sealed at the both end one cm away from each end. 4. The

adopter ((Mouth) should be made of flexible P.V.C. and leak proof at the joint of the tubing & transparent & flexible 5. The

adopter should be provided with well fitting closing device


168 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)








closing device

270 S-270 SPINAL NEEDLE FG22 As per latest BIS specifications




274 S-274 UROBAG

275 S-275 FLATTUS TUBE FG 12





169 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

279 S-279 ENDOTRACHEAL TUBE

CUFFED 2.5mm


medical grade non toxic P.V.C. flexible transparent material with a radio opaqque marker line all along 2.Balloon with non

return valve to facilitate inflation and deflation of the cuff 3. It should be


end one cm away from each end.


CUFFED 3mm




sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad or 2.5 kg gray.

4. The pack should be sealed at the both end one cm away from each end.


170 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 3.5mm







CUFFED 4mm







171 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 4.5mm







CUFFED 5mm







172 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 5.5mm







CUFFED 6mm







173 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 6.5mm







CUFFED 7mm







174 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 7.5mm







CUFFED 8mm







175 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 8.5mm







CUFFED 9mm







176 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 9.5mm







CUFFED 10mm







177 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 10.5mm







CUFFED 11mm






297 S-297 HANDSCRUB 100ml Waterless Alchohal based Chlorhexidine Gluconate 0.5%w/v and Ethyl Aclohol IP

70%v/v


178 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

298 S-298 HANDSCRUB 500ml Waterless Alchohal based Chlorhexidine Gluconate 0.5%w/v and Ethyl Aclohol IP

70%v/v

299 S-299 HANDSCRUB 2.5lt

Waterless Alchohal based Propanol IP 75%w/W, Ethyl-hexadecy-dimethyl-

ammonium ethylsulphate 0-2%w/w with moisturisers and emollients.

300 S-300 HANDSCRUB 500ml

Waterless Alchohal based Propanol IP 75%w/W, Ethyl-hexadecy-dimethyl-

ammonium ethylsulphate 0-2%w/w with moisturisers and emollients.

301 S-301 STERILE PARAFFIN GAUZE 3x3 inch Box of 100

302 S-302 ELASTIC PLAST ADHESSIVE

TAPE 5cmX4/6Mt Stretched length 6mtr


TAPE 7.5cmX4/6Mt Stretched length 6mtr




TAPE 12.5cmX4/6Mt Stretched length 6mtr



307 S-307 ABSORBABLE GELATINE

FOAM 80mmX50mmx10mm


FOAM 80mmX50mmx7mm


FOAM 20mmx20mmx7mm


179 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

310 S-310 DISPOSABLE SYRINGE ALONG WITH NEEDLE

1 ml








10 ml


E.T.O. the washer of the syringe should be non toxic medical grade.Needle should be

properly protected. The product and package should be designed as an


that the seal with is not less than 2 to 3

mm the body of the packing material as well as the seal should not contain

pinholes.As per latest BIS specifications.


180 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


2 ml








3 ml





that the seal with is not less than 2 to 3

mm the body of the packing material as well as the seal should not contain

pinholes.As per latest BIS specifications.


181 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


20ml








5 ml






well as the seal should not contain pinholes.


182 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


50 ml








CUFFED 2.5mm








183 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 3mm








CUFFED 3.5mm

Conforming to following specifications: 1. The tube should be made of special medical grade non toxic rubber. with radioopaque marker line all along.

2..Balloon with non return valve to facilitate inflation and deflation of the cuff3. It

should be sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O.


sealed at the both end one cm away from each end.


184 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 4mm







CUFFED 4.5mm







185 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 5mm







CUFFED 5.5mm







186 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 6mm







CUFFED 6.5mm







187 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 7mm







CUFFED 7.5mm







188 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 8mm







CUFFED 8.5mm







189 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 9mm







CUFFED 9.5mm







190 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 10mm







CUFFED 10.5mm







191 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 11mm






335 S-335 ENDOTRACHEAL TUBE NON

CUFFED 2.5mm

Conforming to following specifications: 1. The tube should be made of special medical grade non toxic rubber. with

radioopaque marker line all along. 2. It should be sterilised in a polythene pack of 300 gauge thickness by Gamma, E.T.O.




192 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 3mm






CUFFED 3.5mm






193 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 4mm






CUFFED 4.5mm






194 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 5mm






CUFFED 5.5mm






195 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 6mm






CUFFED 6.5mm






196 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 7mm






CUFFED 7.5mm






197 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 8mm






CUFFED 8.5mm






198 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 9mm






CUFFED 9.5mm






199 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 10mm






CUFFED 10.5mm






200 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


CUFFED 11mm





353 S-353 INTRA OCULAR LENS POSTERIOR CHAMBER

12.5MM DIAMETER /5.5 mm OPTICS

POLYHYDROXYETHYLMETHACRYLATEWITH MODIFIED C LOOP POWER 15 D TO 28 D

WITH 0.5D INCREMENT


13MM DIAMETER/5.5mm

OPTICS

POLYHYDROXYETHYLMETHACRYLATE WITH MODIFIED C LOOP POWER 15 D TO

28 D WITH 0.5D INCREMENT






12.5MM DIAMETER /6 mm OPTICS


WITH 0.5D INCREMENT


13MM DIAMETER/6 mm OPTICS




201 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


13.5MM DIAMETER /6 mm OPTICS





POLYHYDROXYETHYLMETHACRYLATE

WITH MODIFIED C LOOP POWER 15 D TO 28 D WITH 0.5D INCREMENT


13MM DIAMETER /6.5 mm OPTICS








(FOLDABLE)

12.5mm DIAMETER/5.5 mm

OPTICS

HYDROPHILLIC ACRYLIC WITH INJECTOR UNIT WITH POWER 15D TO 28 D WITH

0.5D INCREMENT


(FOLDABLE)

13mm DIAMETER /5.5 mm OPTICS


0.5D INCREMENT


(FOLDABLE)


OPTICS


0.5D INCREMENT


(FOLDABLE)

12.5mm DIAMETER/6 mm

OPTICS


0.5D INCREMENT


202 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


(FOLDABLE)

13mm DIAMETER /6 mm OPTICS


0.5D INCREMENT

367 S-367

INTRA OCULAR LENS

POSTERIOR CHAMBER (FOLDABLE)

13.5mm

DIAMETER/6 mm OPTICS

HYDROPHILLIC ACRYLIC WITH INJECTOR

UNIT WITH POWER 15D TO 28 D WITH 0.5D INCREMENT


(FOLDABLE)


OPTICS


0.5D INCREMENT


(FOLDABLE)

13mm DIAMETER/6.5 mm

OPTICS


0.5D INCREMENT


(FOLDABLE)

13.5mm DIAMETER /6.5 mm OPTICS


0.5D INCREMENT

371 S-371 INTRA OCULAR LENS ANTERIOR CHAMBER

12.5MM DIAMETER/5.5 mm

OPTICS




13MM DIAMETER/5.5 mm

OPTICS




13.5MM DIAMETER/5.5 mm

OPTICS




203 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)


12.5MM DIAMETER/6 mm

OPTICS




13MM DIAMETER/6 mm OPTICS

POLYHYDROXYETHYLMETHACRYLATE

WITH MODIFIED C LOOP POWER 15 D TO 28 D WITH 0.5D INCREMENT


13.5MM DIAMETER/6 mm

OPTICS






WITH 0.5D INCREMENT


13MM DIAMETER/6.5 mm

OPTICS








204 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

380 S-380 Blood collection Bag :

1. 350 ml blood bag with 49 ml

PRA/CPDA-ICPDA-2 anti coagulant solution with

standard donor tubing .

1. 350 ml blood bag with 49 ml PRA/CPDA-ICPDA-2 anti coagulant solution

with standard donor tubing.2. It

should have non peel off label3. It should have stumper evident as integrated part.4. 16 G needle with ultra thin wall breakaway needle cover with bevel protector.5. Independent sterility

testing report from Govt. recognized laboratory for every batch .6. Tube

length should be about 100 cms with minimum 10 pilots marking on

tube.7. Tube with easily knot ability and sealing with die electric

sealer.8. Anti coagulant solutions should be as per IP/USP/BP

specifications.9. Solution should be sterile, HIV, Hepatitis B & C and Pyrogen

free.


205 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

381 S-381 Blood collection Bag : (i) 100 ml blood

collection bag also as per specification.


with standard donor tubing.2. It

should have non peel off label3. It should have stumper evident as integrated part.4. 16 G needle with ultra thin wall breakaway needle cover with bevel protector.5. Independent sterility






free.


206 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

382 S-382 Blood collection Bag : (ii) Double bag


with standard donor tubing.With one

satellite bag of 300ml 2. It should have non peel off label3. It should

have stumper evident as integrated part.4. 16 G needle with ultra thin wall breakaway needle cover with bevel protector.5. Independent sterility






free.


207 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

383 S-383 Blood collection Bag : (iii) Triple bag


with standard donor tubing.With two

satellite bags of 300ml 2. It should have non peel off label3. It should







free.


208 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

384 S-384 Blood collection Bag : Quadruple bag


with standard donor tubing.With three

satellite bags of 300ml 2. It should have non peel off label3. It should







free.


209 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

385 S-385 Blood collection Bag : Penta bag


with standard donor tubing,. With four

satellite bags of 300ml .2. It should have non peel off label3. It should







free.

386 S-386 A) Blood grouping sera : Anti

A,Anti B,Anti D 5 ml Pack

1. Should be monoclonal agglutinating sera2. Should be HIV and pygogen free3.

Anti A,Anti B,Acceptable 1:256Anti D Acceptable – 1:32

387 S-387 B) Blood grouping sera : Anti

A,Anti B,Anti D 10 ml Pack

1. Should be monoclonal agglutinating sera2. Should be HIV and pygogen free3.

Anti A,Anti B,Acceptable 1:256Anti D Acceptable – 1:32


210 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

388 S-388 C) HCV Elisa Test Kit: a) Should have CORE E1/E2 C-200 (NSB, NS 4a & 4 b) and NS-5b) Sensitivity-98%,

specificity -95%

389 S-389 G) HCV Rapid Test Kit

1- Time upto 30 minutes provisions shall be made for conducting single test at a time.2- Sensitivity-99.5%, specificity-

98%

390 S-390 D) HIV Elisa Test Kit a) Should have CORE E1/E2 C-200 (NSB, NS 4a & 4 b) and NS-5b) Sensitivity-98%,

specificity -95%

391 S-391 F) HIV Rapid Test Kit :


98%

392 S-392 E) HBs Ag Elisa Test Kit a) Should have CORE E1/E2 C-200 (NSB, NS 4a & 4 b) and NS-5b) Sensitivity-98%,

specificity -95%

393 S-393 H ) HBs Ag Rapid Test Kit


98%


211 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

394 S-394 BLOOD TRANSFUSION SET

Conforming to following specifications: 1.

The set should be made of special medical grade non toxic P.V.C. flexible transparent material with a separate air-vent and drop

chamber with a clot filter gauze 2. It should be sterilised in a polythene pack of 300

gauge thickness by Gamma, E.T.O. irradiation to a minimum dose of 2.5 mrad

or 2.5 kg gray. 3. The pack should be sealed at the both end one cm away from each end. The sealing thickness should be

2.5 to 3 mm4. The length of tube should be

30 cm5. The adopter ((Mouth) should be made of flexible P.V.C. and leak proof at the joint of the tubing & transparent &




proof. 7. The needle should be provided with a flexible cap to protect the bevel of

needle8. The adopter should be provided with well fitting closing device


212 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

395 S-395 Pre-injection Swabs Impregnated with 70% IsoPropyl Alchohol

and 2% CHLORHEXIDINE GLUCONATE

396 S-396 Pre-injection Swabs Impregnated with 70% IsoPropyl Alchohol

397 S-397 Elastic Crepe Bandage 7.5cmx4/6mt Stretched length 6mtr

398 S-398 Elastic Crepe Bandage 10cmx4/6mt Stretched length 6mtr

399 S-399 Elastic Crepe Bandage 15cmx4/6mt Stretched length 6mtr

400 S-400 Hydrofibre silver(1%ionic)

Dressing with carboxy methyl cellulose

5cmx5cm Box of 5



10cmx10cm Box of 5


Dressing with carboxy methyl

cellulose

15cmx15cm Box of 5



20cmx30cm Box of 5



5cmx20cm Box of 5

405 S-405 Adhessive Skin closure 6x100mm Sterile Adhesive strips of porous, non- woven rayon backing, reinforced with polyester filaments for skin closure.




213 | P a g e

S. No.


(A)

Service Tax (B)


(A+B)

408 S-408 Syphilis Rapid Test Card Rapid Plasma Reagin 18mm circle Cards

409 S-409 Syphilis Test Strip

410 S-410 Dengue NS -1 Ag +IgG Ab

Test Card

411 S-411 Dengue NS -1 Ag +IgM Ab

Test Card

412 S-412 Salmonella Typhi IgG Test

413 S-413 Salmonella Typhi IgM Test

414 S-414 Malaria Ag Pf/Pv

416 S-416 JEV IgM Rapid Test Card

417 S-417 Troponin I Rapid Test

418 S-418 Troponin T Rapid Test

419 S-419 Urine Analysis Strips pack of 50

420 S-420 Hemoglobin Rapid Test Kit

(One Time & Recording Replishment Cost)

421 S-421 Urine Testing Strips (for

Albumin & Sugar) pack of100


214 | P a g e

7. PRICE SCHEDULE: FOR LIST OF GENERAL ITEMS

S No.

Code Name Strength Quantity Presentation Specification Testing Charge

(A)

Service Tax (B)


(A+B)

1 G-1 Methylene Blue Solution 100 ml

2 G-2 Chlorhexidine Gluconate Solution Liquid 4% w/v 1 Litre

3 G-3 (a) Chlorhexidine Gluconate Solution +(b) Strong Cetrimide Solution Eq.to

Cetrimide Liquid

0.3% v/v + 0.6% w/v

1000 ml

4 G-4

Glutaraldehyde Solution (With Activator Vial)Mint Smell And Rust Inhibitor (Without Surfactant) (Use

Life 14 Days After Activation)

Liquid 2.4% w/v 5 Litre

5 G-5 Benzyl -C12-18 Alkyl Dimethyl

Ammonium chloides Dodecylbispropylene Triamine

Eacg 100ml Contains:

19.9g 5g

Aldehyde free cleaning

dsinfectant

6 G-6

1,6 Dihydroxy, 2-5 Dioxahexane

Glutaraldehyde Benzalkonium Chloride IP

Alkyl Urea Derivative

Liquid

Eacg 100ml Contains:

11.2g 5.0g 5.0g 3.0g

Surface and environmental

dsinfectant

7 G-7 Skin Prep Solution LIQUID 500ml

ISOPROPYL ALCOHAL 70 %

WITH 2% CHLORHEXIDINE

GLUCONATE

8 G-8 Skin Prep Solution LIQUID 1ltr

ISOPROPYL

ALCOHAL 70 % WITH 2%

CHLORHEXIDINE GLUCONATE

9 G-9 Bleaching Powder ISI MARK 25 kg Bag


215 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

10 G-10

8-Potassium Peroxymonosulphate (Triple Salt): 40%-50%, Sulphamidic Acid:1%-10%, Sodium Alkylbenzene Sulphonate: 10%-20% (EPA USA)

10 minute Aldehye free disinfectant

500 gm. Jar

11 G-11

9 - 10 Minute Sporicidal Sterliant Aldehyde Free (CE Approved) Powder

form Sodium Perborate Salt: 40%-60%

162 gm. Jar

12 G-12 Diamond marker Pencil

6" holder with artificial diamond (hard stone)

embedded at one end with screw cap to mark on

microscope glass slides

6 nos.

13 G-13 Grease marking pencil

Marking pencil MPS, Blue or red coloured, 8" length, to write on glass ware/metal

surfaces

8 nos.


216 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

14 G-14 Filter Paper

Filter paper No. 1,12.5 cms diameter for filtering carbol fuchsin using a small funnel

of 10cm maximum diameter, Smooth on one

side and rough on the other side, water permeable

120 packs

15 G-15 Lens paper

Soft microscope lens cleaning tissue, 4" x 6" booklet, each booklet containing 100 sheets

50 booklets

16 G-16 slides Glass microscope slides, 76mm x 26mm x 1.3mm,

plain, one pack of 50 slides. 144 packs

17 G-17 Test tubes Glass

autoclavable & heat resistant, standard rimless,

150 x 16mm with screw caps.

100

18 G-18 Loop Wire

Nichrome wire, 24 Standard Wire Gauge (SWG) or 0.022

inches or 0.559 mm thickness SWG

10 metres


217 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

19 G-19 Glass beads

Acid washed, 3mm diameter, round,

transparent, for dispersing the clumps of micro-

organisms by

500 gms.

20 G-20 Bijou bottles

Borosilicate or corning glass of 5 ml capacity with screw

caps of Aluminium with rubber liners suitable for Bijou bottles, leak proof

250

21 G-21 Spare Caps for Bijou bottles Screw caps of Aluminium with rubber liners suitable

for Bijou bottles 50

22 G-22 Sulphuric acid H2SO4, molecular wt.

98.08, Minimum Assay: 98%, colour: clear

500 ml


218 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

23 G-23 Basic Fuchsin

Chemical name :Pararosaniline

hydrochloride, chemical

structure: C20H20ClN3 mol wt:337.86'Dye content: Approx.85%-88%(dye

content must be mentioned), Colour: Metallic

green.

25gm

24 G-24 Carbolic acid( phenol)

Chemical name: Phenol, Chemical structure: C6H5OH, Molecular

wt:94.11, Melting point:40 °C + 2, Purity:99.5%

500 gm

25 G-25 Methylene blue

Chemical Name: Methylthionine chloride,

Chemical Structure: C16H18ClN3S, molecular Wt: 319.9, Dye content: approx.82% (should be

available on the container)

25 gm


219 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

26 G-26 Potassium Di chromate

Chemicals Formula:K2Cr207, Formula

Wt: 294.2, Minimum assay:99.5%

1 Kg

27 G-27 Malachite Green

Chemicals name:Malachite green Hydro Chloride,

Chemical structure:C23H25CIN2,

Molecular

150 gms

Wt.=364.9,

Colour: Green, Dye content:

80%+9% Solubility: both

in water & alcohol, Stability

:

28 G-28 Auramine C17H22ClN3, mol wt:

303.84 250 gms

29 G-29 Phenol

Chemical name: Phenol, Chemical structure:

C6H5OH, Molecular Wt: 94.11, Melting point:

40°C+2, purity: 99.5%

500gm

30 G-30 Hydrochloric Acid Concentrated Hydro Chloric Acid, Molecular Wt: 36.46

Specific Gravity 1.18 15 Ltrs

31 G-31 Potassium Permanganate KMnO4, Formula Wt:158 500 gms


220 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

32 G-32 Paraffin Liquid(Heavy Grade)

Refractive index of 1.48. It should be colourless,

odurless, transparent, free

from fluorescene in day light with relative density of 0.827 to 0.890, viscosity of 110 to 230 m Pa s., specific

gravity of 0.76-0.78 at 15.5°C

500 ml

33 G-33 N-acetyl L-Cysteine Chemical

structure:C5H9NO3S, mol wt: 163.2

25 gms

34 G-34 Sodium Citrate

Chemical name: Trisodium citrate dihydrate, AR

gradeChemical structure:Na3C6H5O7.2H,O, Molecular Wt (FW):294.10,

Purity: 99%

500 gms

35 G-35 Potassium phosphate

Potassium Di Hydrogen

ortho Phosphate KH2PO4, Molecular

Wt:=136.1Minimum assay=99%

1 Kg.

36 G-36 Magnesium Sulphate MgSO4.7H2O; mol wt 246.48; purity:99.5%

1Kg


221 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

37 G-37 Magnesium Citrate TriBasic C12H10Mg3O14.9H2O mol

wt: 613.28 500 gms

38 G-38 L- asparagine monohydrate L-Asparagine monohydrate ; C4H8N23.H2O mol wt:

150.14

1 Kg

39 G-39 Glycerol CH2OHCHOHCH2OH mol wt: 92.1; purity 99.5%

3 Ltrs

40 G-40 Sodium hydroxide pellets NaOH Formula Wt:40 Minimum Assay :98%

1 Kg

41 G-41 Cetyl Pyridinium chloride Cetyl Pyridinium Chloride;

Chemical structure: C21H38ClN.H2O / 358

500 gms

42 G-42 Sodium Chloride

Chemical name: sodium chloride chemical structure

:NaC1 Molecular Weight:58.44 Minimum

assay:99.9%

1 Kg

43 G-43 Dihydrostreptomycin sesquisulphate sigma D-

7253 5 gms

44 G-44 Isonicotinic acid hydarazide Sigma I -3377 5 gms

45 G-45 Rifampicin Sigma R-3501 5 gms

46 G-46 Ethambutol dihydrochloride Sigma E-4630 25 gms pack


222 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

47 G-47 PARA NITRO BENZOIC ACID Chemical NameFormula Wt:

167.12, Min assay =99% C6H4COOHNO2

100 gms pack

48 G-48 Cyanogen bromide CNBr- Cisco Research

Lab:mol wt:105.9 100 gms pack

49 G-49 O-Tolidine A.R Dimethyl benzidine C14H16N2 form wt: 212.3 50 gms powder pack

50 G-50 Hydrogen peroxide AR or GR grade, assay : 29-

32% solution, FW-34.01 1.5 Ltr

51 G-51 Polyoxyethylenesorbitanmoonooleate.

(Tween-80 ) AR or GR Grade,

Density=1.06-1.09g/ml 500 ml

52 G-52 Oxalic acid(pure) COOHCOOH.2H2; mol

wt:126.07 ; purity 99.8% 500 gms

53 G-53 Absolute alcohol Ethanol 1 Ltrs

54 G-54 Liquor ammonia LR/GR Grade 1 Ltr

55 G-55 Sodium carbonate Formula Na2CO3 Formula Wt: 106 Minimum asay

:99% 500 gms

56 G-56 N-N-dimethyl formamide HCON(CH3)2 mol wt: 73.09 500 ml


223 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

57 G-57 Formaldehyde

HCHO; mol wt: 30.03; wt per ml at 20oC=1.075-

1.095 g; methanol content=10-15%, Assay

(acidimetric) as HCHO 37-41%

2.5 Ltrs

58 G-58

9 - 10 Minute Sporicidal Sterliant Aldehyde Free (CertificateEuropia Approved) Powder form Sodium

Perborate Salt: 40%-60%

810 gm Jar

59 G-59 Disinfectant Fluid Class - Grade - I,

White 5 Litre pack

(RWC-18) Type Normal,

BIS Mark IS-1061

60 G-60 Disinfectant Fluid Class - Grade - II

White 5 Litre pack

(RWC-10), Type Normal,

BIS Mark IS-1061

61 G-61 Disinfectant Fluid Class - Grade -III

White 5 Litre pack

(RWC-5)Type

Normal,

BIS Mark IS-

1061

62 G-62 Disinfectant Fluid Class - Grade -

I,Black 5 Litre pack


BIS Mark IS-1061


Black 5 Litre pack

(RWC-10),, Type Normal,

BIS Mark IS-1061


Black 5 Litre pack

(RWC-5)Type Normal,

BIS Mark IS-1061

65 G-65 Disinfectant Fluid Class - Grade - I,

White 20 Litre pack


BIS Mark IS-1061


White 20 Litre pack


BIS Mark IS-1061


White 20 Litre pack


BIS Mark IS-1061

68 G-68 Disinfectant Fluid Class - Grade -

I,Black 20 Litre pack


BIS Mark IS-1061


Black 20 Litre pack

(RWC-10),, Type Normal,

BIS Mark IS-1061


224 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


Black 20 Litre pack


BIS Mark IS-1061

71 G-71 Malathion TC LIQUID 0.95 250KG conforming to BIS

no1832-1978

72 G-72 Pyrethrum X. LIQUID 0.02 25 LITRE C21H28O3conforming toBIS no 1051-1980

73 G-73 Temephos. EMULSIFIABLE CONCENTRATE

0.5 5 Litre conforming to BIS

no8498- 1977

74 G-74 Bacillus Thuringiensis Israelensis AQUOUS SOLUTION 100kg As per

NVBDCPSpecifications

75 G-75 Bacillus Thuringiensis Israelensis WETTEBLE POWDER 100kg As per


76 G-76 CYPHENOTHRIN EMULSIFIABLE CONCENTRATE

0.05 5L As per


77 G-77 DIFLUBENZURON WETTEBLE POWDER 0.25 500g As per


78 G-78 PYRIPROXYFEN GRANULES 0.005 20kg As per


79 G-79 Deltamethrin WETTEBLE POWDER 0.025

80 G-80 Varible Concentration Mask

. Suitable for oxygen therapy. Swivel

connector for patient comfort


225 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

81 G-81 Aerosol Therapy NEBULIZING KIT

Complete kit consists of :

Nebulizer Mask, Nebulizer Chamber and 210 cm Star

Lumen Tube.

STERILIZED PKD SINGLE PIECE

PACK

. Specially designed nebulizer chamber

with nebulization rate

of appoximately 3 cc in 10 minutes..

Average praticle size generation is

approximately 2 microns

82 G-82 HUB Cutter STERILIZED PKD SINGLE PIECE

PACK

83 G-83 Cord clamp STERILIZED PKD SINGLE PIECE

PACK

84 G-84 cord clamp with cutting facility STERILIZED PKD SINGLE PIECE

PACK


226 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

85 G-85 Xray plate 10x12 Inches PACKETS OF 100

Blue Double sided emulsion coated film

of polyethylene terephthalate(PET)

resin base 185 +/-20 microns thickness

density0 .10+/-0.01 as per BIS

specification no.IS 9644 corners round

cut with 50 GSM interleaving photo graphically inert

paper Yellow / white


227 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










228 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










229 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










230 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










231 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










232 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

91 G-91 Xray plate dental plates PACKETS OF 100






cut covered in plastic pack

92 G-92 Xray plate CT Scan Films 14x17 PACKETS OF 125






cut


233 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


Green Double sided emulsion coated film








234 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










235 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










236 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










237 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










238 | P a g e

S No.


(A)

Service Tax (B)


(A+B)










239 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

99 G-99 Xray plate dental plates PACKETS OF 100






cut covered in plastic pack

100 G-100 Xray plate CT Scan Films 14x17 PACKETS OF 125






cut


240 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

101 G-101 Xray plate Digital Camera

Films8x10 PACKETS OF 150






cut








cut


241 | P a g e

S No.


(A)

Service Tax (B)


(A+B)








cut

104 G-104 Rota haler device

105 G-105 SWINE FLU VIRAL TRANSPORT MEDIUM (HI VIRAL SWAB WITH

3%HI TRANSPORT MEDIUM

15x120mm polypropylene

centrifuge tube, 2ml fill of transport media, nylon

flocked NP swab on a thin flexible plastic shaft that is scored

for breaking, includes a zip lock bag,


242 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

106 G-106 N-95 MASK STERILIZED PKD SINGLE PIECE

PACK

N-95 Face Respirator

Mask: Filter efficiency of 95 % or more

against particulate aerosols. The mask should be provided

with expiration valve. It should be

disposable & to be able to fit for wide

range of face sizes. It should accompany

with certification from

NIOSH or any other internationally

accepted certification.

107 G-107 TRIPPLE LAYER MASK STERILIZED PKD SINGLE PIECE

PACK

Tie on Mask of Non-woven,

Hypoallergenic 3 ply construction with filter in between

offering >99 percent standard with 4 tie

strings.


243 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

108 G-108 PP KIT LOW WITH SEPARATE HOOD STERILIZED PKD SINGLE PIECE

PACK

Pandemic Flu Kit, LOW GOWN WITH

SEPARATE HOOD Including

Gloves, Mask, shoe cover

4 Oz. Sanitizing Lotion, Sanitizing

Wipes, Tissues And Plastic

Resealable Bag.

109 G-109 FACE MASK box of 100 sterlized single

pack Tie band with nasal

clip

110 G-110 SHOE COVER All sizes single pair sterile

pack

Perfect Fitting Smooth Texture Wear and tear

resistant dust proof and waterproof


244 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

111 G-111 STERILE SURGICAL GLOVES

POWDER FREE FG6

STERILIZED PKD SINGLE PAIR

PACK

a pair of 100% natural latex gloves natural/beige color with1. high strength and elasticity,fully

anatomical design to reduce hand fatigue textured surfacefor

excellent wet and dry grip easy to wear and

can prevent rolling back,softnss

providing superior comfort and natural fitness,2. elongaton

at break 550%-750% with tensile strength 14MPa-27MPa and

freedom from holes:AQL 1.5,3.

sterilized by Gamma ray or Ethylene Oxide


245 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


POWDER FREE FG6.5


PACK










246 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


POWDER FREE FG7


PACK










247 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


POWDER FREE FG 7.5


PACK










248 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


POWDER FREE FG8


PACK










249 | P a g e

S No.


(A)

Service Tax (B)


(A+B)


POWDER FREE FG8.5


PACK










250 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

117 G-117 INSULIN NANO PEN UNIT As per latest BIS

specifications

118 G-118 SURGICAL BLADE SS/CS No.11 STERILIZED PKD SINGLE PIECE

PACK


PACK


PACK


PACK


PACK


PACK

124 G-124 DISPOSABLE SURGICAL MASK box of 100 STERILIZED PKD SINGLE PIECE

PACK

Elasti Strip with nasal clip

125 G-125 DISPOSABLE SURGICAL CAP box of 100 STERILIZED PKD SINGLE PIECE

PACK Back Elastic Strip

126 G-126 MACINTOSH SHEET ROLL 100CM x 20M BIS Mark

127 G-127 ECG ROLL ROLL 50 cm x 20 Mtr

128 G-128 ECG ROLL ROLL 50 cm x 30 Mtr

129 G-129 USG ROLL ROLL 2-1/16"X250 ft

130 G-130 USG GEL TUBE 250ml


251 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

131 G-131 ECG GEL TUBE 250ml

132 G-132 STOCKINETTE ROLL 5cmX10Mt

133 G-133 STOCKINETTE ROLL 7.5cmX10Mt

134 G-134 STOCKINETTE ROLL 10cmX10Mt

135 G-135 STOCKINETTE ROLL 15cmX10mm

136 G-136 CAST PADDING ROLL 10cmX2.7mt

137 G-137 CAST PADDING ROLL 15cmx2.7mt

138 G-138 STEAM AUTOCLAVE LEAD FREE TAPE ROLL 3/4''X55mt

139 G-139 STEAM AUTOCLAVE LEAD FREE TAPE ROLL 1/2''X30mt

140 G-140 HCG Pregnancy Test Device single sterile

pack

141 G-141 Sputum container

Cups made of Special Medical

Grade Polypropylene,

thin plastic, translucent, Diameter -

4cm,Capacity - 30 ml, Srewable Cap should also

be made of Special Medical

Grade Polypropylene and should be air tight. Leak

proof.

300 nos.


252 | P a g e

S No.


(A)

Service Tax (B)


(A+B)

142 G-142 Absobent Cotton Wool IP 500 gm. PACKET ROLL in sealed

polypack

LAYERED COTTON PACK .

143 G-143 Steam Chemical Indicator

Moving front Chemical

integration, indicating Accept

or Reject, to verify all

parameters of steam

sterilization together i.e.

time, Temperature and Quality of steam. Can be

used for pack control

monitoring of all 118-138 °C

(245-280 °F) steam

Sterilization cycles


253 | P a g e

8. PRICE SCHEDULE: FOR LIST OF ORTHOPEDIC IMPLANTS

S. No.

Code Name Size/Strength Specifications Basic rate of testing (A)

Service Tax (B)


(A+B)

HUMERUS PLATE:-with hole size

1 OI 1 a Narrow Dynamic Compression plate

4.5mm 5 holes SINGLE PIECE PACK

2 OI 1 b Narrow Dynamic Compression plate


3 OI 1 c Narrow Dynamic Compression plate


4 OI 1 d4.5

Narrow Dynamic Compression plate 4.5mm

8 holes SINGLE PIECE PACK

5 OI 1 e4.5



6 OI 1 f4.5 Narrow Dynamic Compression plate


7 OI 1

g4.5

Narrow Dynamic Compression plate


8 OI 1 h4.5



17 OI 2 a Proximal humerus plate 3.5mm 3 holes SINGLE PIECE PACK

18 OI 2 b Proximal humerus plate 3.5mm 4 holes SINGLE PIECE PACK

19 OI 2c Proximal humerus plate 3.5mm 5 holes SINGLE PIECE PACK

20 OI 2 d Proximal humerus plate 3.5mm 6 holes SINGLE PIECE PACK

21 OI 2e Proximal humerus plate 3.5mm 7 holes SINGLE PIECE PACK

22 OI 2f Proximal humerus plate 3.5mm 8 holes SINGLE PIECE PACK

23 OI 3 a3.5L

Distal Medial Humerus plate 3.5mm left


25 OI 3 c3.5L



27 OI 3 e3.5L




254 | P a g e

S. No.


Service Tax (B)


(A+B)

29 OI 3 g3.5L



35 OI 3 a3.5R

Distal Medial Humerus plate 3.5mm right


37 OI 3 c3.5R

Distal Medial Humerus plate 3.5mm right


39 OI

3e3.5R Distal Medial Humerus plate 3.5mm

right 7 holes SINGLE PIECE PACK

41 OI 3

g3.5R Distal Medial Humerus plate 3.5mm


95 OI 4 a3.5L

Dorso lateral Humerus plate 3.5mm left


97 OI 4 c3.5L



99 OI 4 e3.5L



101 OI 4

g3.5L

Dorso lateral Humerus plate 3.5mm

left 9 holes SINGLE PIECE PACK

107 OI 4 a3.5R

Dorso lateral Humerus plate 3.5mm right


109 OI 4 c3.5R



111 OI 4 e3.5R



113 OI 4

g3.5R Dorso lateral Humerus plate 3.5mm


120 OI 5 bL Extra-articular distal Humerus plate

3.5 left 4 holes SINGLE PIECE PACK

122 OI 5 dL Extra-articular distal Humerus plate


124 OI 5 fL Extra-articular distal Humerus plate


126 OI 5 hL Extra-articular distal Humerus plate



255 | P a g e

S. No.


Service Tax (B)


(A+B)

128 OI 5 jL Extra-articular distal Humerus plate


132 OI 5 bR Extra-articular distal Humerus plate

3.5right 4 holes SINGLE PIECE PACK

134 OI 5 dR Extra-articular distal Humerus plate


136 OI 5 fR Extra-articular distal Humerus plate


138 OI 5 hR Extra-articular distal Humerus plate


140 OI 5 jR Extra-articular distal Humerus plate


143 OI 6 a Locking DCP Narrow plate

4.5mm/5.0mm locking screw 3 holes SINGLE PIECE PACK

144 OI 6 b Locking DCP Narrow plate


145 OI 6c Locking DCP Narrow plate


146 OI 6 d Locking DCP Narrow plate


147 OI 6 e Locking DCP Narrow plate


148 OI 6 f Locking DCP Narrow plate


149 OI 6 g Locking DCP Narrow plate


150 OI 6 h Locking DCP Narrow plate


151 OI 6 i Locking DCP Narrow plate


152 OI 6 l Locking DCP Narrow plate


153 OI 6k Locking DCP Narrow plate



256 | P a g e

S. No.


Service Tax (B)


(A+B)

154 OI 6 l Locking DCP Narrow plate


155 OI 6 m Locking DCP Narrow plate


156 OI 6 n Locking DCP Narrow plate


157 OI 6 o Locking DCP Narrow plate


158 OI 6 p Locking DCP Narrow plate


175 OI 14 aL T-PLATE OBLIQUE ANGLED LEFT

3.5MM 3X3 HOLES SINGLE PIECE PACK

176 OI 14 bL T-PLATE OBLIQUE ANGLED LEFT


177 OI 14 cL T-PLATE OBLIQUE ANGLED LEFT


178 OI 14 dL T-PLATE OBLIQUE ANGLED LEFT


179 OI 14 aR T-PLATE OBLIQUE ANGLED RIGHT


180 OI 14 bR T-PLATE OBLIQUE ANGLED RIGHT


181 OI 14 cR T-PLATE OBLIQUE ANGLED RIGHT


182 OI 14 dR T-PLATE OBLIQUE ANGLED RIGHT


183 OI 15 a T-PLATE RIGHT ANGLED 3.5MM 3X3 HOLES SINGLE PIECE PACK

184 OI 15 b T-PLATE RIGHT ANGLED 3.5MM 3X4 HOLES SINGLE PIECE PACK

185 OI 15 c T-PLATE RIGHT ANGLED 3.5MM 3X5 HOLES SINGLE PIECE PACK

186 OI 15 d T-PLATE RIGHT ANGLED 3.5MM 3X6 HOLES SINGLE PIECE PACK

187 OI 16 PROXIMAL ULNA HOOK PLATE

3.5MM 3 HOLES SINGLE PIECE PACK

OI 17 a SMALL T PLATE 3.5MM 3 Holes


257 | P a g e

S. No.


Service Tax (B)


(A+B)

OI 17b SMALL T PLATE 3.5MM 4 Holes

188 OI 17 c SMALL T PLATE 3.5MM 5 holes SINGLE PIECE PACK

189 OI 17d SMALL T PLATE 3.5MM 6 holes SINGLE PIECE PACK

190 OI 17 e SMALL T PLATE 3.5MM 7 holes SINGLE PIECE PACK

191 OI 17f SMALL T PLATE 3.5MM 8 holes SINGLE PIECE PACK

196 OI 18 a2.4L

DISTAL ANTERIOR RADIUS T-PLATE (OBLIQUE) 2.4MM LEFT

3X3 HOLES SINGLE PIECE PACK

197 OI 18 b2.4L



198 OI 18 c2.4L



199 OI 18 a2.4R

DISTAL ANTERIOR RADIUS T-PLATE (OBLIQUE) 2.4MM RIGHT


200 OI 18 b2.4R



201 OI 18 c2.4R



202 OI 18 a2.7L



203 OI 18 b2.7L



204 OI 18 c2.7L



205 OI 18 a2.7R



206 OI 18

b2.7R

DISTAL ANTERIOR RADIUS T-

PLATE (OBLIQUE) 2.7MM RIGHT 3X4 HOLES SINGLE PIECE PACK

207 OI 18 c2.7R



208 OI 19 a2.4L

DISTAL RADIUS PLATE LONG 2.4MM LEFT


209 OI 19 b2.4L




258 | P a g e

S. No.


Service Tax (B)


(A+B)

210 OI 19 c2.4L



211 OI 19 d2.4L



212 OI 19 e2.4L



213 OI 19 f2.4L



214 OI 19 g2.4L



215 OI 19 h2.4L



220 OI 19 a2.4R

DISTAL RADIUS PLATE LONG 2.4MM RIGHT


221 OI 19 b2.4R



222 OI 19

c2.4R

DISTAL RADIUS PLATE LONG

2.4MM RIGHT 7 holes SINGLE PIECE PACK

223 OI 19 d2.4R



224 OI 19 e2.4R



225 OI 19 f2.4R



226 OI 19 g2.4R



227 OI 19 h2.4R



232 OI 19 a3.5L



233 OI 19 b3.5L



234 OI 19 c3.5L




259 | P a g e

S. No.


Service Tax (B)


(A+B)

235 OI 19 d3.5L



236 OI 19 e3.5L



237 OI 19 f3.5L



244 OI 19 a3.5R



245 OI 19 b3.5R



246 OI 19 c3.5R



247 OI 19 d3.5R



248 OI 19 e3.5R



249 OI 19

f3.5R

DISTAL RADIUS PLATE LONG

3.5MM RIGHT 10 holes SINGLE PIECE PACK

250 OI 19 g3.5R



256 OI 20 a ONE THIRD TUBULAR PLATE 3.5

MM 3 holes SINGLE PIECE PACK

257 OI 20 b ONE THIRD TUBULAR PLATE 3.5


258 OI 20 c ONE THIRD TUBULAR PLATE 3.5


259 OI 20 d ONE THIRD TUBULAR PLATE 3.5


260 OI 20 e ONE THIRD TUBULAR PLATE 3.5


261 OI 20 f ONE THIRD TUBULAR PLATE 3.5


262 OI 20 g ONE THIRD TUBULAR PLATE 3.5



260 | P a g e

S. No.


Service Tax (B)


(A+B)

263 OI 20 h ONE THIRD TUBULAR PLATE 3.5


264 OI 20 i ONE THIRD TUBULAR PLATE 3.5


265 OI 20 j ONE THIRD TUBULAR PLATE 3.5


266 OI 20 k ONE THIRD TUBULAR PLATE 3.5


267 OI 20 l ONE THIRD TUBULAR PLATE 3.5


268 OI 21 a T-PLATE 3.5MM RIGHT ANGLED 3 holes SINGLE PIECE PACK

269 OI 21 b T-PLATE 3.5MM RIGHT ANGLED 4 holes SINGLE PIECE PACK

270 OI 21 c T-PLATE 3.5MM RIGHT ANGLED 5 holes SINGLE PIECE PACK

271 OI 21 d T-PLATE 3.5MM RIGHT ANGLED 6 holes SINGLE PIECE PACK

272 OI 21 e T-PLATE 3.5MM RIGHT ANGLED 7 holes SINGLE PIECE PACK

273 OI 21 f T-PLATE 3.5MM RIGHT ANGLED 8 holes SINGLE PIECE PACK

274 OI 22 a LOCKNIG DCP SMALL PLATE 3.5MM 4 holes SINGLE PIECE PACK

275 OI 22 b LOCKNIG DCP SMALL PLATE 3.5MM 5 holes SINGLE PIECE PACK

276 OI 22 c LOCKNIG DCP SMALL PLATE 3.5MM 6 holes SINGLE PIECE PACK

277 OI 22 d LOCKNIG DCP SMALL PLATE 3.5MM 7 holes SINGLE PIECE PACK

278 OI 22 e LOCKNIG DCP SMALL PLATE 3.5MM 8 holes SINGLE PIECE PACK

279 OI 22 f LOCKNIG DCP SMALL PLATE 3.5MM 9 holes SINGLE PIECE PACK

280 OI 22 g LOCKNIG DCP SMALL PLATE 3.5MM 10 holes SINGLE PIECE PACK

281 OI 22h LOCKNIG DCP SMALL PLATE 3.5MM 11 holes SINGLE PIECE PACK

282 OI 22 i LOCKNIG DCP SMALL PLATE 3.5MM 12 holes SINGLE PIECE PACK

283 OI 32 a One Third Tubular Plate 4.5mm 3 holes SINGLE PIECE PACK

284 OI 32 b One Third Tubular Plate 4.5mm 4 holes SINGLE PIECE PACK

285 OI 32 c One Third Tubular Plate 4.5mm 5 holes SINGLE PIECE PACK


261 | P a g e

S. No.


Service Tax (B)


(A+B)

286 OI 32 d One Third Tubular Plate 4.5mm 6 holes SINGLE PIECE PACK

287 OI 32 e One Third Tubular Plate 4.5mm 7 holes SINGLE PIECE PACK

288 OI 32 f One Third Tubular Plate 4.5mm 8 holes SINGLE PIECE PACK

289 OI 32 g One Third Tubular Plate 4.5mm 9 holes SINGLE PIECE PACK

290 OI 32 h One Third Tubular Plate 4.5mm 10 holes SINGLE PIECE PACK

291 OI 33 a D.C.P. SMALL NON LOCKING

3.5MM 5 holes SINGLE PIECE PACK

292 OI 33 b D.C.P. SMALL NON LOCKING


293 OI 33 c D.C.P. SMALL NON LOCKING


294 OI 33 d D.C.P. SMALL NON LOCKING


295 OI 33 e D.C.P. SMALL NON LOCKING


296 OI 33 f D.C.P. SMALL NON LOCKING


297 OI 34 a CLOVERLEAF PLATE 3.5MM 3 holes SINGLE PIECE PACK

298 OI 34 b CLOVERLEAF PLATE 3.5MM 4 holes SINGLE PIECE PACK

299 OI 34 c CLOVERLEAF PLATE 3.5MM 5 holes SINGLE PIECE PACK

300 OI 34 d CLOVERLEAF PLATE 3.5MM 6 holes SINGLE PIECE PACK

301 OI 34 e CLOVERLEAF PLATE 3.5MM 7 holes SINGLE PIECE PACK

302 OI 34 f CLOVERLEAF PLATE 3.5MM 8 holes SINGLE PIECE PACK

303 OI 35 a RECONSTRUCTION PLATE 3.5MM 5 holes SINGLE PIECE PACK

304 OI 35 b RECONSTRUCTION PLATE 3.5MM 6 holes SINGLE PIECE PACK

305 OI 35 c RECONSTRUCTION PLATE 3.5MM 7 holes SINGLE PIECE PACK

306 OI 35 d RECONSTRUCTION PLATE 3.5MM 8 holes SINGLE PIECE PACK




262 | P a g e

S. No.


Service Tax (B)


(A+B)







HAND/FOOT PLATES

307 OI 36 a2.0

T-PLATE 2.0MM 3 holes SINGLE PIECE PACK

308 OI 36 b2.0


309 OI 36 c2.0


310 OI 36 d2.0


311 OI 36 a3.5


312 OI 36 b3.5


313 OI 36 c3.5


314 OI 36 d3.5


315 OI 37 a T-PLATE OBLIQUE ANGLED 3.5MM 3 holes SINGLE PIECE PACK

316 OI 37b T-PLATE OBLIQUE ANGLED 3.5MM 4 holes SINGLE PIECE PACK

317 OI 37 c T-PLATE OBLIQUE ANGLED 3.5MM 5 holes SINGLE PIECE PACK

318 OI 37 d T-PLATE OBLIQUE ANGLED 3.5MM 6 holes SINGLE PIECE PACK

319 OI

38a2.7 L-PLATE 2.7MM 3 holes SINGLE PIECE PACK

320 OI

38b2.7 L-PLATE 2.7MM 4 holes SINGLE PIECE PACK


263 | P a g e

S. No.


Service Tax (B)


(A+B)

321 OI

38a3.5 L-PLATE 3.5MM 3 holes SINGLE PIECE PACK

322 OI

38b3.5 L-PLATE 3.5MM 4 holes SINGLE PIECE PACK

323 OI

38c3.5 L-PLATE 3.5MM 5 holes SINGLE PIECE PACK

324 OI

38d3.5 L-PLATE 3.5MM 6 holes SINGLE PIECE PACK

325 OI

38e3.5 L-PLATE 3.5MM 7 holes SINGLE PIECE PACK

326 OI

38f3.5 L-PLATE 3.5MM 8 holes SINGLE PIECE PACK

327 OI

38g3.5 L-PLATE 3.5MM 9 holes SINGLE PIECE PACK

328 OI

38h3.5 L-PLATE 3.5MM 10 holes SINGLE PIECE PACK

329 OI 39L L-PLATE 2.7MM LEFT SINGLE PIECE PACK

330 OI 39R L-PLATE 2.7MM RIGHT SINGLE PIECE PACK

331 OI 40 a MINI STRAIGHT PLATE 2.0 MM 3 holes SINGLE PIECE PACK

332 OI 40 b MINI STRAIGHT PLATE 2.0 MM 4 holes SINGLE PIECE PACK

333 OI 40 c MINI STRAIGHT PLATE 2.0 MM 5 holes SINGLE PIECE PACK

334 OI 40 d MINI STRAIGHT PLATE 2.0 MM 6 holes SINGLE PIECE PACK

335 OI 40 e MINI STRAIGHT PLATE 2.0 MM 7 holes SINGLE PIECE PACK

336 OI 40 f MINI STRAIGHT PLATE 2.0 MM 8 holes SINGLE PIECE PACK

337 OI 40 g MINI STRAIGHT PLATE 2.0 MM 9 holes SINGLE PIECE PACK

338 OI 40 h MINI STRAIGHT PLATE 2.0 MM 10 holes SINGLE PIECE PACK

339 OI 41 a DCP 2.7MM 3 holes SINGLE PIECE PACK

340 OI 41 b DCP 2.7MM 4 holes SINGLE PIECE PACK

341 OI 41 c DCP 2.7MM 5 holes SINGLE PIECE PACK

342 OI 41 d DCP 2.7MM 6 holes SINGLE PIECE PACK


264 | P a g e

S. No.


Service Tax (B)


(A+B)

343 OI 41 e DCP 2.7MM 7 holes SINGLE PIECE PACK

344 OI 41 f DCP 2.7MM 8 holes SINGLE PIECE PACK

345 OI 41 g DCP 2.7MM 9 holes SINGLE PIECE PACK

346 OI 41 h DCP 2.7MM 10 holes SINGLE PIECE PACK

347 OI 41 i DCP 2.7MM 11 holes SINGLE PIECE PACK

348 OI 41 j DCP 2.7MM 12 holes SINGLE PIECE PACK

349 OI 41 k DCP 2.7MM 13 holes SINGLE PIECE PACK

350 OI 41 l DCP 2.7MM 14 holes SINGLE PIECE PACK

FEMORAL PLATES SINGLE PIECE PACK

352 OI 42 bL4.5

PROXIMAL FEMUR Locking PLATE 4.5 LEFT/5.0MM Locking screw


354 OI 42 dL4.5



356 OI 42

fL4.5

PROXIMAL FEMUR Locking PLATE

4.5 LEFT/5.0MM Locking screw 8 holes SINGLE PIECE PACK

358 OI 42 hL4.5



360 OI 42 jL4.5



368 OI 42 bR4.5

PROXIMAL FEMUR LOCKING PLATE 4.5 RIGHT/5.0MM LOCKING SCREW


370 OI 42 aR4.5



372 OI 42 aR4.5



374 OI 42 aR4.5



376 OI 42 aR4.5



414 OI 42 pR5.0

PROXIMAL FEMUR PLATE 5.0 RIGHT

18 HOLES SINGLE PIECE PACK


265 | P a g e

S. No.


Service Tax (B)


(A+B)

416 OI 43 b4.5L

PROXIMAL FEMUR LOCKING HOOK PLATE 4.5 LEFT/5.0MM LOCKING

SCREW 4 holes SINGLE PIECE PACK

418 OI 43 d4.5L



420 OI 43 f4.5L



422 OI 43 h4.5L



424 OI 43 j4.5L



426 OI 43 l4.5L



432 OI 43 b4.5R

PROXIMAL FEMUR LOCKING HOOK PLATE 4.5RIGHT/5.0MM LOCKING


434 OI 43 d4.5R



436 OI 43 f4.5R



438 OI 43 h4.5R

PROXIMAL FEMUR LOCKING HOOK

PLATE 4.5RIGHT/5.0MM LOCKING SCREW


440 OI 43 j4.5R




266 | P a g e

S. No.


Service Tax (B)


(A+B)

442 OI 43 l4.5R



479 OI 44 a DHS BARREL PLATE 3 holes SINGLE PIECE PACK

480 OI 44 b DHS BARREL PLATE 4 holes SINGLE PIECE PACK

481 OI 44 c DHS BARREL PLATE 5 holes SINGLE PIECE PACK

482 OI 44 d DHS BARREL PLATE 6 holes SINGLE PIECE PACK

483 OI 44 e DHS BARREL PLATE 7 holes SINGLE PIECE PACK

484 OI 44 f DHS BARREL PLATE 8 holes SINGLE PIECE PACK

485 OI 44 g DHS BARREL PLATE 9 holes SINGLE PIECE PACK

486 OI 44 h DHS BARREL PLATE 10 holes SINGLE PIECE PACK

487 OI 44 i DHS BARREL PLATE 11 holes SINGLE PIECE PACK

488 OI 44 j DHS BARREL PLATE 12 holes SINGLE PIECE PACK

489 OI 44 k DHS BARREL PLATE 13 holes SINGLE PIECE PACK

490 OI 44 l DHS BARREL PLATE 14 holes SINGLE PIECE PACK

491 OI 44 m DHS BARREL PLATE 15 holes SINGLE PIECE PACK

492 OI 44 n DHS BARREL PLATE 16 HOLES SINGLE PIECE PACK

493 OI 44 o DHS BARREL PLATE 17 holes SINGLE PIECE PACK

494 OI 44 p DHS BARREL PLATE 18 HOLES SINGLE PIECE PACK

495 OI 45a DHS/DCS LAG SCREW 45MM SINGLE PIECE PACK

496 OI 45b DHS/DCS LAG SCREW 50 MM SINGLE PIECE PACK

497 OI 45c DHS/DCS LAG SCREW 55MM SINGLE PIECE PACK

498 OI 45d DHS/DCS LAG SCREW 60 MM SINGLE PIECE PACK

499 OI 45e DHS/DCS LAG SCREW 65MM SINGLE PIECE PACK

500 OI 45f DHS/DCS LAG SCREW 70MM SINGLE PIECE PACK

501 OI 45g DHS/DCS LAG SCREW 75MM SINGLE PIECE PACK

502 OI 45h DHS/DCS LAG SCREW 80MM SINGLE PIECE PACK


267 | P a g e

S. No.


Service Tax (B)


(A+B)

503 OI 45i DHS/DCS LAG SCREW 85MM SINGLE PIECE PACK

504 OI 45j DHS/DCS LAG SCREW 90MM SINGLE PIECE PACK

505 OI 45k DHS/DCS LAG SCREW 95MM SINGLE PIECE PACK

506 OI 45l DHS/DCS LAG SCREW 100MM SINGLE PIECE PACK

507 OI 45m DHS/DCS LAG SCREW 105MM SINGLE PIECE PACK

508 OI 45n DHS/DCS LAG SCREW 110MM SINGLE PIECE PACK

509 OI 45o DHS/DCS LAG SCREW 115MM SINGLE PIECE PACK

510 OI 45p DHS/DCS LAG SCREW 120MM SINGLE PIECE PACK

511 OI 46 aL CONDYLAR BUTTERESS PLATE

LEFT 5 holes SINGLE PIECE PACK

512 OI 46 bL CONDYLAR BUTTERESS PLATE


513 OI 46 cL CONDYLAR BUTTERESS PLATE


514 OI 46 dL CONDYLAR BUTTERESS PLATE


515 OI 46 eL CONDYLAR BUTTERESS PLATE


516 OI 46 fL CONDYLAR BUTTERESS PLATE


517 OI 46 gL CONDYLAR BUTTERESS PLATE


518 OI 46 hL CONDYLAR BUTTERESS PLATE


519 OI 46 iL CONDYLAR BUTTERESS PLATE


520 OI 46 jL CONDYLAR BUTTERESS PLATE


525 OI 46 aR CONDYLAR BUTTERESS PLATE

RIGHT 5 holes SINGLE PIECE PACK

526 OI 46 bR CONDYLAR BUTTERESS PLATE



268 | P a g e

S. No.


Service Tax (B)


(A+B)

527 OI 46 cR CONDYLAR BUTTERESS PLATE


528 OI 46 dR CONDYLAR BUTTERESS PLATE


529 OI 46 eR CONDYLAR BUTTERESS PLATE


530 OI 46 fR CONDYLAR BUTTERESS PLATE


531 OI 46 gR CONDYLAR BUTTERESS PLATE


532 OI 46 hR CONDYLAR BUTTERESS PLATE


533 OI 46 iR CONDYLAR BUTTERESS PLATE


534 OI 46 jR CONDYLAR BUTTERESS PLATE


539 OI 47 a DCS BARREL PLATE 95° WITH 'DC'

HOLES 5 holes SINGLE PIECE PACK

540 OI 47 b DCS BARREL PLATE 95° WITH 'DC'


541 OI 47 c DCS BARREL PLATE 95° WITH 'DC'


542 OI 47 d DCS BARREL PLATE 95° WITH 'DC'


543 OI 47 e DCS BARREL PLATE 95° WITH 'DC'


544 OI 47 f DCS BARREL PLATE 95° WITH 'DC'


545 OI 47 g DCS BARREL PLATE 95° WITH 'DC'


546 OI 47 h DCS BARREL PLATE 95° WITH 'DC'


547 OI 47 i DCS BARREL PLATE 95° WITH 'DC'



269 | P a g e

S. No.


Service Tax (B)


(A+B)

548 OI 47 j DCS BARREL PLATE 95° WITH 'DC'


549 OI 47 k DCS BARREL PLATE 95° WITH 'DC'


550 OI 47 l DCS BARREL PLATE 95° WITH 'DC'

HOLES 16 HOLES SINGLE PIECE PACK

551 OI 48 a4.5

LOCKING DCP BROAD LOCKING PLATE 4.5MM/5.0MM LOCKING


552 OI 48 b4.5



553 OI 48 c4.5



554 OI 48 d4.5


SCREW


555 OI 48 e4.5



556 OI 48 f4.5



557 OI 48 g4.5



558 OI 48 h4.5

LOCKING DCP BROAD LOCKING

PLATE 4.5MM/5.0MM LOCKING SCREW


559 OI 48 i4.5




270 | P a g e

S. No.


Service Tax (B)


(A+B)

560 OI 48 j4.5



561 OI 48 k4.5



562 OI 48 l4.5



563 OI 48 m4.5



564 OI 48 n4.5


SCREW 16 HOLES SINGLE PIECE PACK

565 OI 48 o4.5



566 OI 48 p4.5


SCREW 18 HOLES SINGLE PIECE PACK

583 OI 49 a4.5

BROAD PLATE CURVED 4.5MM 12 holes SINGLE PIECE PACK

584 OI 49 b4.5


585 OI 49 c4.5


586 OI 49 d4.5


587 OI 49 e4.5

BROAD PLATE CURVED 4.5MM 16 HOLES SINGLE PIECE PACK

588 OI 49 f4.5


589 OI 49 g4.5



271 | P a g e

S. No.


Service Tax (B)


(A+B)

590 OI 49 h4.5


591 OI 49 i4.5


592 OI 49 j4.5


593 OI 49 k4.5


594 OI 49 l4.5


607 OI 50 a DCP BROAD NON LOCKING PLATE


608 OI 50 b DCP BROAD NON LOCKING PLATE


609 OI 50 c DCP BROAD NON LOCKING PLATE


610 OI 50 d DCP BROAD NON LOCKING PLATE


611 OI 50 e DCP BROAD NON LOCKING PLATE


612 OI 50 f DCP BROAD NON LOCKING PLATE


613 OI 50 g DCP BROAD NON LOCKING PLATE


614 OI 50 h DCP BROAD NON LOCKING PLATE


615 OI 50 i DCP BROAD NON LOCKING PLATE


616 OI 50 j DCP BROAD NON LOCKING PLATE


617 OI 50 k DCP BROAD NON LOCKING PLATE


618 OI 50 l DCP BROAD NON LOCKING PLATE



272 | P a g e

S. No.


Service Tax (B)


(A+B)

619 OI 50 m DCP BROAD NON LOCKING PLATE


620 OI 50 n DCP BROAD NON LOCKING PLATE


621 OI 50 o DCP BROAD NON LOCKING PLATE


622 OI 50 p DCP BROAD NON LOCKING PLATE


623 OI 51 aL

4.5

DISTAL LATERAL FEMUR LOCKING PLATE 4.5MM LEFT/5.0MM

LOCKING SCREW 5 holes SINGLE PIECE PACK

625 OI 51 cL

4.5



627 OI 51 eL

4.5



629 OI 51 gL

4.5



631 OI 51 iL

4.5



632 OI 51 a4.5R

DISTAL LATERAL FEMUR LOCKING PLATE 4.5MM RIGHT/5.0MM


634 OI 51 c4.5R



636 OI 51 e4.5R



638 OI 51 g4.5R




273 | P a g e

S. No.


Service Tax (B)


(A+B)

640 OI 51 i4.5R



TIBIAL PLATES

659 OI 60 aL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


660 OI 60 bL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


661 OI 60 cL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


662 OI 60 dL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


663 OI 60 eL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


664 OI 60 fL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


665 OI 60 gL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


666 OI 60 hL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


667 OI 60 iL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


668 OI 60 jL PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 LEFT


671 OI 60 aR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


672 OI 60 bR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


673 OI 60 cR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


674 OI 60 dR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


675 OI 60 eR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT



274 | P a g e

S. No.


Service Tax (B)


(A+B)

676 OI 60 fR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


677 OI 60 gR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


678 OI 60 hR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


679 OI 60 iR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


680 OI 60 jR PROXIMAL LATERAL TIBIAL LOCKING PLATE 3.5 RIGHT


683 OI 61 a4.5L

PROXIMAL LATERAL TIBIAL NON LOCKING PLATE 4.5 LEFT


684 OI 61 b4.5L



685 OI 61 c4.5L



686 OI 61

d4.5L

PROXIMAL LATERAL TIBIAL NON

LOCKING PLATE 4.5 LEFT 8 holes SINGLE PIECE PACK

687 OI 61 e4.5L



688 OI 61 f4.5L



689 OI 61 g4.5L



690 OI 61 h4.5L



691 OI 61 i4.5L



692 OI 61 j4.5L



695 OI 61 a

4.5R PROXIMAL LATERAL TIBIAL NON

LOCKING PLATE 4.5 RIGHT 5 holes SINGLE PIECE PACK

696 OI 61 b




275 | P a g e

S. No.


Service Tax (B)


(A+B)

697 OI 61 c 4.5R

PROXIMAL LATERAL TIBIAL NON LOCKING PLATE 4.5 RIGHT


698 OI 61 d



699 OI 61 e



700 OI 61 f 4.5R



701 OI 61 g



702 OI 61 h



703 OI 61 I 4.5R



704 OI 61 j 4.5R



707 OI 61 a5.0L

PROXIMAL LATERAL TIBIAL LOCKING PLATE 4.5MM

LEFT/5.0MM LOCKING SCREW 5 holes SINGLE PIECE PACK

709 OI 61 c5.0L



711 OI 61 e5.0L



713 OI 61 g5.0L



715 OI 61 i5.0L



719 OI 61 a5.0R


RIGHT/5.0MM LOCKING SCREW 5 holes SINGLE PIECE PACK


276 | P a g e

S. No.


Service Tax (B)


(A+B)

721 OI 61 c5.0R



723 OI 61 e5.0R



725 OI 61 g5.0R



727 OI 61 i5.0R



731 OI 62 aL PROXIMAL LATERAL TIBIAL PLATE

T-SHAPED 3.5MM LEFT 4 holes SINGLE PIECE PACK

732 OI 62 bL PROXIMAL LATERAL TIBIAL PLATE


734 OI 62 dL PROXIMAL LATERAL TIBIAL PLATE


736 OI 62 fL PROXIMAL LATERAL TIBIAL PLATE


738 OI 62 hL PROXIMAL LATERAL TIBIAL PLATE


740 OI 62 jL PROXIMAL LATERAL TIBIAL PLATE


731 OI 62 aL PROXIMAL LATERAL TIBIAL PLATE

T-SHAPED 3.5MM RIGHT 4 holes SINGLE PIECE PACK

732 OI 62 bL PROXIMAL LATERAL TIBIAL PLATE


734 OI 62 dL PROXIMAL LATERAL TIBIAL PLATE


736 OI 62 fL PROXIMAL LATERAL TIBIAL PLATE


738 OI 62 hL PROXIMAL LATERAL TIBIAL PLATE



277 | P a g e

S. No.


Service Tax (B)


(A+B)

740 OI 62 jL PROXIMAL LATERAL TIBIAL PLATE


755 OI 63 a4.5L

PROXIMAL LATERAL TIBIAL NON LOCKING PLATE T-SHAPED 4.5MM


756 OI 63 b4.5L

PROXIMAL LATERAL TIBIAL NON

LOCKING PLATE T-SHAPED 4.5MM LEFT


757 OI 63 c4.5L



758 OI 63 d4.5L



759 OI 63 e4.5L



760 OI 63 f4.5L



761 OI 63 g4.5L



762 OI 63 h4.5L



763 OI 63 i4.5L



764 OI 63 j4.5L



765 OI 63 k4.5L




278 | P a g e

S. No.


Service Tax (B)


(A+B)

766 OI 63 l4.5L



769 OI 63 a4.5R



770 OI 63 b4.5R

PROXIMAL LATERAL TIBIAL PLATE T-SHAPED 4.5MM RIGHT


771 OI 63 c4.5R



772 OI 63 d4.5R



773 OI 63 e4.5R



774 OI 63 f4.5R



775 OI 63 g4.5R



776 OI 63 h4.5R



777 OI 63 i4.5R



778 OI 63 j4.5R



779 OI 63 k4.5R



780 OI 63 l4.5R



783 OI 63 a5.0L

PROXIMAL LATERAL TIBIAL PLATE T-SHAPED 4.5MM/ 5.0MM LOCKING

SCREW LEFT 3 holes SINGLE PIECE PACK

785 OI 63 c5.0L




279 | P a g e

S. No.


Service Tax (B)


(A+B)

787 OI 63 e5.0L



789 OI 63 g5.0L



791 OI 63 i5.0L



793 OI 63 k5.0L



797 OI 63 a5.0R


SCREW RIGHT 3 holes SINGLE PIECE PACK

799 OI 63 c5.0R



801 OI 63 e5.0R



803 OI 63 g5.0R



805 OI 63 i5.0R



807 OI 63 k5.0R

PROXIMAL LATERAL TIBIAL PLATE

T-SHAPED 4.5MM/ 5.0MM LOCKING SCREW RIGHT


811 OI 64 aL L-BUTTRESS PLATE 4.5LEFT 3 holes SINGLE PIECE PACK

812 OI 64 bL L-BUTTRESS PLATE 4.5LEFT 4 holes SINGLE PIECE PACK

813 OI 64 cL L-BUTTRESS PLATE 4.5LEFT 5 holes SINGLE PIECE PACK

814 OI 64 dL L-BUTTRESS PLATE 4.5LEFT 6 holes SINGLE PIECE PACK


280 | P a g e

S. No.


Service Tax (B)


(A+B)

815 OI 64 eL L-BUTTRESS PLATE 4.5LEFT 7 holes SINGLE PIECE PACK

816 OI 64 fL L-BUTTRESS PLATE 4.5LEFT 8 holes SINGLE PIECE PACK

817 OI 64 gL L-BUTTRESS PLATE 4.5LEFT 9 holes SINGLE PIECE PACK

818 OI 64 aR L-BUTTRESS PLATE 4.5RIGHT 3 holes SINGLE PIECE PACK

819 OI 64 bR L-BUTTRESS PLATE 4.5RIGHT 4 holes SINGLE PIECE PACK

820 OI 64 cR L-BUTTRESS PLATE 4.5RIGHT 5 holes SINGLE PIECE PACK

821 OI 64 dR L-BUTTRESS PLATE 4.5RIGHT 6 holes SINGLE PIECE PACK

822 OI 64 eR L-BUTTRESS PLATE 4.5RIGHT 7 holes SINGLE PIECE PACK

823 OI 64 fR L-BUTTRESS PLATE 4.5RIGHT 8 holes SINGLE PIECE PACK

824 OI 64 gR L-BUTTRESS PLATE 4.5RIGHT 9 holes SINGLE PIECE PACK

825 OI 65 aL L-BUTTRESS LOCKING PLATE 5.0


826 OI 65 bL L-BUTTRESS LOCKING PLATE 5.0


827 OI 65 cL L-BUTTRESS LOCKING PLATE 5.0


828 OI 65 dL L-BUTTRESS LOCKING PLATE 5.0


829 OI 65 eL L-BUTTRESS LOCKING PLATE 5.0


830 OI 65 fL L-BUTTRESS LOCKING PLATE 5.0


831 OI 65 gL L-BUTTRESS LOCKING PLATE 5.0


832 OI 65 hL L-BUTTRESS LOCKING PLATE 5.0

LEFT 10 HOLES SINGLE PIECE PACK

833 OI 65 aR L-BUTTRESS LOCKING PLATE 5.0


834 OI 65 bR L-BUTTRESS LOCKING PLATE 5.0



281 | P a g e

S. No.


Service Tax (B)


(A+B)

835 OI 65 cR L-BUTTRESS LOCKING PLATE 5.0


836 OI 65 dR L-BUTTRESS LOCKING PLATE 5.0


837 OI 65 eR L-BUTTRESS LOCKING PLATE 5.0


838 OI 65 fR L-BUTTRESS LOCKING PLATE 5.0


839 OI 65 gR L-BUTTRESS LOCKING PLATE 5.0


840 OI 65 hR L-BUTTRESS LOCKING PLATE 5.0

RIGHT 10 HOLES SINGLE PIECE PACK

841 OI 66 a T-BUTTRESS LOCKING PLATE 4.5 3 holes SINGLE PIECE PACK

842 OI 66 b T-BUTTRESS LOCKING PLATE 4.5 4 holes SINGLE PIECE PACK

843 OI 66 c T-BUTTRESS LOCKING PLATE 4.5 5 holes SINGLE PIECE PACK

844 OI 66 d T-BUTTRESS LOCKING PLATE 4.5 6 holes SINGLE PIECE PACK

845 OI 66 e T-BUTTRESS LOCKING PLATE 4.5 7 holes SINGLE PIECE PACK

846 OI 66 f T-BUTTRESS LOCKING PLATE 4.5 8 holes SINGLE PIECE PACK

847 OI 66 g T-BUTTRESS LOCKING PLATE 4.5 9 holes SINGLE PIECE PACK

848 OI 66 h T-BUTTRESS LOCKING PLATE 4.5 10 HOLES SINGLE PIECE PACK

849 OI 67 a T-BUTTRESS LOCKING PLATE 5.0 3 holes SINGLE PIECE PACK

850 OI 67 b T-BUTTRESS LOCKING PLATE 5.0 4 holes SINGLE PIECE PACK

851 OI 67 c T-BUTTRESS LOCKING PLATE 5.0 5 holes SINGLE PIECE PACK

852 OI 67 d T-BUTTRESS LOCKING PLATE 5.0 6 holes SINGLE PIECE PACK

853 OI 67 e T-BUTTRESS LOCKING PLATE 5.0 7 holes SINGLE PIECE PACK

854 OI 67 f T-BUTTRESS LOCKING PLATE 5.0 8 holes SINGLE PIECE PACK

855 OI 67 g T-BUTTRESS LOCKING PLATE 5.0 9 holes SINGLE PIECE PACK

856 OI 67 h T-BUTTRESS LOCKING PLATE 5.0 10 HOLES SINGLE PIECE PACK


282 | P a g e

S. No.


Service Tax (B)


(A+B)

857 OI 68 aL DISTAL MEDIAL TIBIA LOCKING

PLATE 3.5MM LEFT 3 holes SINGLE PIECE PACK

858 OI 68 bL DISTAL MEDIAL TIBIA LOCKING


859 OI 68 cL DISTAL MEDIAL TIBIA LOCKING


860 OI 68 dL DISTAL MEDIAL TIBIA LOCKING


861 OI 68 eL DISTAL MEDIAL TIBIA LOCKING


862 OI 68 fL DISTAL MEDIAL TIBIA LOCKING


863 OI 68 gL DISTAL MEDIAL TIBIA LOCKING


864 OI 68 hL DISTAL MEDIAL TIBIA LOCKING


865 OI 68 iL DISTAL MEDIAL TIBIA LOCKING


866 OI 68 jL DISTAL MEDIAL TIBIA LOCKING


869 OI 68 aR DISTAL MEDIAL TIBIA LOCKING

PLATE 3.5MM RIGHT 3 holes SINGLE PIECE PACK

870 OI 68 bR DISTAL MEDIAL TIBIA LOCKING


871 OI 68 cR DISTAL MEDIAL TIBIA LOCKING


872 OI 68 dR DISTAL MEDIAL TIBIA LOCKING


873 OI 68 eR DISTAL MEDIAL TIBIA LOCKING


874 OI 68 fR DISTAL MEDIAL TIBIA LOCKING


875 OI 68 gR DISTAL MEDIAL TIBIA LOCKING



283 | P a g e

S. No.


Service Tax (B)


(A+B)

876 OI 68 hR DISTAL MEDIAL TIBIA LOCKING


877 OI 68 iR DISTAL MEDIAL TIBIA LOCKING


878 OI 68 jR DISTAL MEDIAL TIBIA LOCKING


881 OI 69 a FIBULA METAPHYSIAL PLATE


882 OI 69 b FIBULA METAPHYSIAL PLATE


883 OI 69 c FIBULA METAPHYSIAL PLATE


884 OI 69 d FIBULA METAPHYSIAL PLATE


885 OI 69 e FIBULA METAPHYSIAL PLATE


886 OI 69 f FIBULA METAPHYSIAL PLATE


887 OI 69 g FIBULA METAPHYSIAL PLATE


888 OI 69 h FIBULA METAPHYSIAL PLATE


889 OI 69 i FIBULA METAPHYSIAL PLATE


890 OI 69 j FIBULA METAPHYSIAL PLATE


891 OI 69 k FIBULA METAPHYSIAL PLATE


892 OI 69 l FIBULA METAPHYSIAL PLATE


893 OI 69 m FIBULA METAPHYSIAL PLATE


894 OI 69 n FIBULA METAPHYSIAL PLATE



284 | P a g e

S. No.


Service Tax (B)


(A+B)

895 OI 69 o FIBULA METAPHYSIAL PLATE


896 OI 69 p FIBULA METAPHYSIAL PLATE


897 OI 70 a CLOVER LEAF PLATE 3.5MM 3 holes SINGLE PIECE PACK

898 OI 70 b CLOVER LEAF PLATE 3.5MM 4 holes SINGLE PIECE PACK

899 OI 70 c CLOVER LEAF PLATE 3.5MM 5 holes SINGLE PIECE PACK

900 OI 70 d CLOVER LEAF PLATE 3.5MM 6 holes SINGLE PIECE PACK

901 OI 70 e CLOVER LEAF PLATE 3.5MM 7 holes SINGLE PIECE PACK

902 OI 70 f CLOVER LEAF PLATE 3.5MM 8 holes SINGLE PIECE PACK

903 OI 70 g CLOVER LEAF PLATE 3.5MM 9 holes SINGLE PIECE PACK

904 OI 70 h CLOVER LEAF PLATE 3.5MM 10 holes SINGLE PIECE PACK

905 OI 71 a SEMI TUBULAR PLATE 4.5MM 5 holes SINGLE PIECE PACK

906 OI 71 b SEMI TUBULAR PLATE 4.5MM 6 holes SINGLE PIECE PACK

907 OI 71 c SEMI TUBULAR PLATE 4.5MM 7 holes SINGLE PIECE PACK

908 OI 71 d SEMI TUBULAR PLATE 4.5MM 8 holes SINGLE PIECE PACK

909 OI 71 e SEMI TUBULAR PLATE 4.5MM 9 holes SINGLE PIECE PACK

910 OI 71 f SEMI TUBULAR PLATE 4.5MM 10 holes SINGLE PIECE PACK

911 OI 71 g SEMI TUBULAR PLATE 4.5MM 11 holes SINGLE PIECE PACK

912 OI 71 h SEMI TUBULAR PLATE 4.5MM 12 holes SINGLE PIECE PACK

HIP & KNEE OSTEOTOMY PLATES

913 OI 73 aL

MEDIAL PROXIMAL TIBIAL HEAD

OSTEOTOMY PLATE 4.5 MM T-SHAPED LEFT


914 OI 73 aR MEDIAL PROXIMAL TIBIAL HEAD

OSTEOTOMY PLATE 4.5MM T-SHAPED RIGHT



285 | P a g e

S. No.


Service Tax (B)


(A+B)

915 OI 73 bL MEDIAL PROXIMAL TIBIAL HEAD OSTEOTOMY PLATE 5.0 MM T-

SHAPED LEFT 4 HOLES SINGLE PIECE PACK

916 OI 73 bR MEDIAL PROXIMAL TIBIAL HEAD OSTEOTOMY PLATE 5.0 MM T-

SHAPED RIGHT 4 HOLES SINGLE PIECE PACK

917 OI 74 aL DISTAL MEDIAL FEMUR

OSTEOTOMY PLATE 4.5 MM LEFT 4 HOLES SINGLE PIECE PACK

918 OI 74 aR DISTAL MEDIAL FEMUR

OSTEOTOMY PLATE 4.5MM RIGHT 4 HOLES SINGLE PIECE PACK

919 OI 74 bL DISTAL MEDIAL FEMUR


920 OI 74 bR DISTAL MEDIAL FEMUR

OSTEOTOMY PLATE 5.0 MM RIGHT 4 HOLES SINGLE PIECE PACK

921 OI 75 a3.5L

DISTAL LATERAL FEMUR OSTEOTOMY PLATE 3.5 MM LEFT


922 OI 75 a3.5R

DISTAL LATERAL FEMUR OSTEOTOMY PLATE 3.5 MM RIGHT


923 OI

75b4.5L DISTAL LATERAL FEMUR


924 OI 75 b4.5R



925 OI

75c5.0L DISTAL LATERAL FEMUR


926 OI 75 c5.0R



927 OI 76 aL PROXIMAL LATERAL TIBIAL


928 OI 76 aR PROXIMAL LATERAL TIBIAL



286 | P a g e

S. No.


Service Tax (B)


(A+B)

929 OI 76 bR PROXIMAL LATERAL TIBIAL


930 OI 76 bR PROXIMAL LATERAL TIBIAL


PELVIC PLATES

931 OI 77 a RECONSTRUCTION PLATE-

STRAIGHT 3.5MM 5 holes SINGLE PIECE PACK

932 OI 77 b RECONSTRUCTION PLATE-


933 OI 77 c RECONSTRUCTION PLATE-


934 OI 77 d RECONSTRUCTION PLATE-


935 OI 77 e RECONSTRUCTION PLATE-


936 OI 77 f RECONSTRUCTION PLATE-


937 OI 77 g RECONSTRUCTION PLATE-


938 OI 77 h RECONSTRUCTION PLATE-


939 OI 77 i RECONSTRUCTION PLATE-


940 OI 77 j RECONSTRUCTION PLATE-


941 OI 77 k RECONSTRUCTION PLATE-


942 OI 77 l RECONSTRUCTION PLATE-

STRAIGHT 3.5MM 16 HOLES SINGLE PIECE PACK

943 OI 77 m RECONSTRUCTION PLATE-


944 OI 77 n RECONSTRUCTION PLATE-



287 | P a g e

S. No.


Service Tax (B)


(A+B)

945 OI 77 o RECONSTRUCTION PLATE-


946 OI 77 p RECONSTRUCTION PLATE-


947 OI 78 a RECONSTRUCTION PLATE-


948 OI 78 b RECONSTRUCTION PLATE-


949 OI 78 c RECONSTRUCTION PLATE-


950 OI 78 d RECONSTRUCTION PLATE-


951 OI 78 e RECONSTRUCTION PLATE-


952 OI 78 f RECONSTRUCTION PLATE-


953 OI 78 g RECONSTRUCTION PLATE-


954 OI 78 h RECONSTRUCTION PLATE-


955 OI 78 i RECONSTRUCTION PLATE-


956 OI 78 j RECONSTRUCTION PLATE-


957 OI 78 k RECONSTRUCTION PLATE-


958 OI 78 l RECONSTRUCTION PLATE-


959 OI 78 m RECONSTRUCTION PLATE-


960 OI 78 n RECONSTRUCTION PLATE-


961 OI 78 o RECONSTRUCTION PLATE-



288 | P a g e

S. No.


Service Tax (B)


(A+B)

962 OI 78 p RECONSTRUCTION PLATE-


963 OI 79 a RECONSTRUCTION PLATE- CURVED


964 OI 79 b RECONSTRUCTION PLATE- CURVED


965 OI 79 c RECONSTRUCTION PLATE- CURVED


966 OI 79 d RECONSTRUCTION PLATE- CURVED


967 OI 79 e RECONSTRUCTION PLATE- CURVED


968 OI 79 f RECONSTRUCTION PLATE- CURVED


969 OI 79 g RECONSTRUCTION PLATE- CURVED


970 OI 79 h RECONSTRUCTION PLATE- CURVED


971 OI 79 i RECONSTRUCTION PLATE- CURVED


972 OI 79 j RECONSTRUCTION PLATE- CURVED


973 OI 79 k RECONSTRUCTION PLATE- CURVED


974 OI 79 l RECONSTRUCTION PLATE- CURVED


975 OI 79 m RECONSTRUCTION PLATE- CURVED


976 OI 79 n RECONSTRUCTION PLATE- CURVED


977 OI 80 a LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


978 OI 80 b LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM



289 | P a g e

S. No.


Service Tax (B)


(A+B)

979 OI 80 c LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


980 OI 80 d LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


981 OI 80 e LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


982 OI 80 f LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


983 OI 80 g LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


984 OI 80 h LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


985 OI 80 i LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


986 OI 80 j LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


987 OI 80 k LOCKNIG RECONSTRUCTION

PLATE- STRAIGHT 3.5 MM 15 holes SINGLE PIECE PACK

988 OI 80 l LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


989 OI 80 m LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


990 OI 80 n LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


991 OI 80 o LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


992 OI 80 p LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 3.5 MM


993 OI 81 a LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


994 OI 81 b LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


995 OI 81 c LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM



290 | P a g e

S. No.


Service Tax (B)


(A+B)

996 OI 81 d LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


997 OI 81 e LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


998 OI 81 f LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


999 OI 81 g LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1000 OI 81 h LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1001 OI 81 i LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1002 OI 81 j LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1003 OI 81 k LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1004 OI 81 l LOCKNIG RECONSTRUCTION

PLATE- STRAIGHT 4.5 MM 14 holes SINGLE PIECE PACK

1005 OI 81 m LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1006 OI 81 n LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1007 OI 81 o LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1008 OI 81 p LOCKNIG RECONSTRUCTION PLATE- STRAIGHT 4.5 MM


1009 OI 82 a LOCKNIG RECONSTRUCTION

PLATE- CURVED 3.5 MM 3 holes SINGLE PIECE PACK

1010 OI 82 b LOCKNIG RECONSTRUCTION


1011 OI 82 c LOCKNIG RECONSTRUCTION


1012 OI 82 d LOCKNIG RECONSTRUCTION



291 | P a g e

S. No.


Service Tax (B)


(A+B)

1013 OI 82 e LOCKNIG RECONSTRUCTION


1014 OI 82 f LOCKNIG RECONSTRUCTION


1015 OI 82 g LOCKNIG RECONSTRUCTION


1016 OI 82 h LOCKNIG RECONSTRUCTION


1017 OI 82 i LOCKNIG RECONSTRUCTION


1018 OI 82 j LOCKNIG RECONSTRUCTION


1019 OI 82 k LOCKNIG RECONSTRUCTION


1020 OI 82 l LOCKNIG RECONSTRUCTION


1021 OI 82 m LOCKNIG RECONSTRUCTION


1022 OI 82n LOCKNIG RECONSTRUCTION

PLATE- CURVED 3.5 MM 16 HOLES SINGLE PIECE PACK

1023 OI 82 o LOCKNIG RECONSTRUCTION


1024 OI 82 p LOCKNIG RECONSTRUCTION


1025 OI 96 a D.H.S. LOCKING Plate 135* 4, Holes SINGLE PIECE PACK

1026 OI 96 b D.H.S. LOCKING Plate 135* 5 Holes SINGLE PIECE PACK

1027 OI 96 c D.H.S. LOCKING Plate 135* 6 Holes SINGLE PIECE PACK

1028 OI 96 d D.H.S. LOCKING Plate 135* 7 Holes SINGLE PIECE PACK

1029 OI 96 e D.H.S. LOCKING Plate 135* 8 Holes SINGLE PIECE PACK

1030 OI 96 f D.H.S. LOCKING Plate 135* 9Holes SINGLE PIECE PACK

1031 OI 97 a D.C.S. LOCKING Plate 95* 5 Holes SINGLE PIECE PACK

1032 OI 97 b D.C.S. LOCKING Plate 95* 6 Holes SINGLE PIECE PACK


292 | P a g e

S. No.


Service Tax (B)


(A+B)

1033 OI 97 c D.C.S. LOCKING Plate 95* 7 Holes SINGLE PIECE PACK

1034 OI 97 d D.C.S. LOCKING Plate 95* 8 Holes SINGLE PIECE PACK

1035 OI 97 e D.C.S. LOCKING Plate 95* 9 Holes SINGLE PIECE PACK

1036 OI 97 f D.C.S. LOCKING Plate 95* 10 Holes SINGLE PIECE PACK

Locking compression Screws: SINGLE PIECE PACK

1038 OI 92 a Lag Screw with Compression screw 55mm SINGLE PIECE PACK

1039 OI 92 b Lag Screw with Compression screw 60mm SINGLE PIECE PACK

1040 OI 92 c Lag Screw with Compression screw 65mm SINGLE PIECE PACK

1041 OI 92 d Lag Screw with Compression screw 70mm SINGLE PIECE PACK

1042 OI 92 e Lag Screw with Compression screw 75mm SINGLE PIECE PACK

1043 OI 92 f Lag Screw with Compression screw 80mm SINGLE PIECE PACK

1044 OI 92 g Lag Screw with Compression screw 85mm SINGLE PIECE PACK

1045 OI 92 h Lag Screw with Compression screw 90mm SINGLE PIECE PACK

1046 OI 92 i Lag Screw with Compression screw 95mm SINGLE PIECE PACK

1047 OI 92 j Lag Screw with Compression screw 100mm SINGLE PIECE PACK

1048 OI 92 k Lag Screw with Compression screw 105mm SINGLE PIECE PACK

1049 OI 92 l Lag Screw with Compression screw 110mm SINGLE PIECE PACK

CANNULATED SCREWS 4MM AND

7MM SINGLE PIECE PACK

1050 OI 104 a Cannulated Screw 7mm 45mm SINGLE PIECE PACK

1051 OI 104 b Cannulated Screw 7mm 50m SINGLE PIECE PACK

1052 OI 104 c Cannulated Screw 7mm 55mm SINGLE PIECE PACK

1053 OI 104 d Cannulated Screw 7mm 60mm SINGLE PIECE PACK

1054 OI 104 e Cannulated Screw 7mm 65mm SINGLE PIECE PACK

1055 OI 104 f Cannulated Screw 7mm 70mm SINGLE PIECE PACK

1056 OI 104g Cannulated Screw 7mm 75mm SINGLE PIECE PACK


293 | P a g e

S. No.


Service Tax (B)


(A+B)

1057 OI 104 h Cannulated Screw 7mm 80mm SINGLE PIECE PACK

1058 OI 104 i Cannulated Screw 7mm 85mm SINGLE PIECE PACK

1059 OI 104 j Cannulated Screw 7mm 90mm SINGLE PIECE PACK

1060 OI 104 k Cannulated Screw 7mm 95mm SINGLE PIECE PACK

1061 OI 104 l Cannulated Screw 7mm 100mm SINGLE PIECE PACK

1062 OI 104

m Cannulated Screw 7mm 105mm SINGLE PIECE PACK

1063 OI 104 n Cannulated Screw 7mm 110mm SINGLE PIECE PACK

1064 OI 105 a Cannulated Screw 4mm 35mm SINGLE PIECE PACK

1065 OI 105 b Cannulated Screw 4mm 40mm SINGLE PIECE PACK

1066 OI 105 c Cannulated Screw 4mm 45mm SINGLE PIECE PACK

1067 OI 105 d Cannulated Screw 4mm 50mm SINGLE PIECE PACK

1068 OI 105 e Cannulated Screw 4mm 55mm SINGLE PIECE PACK

1069 OI 105 f Cannulated Screw 4mm 60mm SINGLE PIECE PACK

1070 OI 105 g Cannulated Screw 4mm 65mm SINGLE PIECE PACK

1071 OI 105 h Cannulated Screw 4mm 70mm SINGLE PIECE PACK

SMALL SCREW

3.5MM/4.0MM/4.5MM/6.5MM SINGLE PIECE PACK

1072 OI 106 a Cortex Screw 3.5mm 10 MM SINGLE PIECE PACK

1073 OI 106b Cortex Screw 3.5mm 12 MM SINGLE PIECE PACK

1074 OI 106 c Cortex Screw 3.5mm 14 MM SINGLE PIECE PACK

1075 OI 106 d Cortex Screw 3.5mm 16 MM SINGLE PIECE PACK

1076 OI 106 e Cortex Screw 3.5mm 18 MM SINGLE PIECE PACK

1077 OI 106 f Cortex Screw 3.5mm 20 MM SINGLE PIECE PACK

1078 OI 106 g Cortex Screw 3.5mm 22 MM SINGLE PIECE PACK

1079 OI 106 h Cortex Screw 3.5mm 24 MM SINGLE PIECE PACK

1079 OI 106 i Cortex Screw 3.5mm 26 MM SINGLE PIECE PACK


294 | P a g e

S. No.


Service Tax (B)


(A+B)

1079 OI 106 j Cortex Screw 3.5mm 28 MM SINGLE PIECE PACK

1079 OI 106 k Cortex Screw 3.5mm 30 MM SINGLE PIECE PACK

1079 OI 106 l Cortex Screw 3.5mm 32 MM SINGLE PIECE PACK

1079 OI 106

m Cortex Screw 3.5mm 34 MM SINGLE PIECE PACK

1079 OI 106 n Cortex Screw 3.5mm 36 MM SINGLE PIECE PACK

1079 OI 106 o Cortex Screw 3.5mm 38 MM SINGLE PIECE PACK

1079 OI 106 p Cortex Screw 3.5mm 40 MM SINGLE PIECE PACK

1079 OI 106 q Cortex Screw 3.5mm 42 MM SINGLE PIECE PACK

1079 OI 106 r Cortex Screw 3.5mm 44 MM SINGLE PIECE PACK

1079 OI 106 s Cortex Screw 3.5mm 46 MM SINGLE PIECE PACK

1079 OI 106 t Cortex Screw 3.5mm 48 MM SINGLE PIECE PACK

1079 OI 106 u Cortex Screw 3.5mm 50 MM SINGLE PIECE PACK

1080 OI 107 a Cortex Screw 4.5mm 20 mm SINGLE PIECE PACK

1081 OI 107 b Cortex Screw 4.5mm 22 mm SINGLE PIECE PACK

1082 OI 107c Cortex Screw 4.5mm 24 mm SINGLE PIECE PACK

1083 OI 107 d Cortex Screw 4.5mm 26 mm SINGLE PIECE PACK

1084 OI 107 e Cortex Screw 4.5mm 28 mm SINGLE PIECE PACK

1085 OI 107 f Cortex Screw 4.5mm 30 mm SINGLE PIECE PACK

1086 OI 107 g Cortex Screw 4.5mm 32 mm SINGLE PIECE PACK

1087 OI 107 h Cortex Screw 4.5mm 34 mm SINGLE PIECE PACK

1087 OI 107 i Cortex Screw 4.5mm 36 mm SINGLE PIECE PACK

1081 OI 107 j Cortex Screw 4.5mm 38 mm SINGLE PIECE PACK

1082 OI 107 k Cortex Screw 4.5mm 40 mm SINGLE PIECE PACK

1083 OI 107 l Cortex Screw 4.5mm 42 mm SINGLE PIECE PACK

1084 OI 107

m Cortex Screw 4.5mm 44mm SINGLE PIECE PACK


295 | P a g e

S. No.


Service Tax (B)


(A+B)

1085 OI 107 n Cortex Screw 4.5mm 46mm SINGLE PIECE PACK

1086 OI 107 o Cortex Screw 4.5mm 48mm SINGLE PIECE PACK

1087 OI 107 p Cortex Screw 4.5mm 50mm SINGLE PIECE PACK

1081 OI 107q Cortex Screw 4.5mm 52 mm SINGLE PIECE PACK

1082 OI 107 r Cortex Screw 4.5mm 54 mm SINGLE PIECE PACK

1083 OI 107 s Cortex Screw 4.5mm 56 mm SINGLE PIECE PACK

1084 OI 107 t Cortex Screw 4.5mm 58 mm SINGLE PIECE PACK

1085 OI 107 u Cortex Screw 4.5mm 60mm SINGLE PIECE PACK

1086 OI 107 v Cortex Screw 4.5mm 62 mm SINGLE PIECE PACK

1087 OI 107

w Cortex Screw 4.5mm 64 mm SINGLE PIECE PACK

1081 OI 107 x Cortex Screw 4.5mm 66 mm SINGLE PIECE PACK

1081 OI 107 y Cortex Screw 4.5mm 68 mm SINGLE PIECE PACK

1082 OI 107z Cortex Screw 4.5mm 70 mm SINGLE PIECE PACK

1088 OI 108 a CANCELLOUS SCREW 3.5 MM 15MM SINGLE PIECE PACK

1089 OI 108b CANCELLOUS SCREW 3.5 MM 20 MM SINGLE PIECE PACK

1090 OI 108 c CANCELLOUS SCREW 3.5 MM 25MM SINGLE PIECE PACK

1091 OI 108 d CANCELLOUS SCREW 3.5 MM 30 MM SINGLE PIECE PACK

1092 OI 108 e CANCELLOUS SCREW 3.5 MM 35 MM SINGLE PIECE PACK

1093 OI 108 f CANCELLOUS SCREW 3.5 MM 40 MM SINGLE PIECE PACK

1094 OI 108 g CANCELLOUS SCREW 3.5 MM 45MM SINGLE PIECE PACK

1095 OI 108 h CANCELLOUS SCREW 3.5 MM 50MM SINGLE PIECE PACK

1096 OI 109 a CANCELLOUS SCREW 4.0 MM (FULL

THREAD) 15MM SINGLE PIECE PACK

1097 OI 109 b CANCELLOUS SCREW 4.0 MM (FULL

THREAD) 20 MM SINGLE PIECE PACK

1098 OI 109 c CANCELLOUS SCREW 4.0 MM (FULL



296 | P a g e

S. No.


Service Tax (B)


(A+B)

1099 OI 109 d CANCELLOUS SCREW 4.0 MM (FULL


1100 OI 109 e CANCELLOUS SCREW 4.0 MM (FULL


1101 OI 109 f CANCELLOUS SCREW 4.0 MM (FULL


1102 OI 109g CANCELLOUS SCREW 4.0 MM (FULL


1103 OI 109 h CANCELLOUS SCREW 4.0 MM (FULL


1104 OI 109 i CANCELLOUS SCREW 4.0 MM (FULL


1105 OI 109 j CANCELLOUS SCREW 4.0 MM (FULL


1106 OI 110 a CANCELLOUS SCREW 4.0 MM

(SHORT THREAD) 15MM SINGLE PIECE PACK

1107 OI 110 b CANCELLOUS SCREW 4.0 MM

(SHORT THREAD) 20 MM SINGLE PIECE PACK

1108 OI 110 c CANCELLOUS SCREW 4.0 MM


1109 OI 110 d CANCELLOUS SCREW 4.0 MM


1110 OI 110 e CANCELLOUS SCREW 4.0 MM


1111 OI 110 f CANCELLOUS SCREW 4.0 MM


1112 OI 110 g CANCELLOUS SCREW 4.0 MM


1113 OI 110 h CANCELLOUS SCREW 4.0 MM


1114 OI 110 i CANCELLOUS SCREW 4.0 MM


1115 OI 110 j CANCELLOUS SCREW 4.0 MM



297 | P a g e

S. No.


Service Tax (B)


(A+B)

1116 OI 111 a CANCELLOUS SCREW 6.5MM

(16MM THREAD) 35 MM SINGLE PIECE PACK

1117 OI 111 b CANCELLOUS SCREW 6.5MM


1118 OI 111 c CANCELLOUS SCREW 6.5MM

(16MM THREAD) 45mm SINGLE PIECE PACK

1119 OI 111d CANCELLOUS SCREW 6.5MM

(16MM THREAD) 50m SINGLE PIECE PACK

1120 OI 111 e CANCELLOUS SCREW 6.5MM


1121 OI 111 f CANCELLOUS SCREW 6.5MM


1122 OI 111 g CANCELLOUS SCREW 6.5MM


1123 OI 111 h CANCELLOUS SCREW 6.5MM


1124 OI 111 i CANCELLOUS SCREW 6.5MM


1125 OI 111 j CANCELLOUS SCREW 6.5MM


1126 OI 111 k CANCELLOUS SCREW 6.5MM


1127 OI 111 l CANCELLOUS SCREW 6.5MM


1128 OI 111

m CANCELLOUS SCREW 6.5MM


1129 OI 111 n CANCELLOUS SCREW 6.5MM


1130 OI 111 o CANCELLOUS SCREW 6.5MM


1131 OI 111 p CANCELLOUS SCREW 6.5MM


1132 OI 112 a CANCELLOUS SCREW 6.5MM



298 | P a g e

S. No.


Service Tax (B)


(A+B)

1133 OI 112 b CANCELLOUS SCREW 6.5MM


1134 OI 112 c CANCELLOUS SCREW 6.5MM


1135 OI 112 d CANCELLOUS SCREW 6.5MM

(32MM THREAD) 50m SINGLE PIECE PACK

1136 OI 112 e CANCELLOUS SCREW 6.5MM


1137 OI 112 f CANCELLOUS SCREW 6.5MM


1138 OI 112 g CANCELLOUS SCREW 6.5MM


1139 OI 112 h CANCELLOUS SCREW 6.5MM


1140 OI 112 i CANCELLOUS SCREW 6.5MM


1141 OI 112 j CANCELLOUS SCREW 6.5MM


1142 OI 112 k CANCELLOUS SCREW 6.5MM


1143 OI 112 l CANCELLOUS SCREW 6.5MM


1144 OI 113 a CANCELLOUS SCREW 6.5MM (FULL


1145 OI 113 b CANCELLOUS SCREW 6.5MM (FULL


1146 OI 113 c CANCELLOUS SCREW 6.5MM (FULL


1147 OI 113 d CANCELLOUS SCREW 6.5MM (FULL


1148 OI 113 e CANCELLOUS SCREW 6.5MM (FULL

THREAD) 45mm SINGLE PIECE PACK

1149 OI 113 f CANCELLOUS SCREW 6.5MM (FULL

THREAD) 50m SINGLE PIECE PACK


299 | P a g e

S. No.


Service Tax (B)


(A+B)

1150 OI 113 g CANCELLOUS SCREW 6.5MM (FULL


1151 OI 113 h CANCELLOUS SCREW 6.5MM (FULL


1152 OI 113 i CANCELLOUS SCREW 6.5MM (FULL


1153 OI 113 j CANCELLOUS SCREW 6.5MM (FULL


1154 OI 114 WASHER LARGE SINGLE PIECE PACK

1155 OI 115 WASHER SMALL SINGLE PIECE PACK

1156 OI 116 a MALLEOLAR SCREWS 4.5MM 25 MM SINGLE PIECE PACK

1157 OI 116 b MALLEOLAR SCREWS 4.5MM 30 MM SINGLE PIECE PACK

1158 OI 116 c MALLEOLAR SCREWS 4.5MM 35 MM SINGLE PIECE PACK

1159 OI 116 d MALLEOLAR SCREWS 4.5MM 40 MM SINGLE PIECE PACK

1160 OI 116 e MALLEOLAR SCREWS 4.5MM 45mm SINGLE PIECE PACK

1161 OI 116 f MALLEOLAR SCREWS 4.5MM 50m SINGLE PIECE PACK

1162 OI 116 g MALLEOLAR SCREWS 4.5MM 55mm SINGLE PIECE PACK

1163 OI 116 h MALLEOLAR SCREWS 4.5MM 60mm SINGLE PIECE PACK

1164 OI 116 i MALLEOLAR SCREWS 4.5MM 65mm SINGLE PIECE PACK

1165 OI 116 j MALLEOLAR SCREWS 4.5MM 70mm SINGLE PIECE PACK

1166 OI 117 a U-STAPLES 1.5 MM DIA 12 MM

1167 OI 117 b U-STAPLES 2.0 MM DIA 18 MM

1168 OI 117 c U-STAPLES 2.5 MM DIA 24 MM

1169 OI 117 d U-STAPLES 3.0 MM DIA 36 MM

1170 OI 118 a COVANTARY STAPLES SMALL

1171 OI 118 b COVANTARY STAPLES MEDIUM

1172 OI 118 c COVANTARY STAPLES LARGE

Spinal SCREW & wire


300 | P a g e

S. No.


Service Tax (B)


(A+B)

1173 OI 119 a PEDICAL SCREW 42 MM

1174 OI 119 b PEDICAL SCREW 44 MM

1175 OI 119 c PEDICAL SCREW 46 MM

1176 OI 119 d PEDICAL SCREW 48 MM

1177 OI 119 e PEDICAL SCREW 50 MM

1178 OI 119 f PEDICAL SCREW 52 mm

1179 OI 119 g PEDICAL SCREW 54 MM

1180 OI 120 a HEART SHILL CAGE 20 MM

1181 OI 120 b HEART SHILL CAGE 30 MM

1182 OI 120 c HEART SHILL CAGE 40 MM

1183 OI 120 d HEART SHILL CAGE 50 MM

1184 OI 120 e HEART SHILL CAGE 60 MM

1185 OI 120 f HEART SHILL CAGE 70 MM

1186 OI 120 g HEART SHILL CAGE 80 MM

1187 OI 121 DOUBLE WIRE 1 MM TO 2 MM